Stem definition | Drug id | CAS RN |
---|---|---|
calcium channel blockers, nifedipine derivatives | 183 | 88150-42-9 |
Dose | Unit | Route |
---|---|---|
5 | mg | O |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 1 | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 10 % | Benet LZ, Broccatelli F, Oprea TI |
MRTD (Maximum Recommended Therapeutic Daily Dose) | 0.35 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
BA (Bioavailability) | 74 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Vd (Volume of distribution) | 17 L/kg | Lombardo F, Berellini G, Obach RS |
CL (Clearance) | 7 mL/min/kg | Lombardo F, Berellini G, Obach RS |
fu (Fraction unbound in plasma) | 0.01 % | Lombardo F, Berellini G, Obach RS |
t_half (Half-life) | 34 hours | Lombardo F, Berellini G, Obach RS |
Date | Agency | Company | Orphan |
---|---|---|---|
July 31, 1992 | FDA | PFIZER |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Pemphigus | 1110.72 | 10.01 | 37 | 441248 | 183689 | 62864048 |
Drug ineffective | 1041.65 | 10.01 | 3759 | 437526 | 1041006 | 62006731 |
Systemic lupus erythematosus | 902.32 | 10.01 | 178 | 441107 | 208740 | 62838997 |
Glossodynia | 877.78 | 10.01 | 106 | 441179 | 178770 | 62868967 |
Hand deformity | 871.68 | 10.01 | 61 | 441224 | 159396 | 62888341 |
Maternal exposure during pregnancy | 863.81 | 10.01 | 231 | 441054 | 219831 | 62827906 |
Completed suicide | 858.88 | 10.01 | 2591 | 438694 | 143082 | 62904655 |
Contraindicated product administered | 853.30 | 10.01 | 229 | 441056 | 217419 | 62830318 |
Hypotension | 798.06 | 10.01 | 3877 | 437408 | 268727 | 62779010 |
Anti-cyclic citrullinated peptide antibody positive | 758.99 | 10.01 | 9 | 441276 | 116203 | 62931534 |
Synovitis | 726.32 | 10.01 | 200 | 441085 | 186718 | 62861019 |
Pericarditis | 694.67 | 10.01 | 59 | 441226 | 131520 | 62916217 |
Treatment failure | 678.64 | 10.01 | 267 | 441018 | 198776 | 62848961 |
Drug intolerance | 657.04 | 10.01 | 706 | 440579 | 307955 | 62739782 |
Arthropathy | 653.13 | 10.01 | 413 | 440872 | 234379 | 62813358 |
Infusion related reaction | 616.84 | 10.01 | 482 | 440803 | 245039 | 62802698 |
Therapeutic product effect decreased | 600.42 | 10.01 | 296 | 440989 | 192891 | 62854846 |
Acute kidney injury | 584.44 | 10.01 | 3473 | 437812 | 259942 | 62787795 |
Wound | 583.40 | 10.01 | 203 | 441082 | 163060 | 62884677 |
Alopecia | 575.65 | 10.01 | 911 | 440374 | 336625 | 62711112 |
Duodenal ulcer perforation | 505.04 | 10.01 | 24 | 441261 | 87185 | 62960552 |
Off label use | 501.63 | 10.01 | 2702 | 438583 | 671760 | 62375977 |
Hyponatraemia | 500.34 | 10.01 | 1813 | 439472 | 110087 | 62937650 |
Discomfort | 463.07 | 10.01 | 296 | 440989 | 167078 | 62880659 |
Helicobacter infection | 462.38 | 10.01 | 52 | 441233 | 92733 | 62955004 |
Shock | 448.61 | 10.01 | 676 | 440609 | 22787 | 63024950 |
Blood pressure increased | 436.68 | 10.01 | 2253 | 439032 | 159809 | 62887928 |
Gingival hypertrophy | 424.12 | 10.01 | 215 | 441070 | 1456 | 63046281 |
Hepatic enzyme increased | 422.18 | 10.01 | 470 | 440815 | 201858 | 62845879 |
Folliculitis | 421.74 | 10.01 | 15 | 441270 | 70302 | 62977435 |
Fall | 420.84 | 10.01 | 4370 | 436915 | 387964 | 62659773 |
Blood pressure inadequately controlled | 413.23 | 10.01 | 314 | 440971 | 4664 | 63043073 |
Hypersensitivity | 396.93 | 10.01 | 906 | 440379 | 291779 | 62755958 |
Oedema peripheral | 381.62 | 10.01 | 2438 | 438847 | 187073 | 62860664 |
Exposure during pregnancy | 377.12 | 10.01 | 316 | 440969 | 155231 | 62892506 |
Rheumatoid factor positive | 376.78 | 10.01 | 66 | 441219 | 84340 | 62963397 |
Orthostatic hypotension | 364.12 | 10.01 | 788 | 440497 | 35372 | 63012365 |
Cerebrovascular accident | 359.15 | 10.01 | 1596 | 439689 | 106428 | 62941309 |
Bradycardia | 356.09 | 10.01 | 1220 | 440065 | 72007 | 62975730 |
Abdominal discomfort | 345.82 | 10.01 | 1112 | 440173 | 319773 | 62727964 |
Rheumatoid arthritis | 338.16 | 10.01 | 793 | 440492 | 253026 | 62794711 |
Muscle injury | 337.50 | 10.01 | 32 | 441253 | 65313 | 62982424 |
Product use issue | 335.58 | 10.01 | 639 | 440646 | 219881 | 62827856 |
Swelling | 332.32 | 10.01 | 905 | 440380 | 274473 | 62773264 |
Non-cardiogenic pulmonary oedema | 329.36 | 10.01 | 140 | 441145 | 591 | 63047146 |
Sleep disorder due to general medical condition, insomnia type | 324.56 | 10.01 | 8 | 441277 | 52209 | 62995528 |
Toxicity to various agents | 311.66 | 10.01 | 2850 | 438435 | 244400 | 62803337 |
Vasoplegia syndrome | 297.89 | 10.01 | 171 | 441114 | 1528 | 63046209 |
Renal impairment | 286.57 | 10.01 | 1296 | 439989 | 87059 | 62960678 |
C-reactive protein abnormal | 282.98 | 10.01 | 8 | 441277 | 46088 | 63001649 |
Impaired healing | 271.84 | 10.01 | 190 | 441095 | 102352 | 62945385 |
Irritable bowel syndrome | 270.21 | 10.01 | 117 | 441168 | 82295 | 62965442 |
Pain | 267.41 | 10.01 | 3588 | 437697 | 737040 | 62310697 |
Lactic acidosis | 266.98 | 10.01 | 724 | 440561 | 37563 | 63010174 |
Hyperkalaemia | 246.14 | 10.01 | 883 | 440402 | 53320 | 62994417 |
Intentional overdose | 242.93 | 10.01 | 1091 | 440194 | 73061 | 62974676 |
Lower respiratory tract infection | 232.84 | 10.01 | 349 | 440936 | 131958 | 62915779 |
Metabolic acidosis | 220.01 | 10.01 | 752 | 440533 | 44317 | 63003420 |
Infection | 219.24 | 10.01 | 835 | 440450 | 228338 | 62819399 |
Joint swelling | 214.14 | 10.01 | 1366 | 439919 | 326300 | 62721437 |
Dizziness | 210.43 | 10.01 | 4173 | 437112 | 425752 | 62621985 |
Depressed level of consciousness | 208.33 | 10.01 | 920 | 440365 | 61158 | 62986579 |
Creatinine renal clearance decreased | 207.83 | 10.01 | 392 | 440893 | 15916 | 63031821 |
Angioedema | 206.49 | 10.01 | 768 | 440517 | 47197 | 63000540 |
Ill-defined disorder | 200.63 | 10.01 | 164 | 441121 | 81591 | 62966146 |
Sinusitis | 197.21 | 10.01 | 857 | 440428 | 225796 | 62821941 |
Balance disorder | 196.32 | 10.01 | 1128 | 440157 | 83294 | 62964443 |
Therapeutic product effect incomplete | 195.72 | 10.01 | 356 | 440929 | 124700 | 62923037 |
Hypokalaemia | 193.84 | 10.01 | 1311 | 439974 | 102493 | 62945244 |
Arthralgia | 193.39 | 10.01 | 2793 | 438492 | 566917 | 62480820 |
Musculoskeletal stiffness | 187.50 | 10.01 | 656 | 440629 | 183962 | 62863775 |
Psoriatic arthropathy | 187.01 | 10.01 | 216 | 441069 | 91304 | 62956433 |
Fibromyalgia | 185.60 | 10.01 | 171 | 441114 | 80249 | 62967488 |
Distributive shock | 182.53 | 10.01 | 116 | 441169 | 1267 | 63046470 |
Cardiac failure congestive | 178.36 | 10.01 | 1177 | 440108 | 91256 | 62956481 |
Sedation complication | 175.83 | 10.01 | 332 | 440953 | 13490 | 63034247 |
Condition aggravated | 172.63 | 10.01 | 1875 | 439410 | 400342 | 62647395 |
Pregnancy | 168.36 | 10.01 | 27 | 441258 | 36809 | 63010928 |
Hypoglycaemia | 167.08 | 10.01 | 843 | 440442 | 59222 | 62988515 |
Abortion spontaneous | 162.82 | 10.01 | 62 | 441223 | 47133 | 63000604 |
Intentional product use issue | 160.36 | 10.01 | 412 | 440873 | 127480 | 62920257 |
Blood creatinine increased | 154.86 | 10.01 | 1094 | 440191 | 86750 | 62960987 |
Atrial fibrillation | 153.08 | 10.01 | 1357 | 439928 | 115279 | 62932458 |
Gastrointestinal disorder | 148.75 | 10.01 | 444 | 440841 | 130795 | 62916942 |
Hypertensive crisis | 148.04 | 10.01 | 328 | 440957 | 14958 | 63032779 |
Drug interaction | 147.50 | 10.01 | 2324 | 438961 | 226807 | 62820930 |
Rash | 146.97 | 10.01 | 2882 | 438403 | 557989 | 62489748 |
Myocardial infarction | 145.75 | 10.01 | 1190 | 440095 | 98703 | 62949034 |
Renal failure | 145.34 | 10.01 | 1351 | 439934 | 116301 | 62931436 |
Blister | 144.39 | 10.01 | 443 | 440842 | 129371 | 62918366 |
Stomatitis | 144.15 | 10.01 | 488 | 440797 | 138237 | 62909500 |
Device expulsion | 143.93 | 10.01 | 33 | 441252 | 34889 | 63012848 |
Hip arthroplasty | 141.91 | 10.01 | 77 | 441208 | 47569 | 63000168 |
Neurologic neglect syndrome | 133.78 | 10.01 | 127 | 441158 | 2594 | 63045143 |
Injection site reaction | 129.71 | 10.01 | 129 | 441156 | 58395 | 62989342 |
Blood calcium decreased | 129.64 | 10.01 | 442 | 440843 | 26009 | 63021728 |
Carotid artery thrombosis | 123.48 | 10.01 | 123 | 441162 | 2671 | 63045066 |
Dehydration | 123.40 | 10.01 | 1789 | 439496 | 171565 | 62876172 |
Syncope | 119.89 | 10.01 | 1296 | 439989 | 116089 | 62931648 |
Cognitive disorder | 119.57 | 10.01 | 730 | 440555 | 55085 | 62992652 |
Live birth | 118.91 | 10.01 | 18 | 441267 | 25612 | 63022125 |
Overdose | 118.67 | 10.01 | 1273 | 440012 | 113805 | 62933932 |
Decreased appetite | 117.57 | 10.01 | 2422 | 438863 | 248630 | 62799107 |
Asthenia | 116.63 | 10.01 | 3490 | 437795 | 380114 | 62667623 |
Swollen tongue | 114.65 | 10.01 | 513 | 440772 | 34287 | 63013450 |
Palpitations | 111.00 | 10.01 | 1236 | 440049 | 111534 | 62936203 |
Cerebral infarction | 110.80 | 10.01 | 392 | 440893 | 23501 | 63024236 |
Drug level increased | 106.28 | 10.01 | 374 | 440911 | 22362 | 63025375 |
Liver injury | 106.07 | 10.01 | 160 | 441125 | 60360 | 62987377 |
Rhabdomyolysis | 105.91 | 10.01 | 593 | 440692 | 43358 | 63004379 |
Anuria | 105.79 | 10.01 | 255 | 441030 | 12296 | 63035441 |
Product use in unapproved indication | 105.64 | 10.01 | 769 | 440516 | 178311 | 62869426 |
Hemiplegia | 105.29 | 10.01 | 213 | 441072 | 9110 | 63038627 |
Cardiac failure | 104.28 | 10.01 | 1012 | 440273 | 88130 | 62959607 |
Drug abuse | 104.26 | 10.01 | 217 | 441068 | 72301 | 62975436 |
Blood pressure decreased | 102.71 | 10.01 | 789 | 440496 | 64233 | 62983504 |
Schizoaffective disorder | 100.55 | 10.01 | 124 | 441161 | 3438 | 63044299 |
Coronary artery disease | 100.51 | 10.01 | 469 | 440816 | 31908 | 63015829 |
Type 2 diabetes mellitus | 99.72 | 10.01 | 182 | 441103 | 63686 | 62984051 |
Injection site erythema | 98.89 | 10.01 | 275 | 441010 | 82899 | 62964838 |
Knee arthroplasty | 98.23 | 10.01 | 140 | 441145 | 54066 | 62993671 |
Circulatory collapse | 96.69 | 10.01 | 354 | 440931 | 21584 | 63026153 |
Atrioventricular block complete | 96.16 | 10.01 | 191 | 441094 | 8060 | 63039677 |
Adjustment disorder | 95.19 | 10.01 | 114 | 441171 | 3064 | 63044673 |
Angina pectoris | 94.33 | 10.01 | 437 | 440848 | 29641 | 63018096 |
Chronic kidney disease | 93.62 | 10.01 | 588 | 440697 | 44810 | 63002927 |
Sprue-like enteropathy | 92.32 | 10.01 | 60 | 441225 | 683 | 63047054 |
Sinus bradycardia | 89.51 | 10.01 | 263 | 441022 | 14288 | 63033449 |
Injury | 89.46 | 10.01 | 239 | 441046 | 73008 | 62974729 |
Sedation | 88.51 | 10.01 | 516 | 440769 | 38293 | 63009444 |
Acute myocardial infarction | 88.01 | 10.01 | 449 | 440836 | 31675 | 63016062 |
Product prescribing error | 87.70 | 10.01 | 389 | 440896 | 25900 | 63021837 |
Pulmonary oedema | 87.31 | 10.01 | 667 | 440618 | 54206 | 62993531 |
Pyrexia | 86.94 | 10.01 | 2548 | 438737 | 467930 | 62579807 |
Dysarthria | 86.71 | 10.01 | 551 | 440734 | 42160 | 63005577 |
Dyspnoea | 86.43 | 10.01 | 5511 | 435774 | 655802 | 62391935 |
Blood urea increased | 85.50 | 10.01 | 387 | 440898 | 25992 | 63021745 |
Hypertensive emergency | 85.30 | 10.01 | 84 | 441201 | 1798 | 63045939 |
Hypomagnesaemia | 83.92 | 10.01 | 409 | 440876 | 28328 | 63019409 |
Blood cholesterol increased | 82.62 | 10.01 | 354 | 440931 | 93678 | 62954059 |
Prescribed overdose | 80.72 | 10.01 | 71 | 441214 | 34082 | 63013655 |
Personality disorder | 79.46 | 10.01 | 144 | 441141 | 5667 | 63042070 |
Renin increased | 77.08 | 10.01 | 34 | 441251 | 160 | 63047577 |
Proteinuria | 76.98 | 10.01 | 300 | 440985 | 18845 | 63028892 |
Injection site pain | 76.22 | 10.01 | 558 | 440727 | 129242 | 62918495 |
Subacute cutaneous lupus erythematosus | 76.21 | 10.01 | 93 | 441192 | 2550 | 63045187 |
Cardiogenic shock | 75.38 | 10.01 | 285 | 441000 | 17647 | 63030090 |
Constipation | 74.40 | 10.01 | 2069 | 439216 | 222874 | 62824863 |
Anaemia | 73.12 | 10.01 | 2608 | 438677 | 290822 | 62756915 |
Transient ischaemic attack | 72.94 | 10.01 | 481 | 440804 | 37272 | 63010465 |
Suspected suicide | 72.92 | 10.01 | 149 | 441136 | 6419 | 63041318 |
Blood pressure systolic increased | 72.56 | 10.01 | 571 | 440714 | 46826 | 63000911 |
Atrioventricular block first degree | 71.49 | 10.01 | 157 | 441128 | 7116 | 63040621 |
Migraine | 70.89 | 10.01 | 424 | 440861 | 102922 | 62944815 |
Hyperglycaemia | 70.04 | 10.01 | 515 | 440770 | 41352 | 63006385 |
Intentional self-injury | 68.83 | 10.01 | 47 | 441238 | 25640 | 63022097 |
Facet joint syndrome | 68.18 | 10.01 | 4 | 441281 | 12134 | 63035603 |
Foetal exposure during pregnancy | 67.94 | 10.01 | 73 | 441212 | 31889 | 63015848 |
Hepatic function abnormal | 66.84 | 10.01 | 465 | 440820 | 36677 | 63011060 |
Deep vein thrombosis postoperative | 66.21 | 10.01 | 3 | 441282 | 11366 | 63036371 |
Atrioventricular block | 66.21 | 10.01 | 157 | 441128 | 7490 | 63040247 |
Oliguria | 65.33 | 10.01 | 174 | 441111 | 8927 | 63038810 |
Left ventricular hypertrophy | 64.32 | 10.01 | 125 | 441160 | 5190 | 63042547 |
Blood glucose increased | 63.81 | 10.01 | 875 | 440410 | 82881 | 62964856 |
Diabetes mellitus inadequate control | 62.43 | 10.01 | 239 | 441046 | 14887 | 63032850 |
Grip strength decreased | 60.76 | 10.01 | 40 | 441245 | 22247 | 63025490 |
Hypertension | 60.62 | 10.01 | 2445 | 438840 | 276858 | 62770879 |
Nasopharyngitis | 58.85 | 10.01 | 1332 | 439953 | 252925 | 62794812 |
Lung diffusion test abnormal | 58.74 | 10.01 | 34 | 441251 | 309 | 63047428 |
Bursitis | 58.31 | 10.01 | 105 | 441180 | 36936 | 63010801 |
Loss of consciousness | 57.99 | 10.01 | 1148 | 440137 | 116973 | 62930764 |
Melaena | 57.52 | 10.01 | 385 | 440900 | 29980 | 63017757 |
Altered state of consciousness | 56.58 | 10.01 | 334 | 440951 | 24896 | 63022841 |
Eating disorder | 56.50 | 10.01 | 272 | 441013 | 18744 | 63028993 |
Renal artery stenosis | 56.39 | 10.01 | 68 | 441217 | 1841 | 63045896 |
Weight increased | 55.71 | 10.01 | 1383 | 439902 | 259409 | 62788328 |
Blood potassium decreased | 55.62 | 10.01 | 490 | 440795 | 41536 | 63006201 |
Hepatotoxicity | 54.80 | 10.01 | 109 | 441176 | 36932 | 63010805 |
Glomerular filtration rate decreased | 54.35 | 10.01 | 211 | 441074 | 13230 | 63034507 |
Breast cancer stage III | 53.85 | 10.01 | 5 | 441280 | 10381 | 63037356 |
Drug resistance | 53.80 | 10.01 | 48 | 441237 | 22885 | 63024852 |
Malaise | 53.72 | 10.01 | 3464 | 437821 | 412490 | 62635247 |
Carotid artery stenosis | 53.56 | 10.01 | 114 | 441171 | 5056 | 63042681 |
Linear IgA disease | 53.55 | 10.01 | 58 | 441227 | 1393 | 63046344 |
Urticaria | 53.15 | 10.01 | 821 | 440464 | 164981 | 62882756 |
Adjustment disorder with depressed mood | 52.67 | 10.01 | 5 | 441280 | 10199 | 63037538 |
Aphasia | 52.41 | 10.01 | 401 | 440884 | 32599 | 63015138 |
Foot deformity | 52.40 | 10.01 | 70 | 441215 | 27783 | 63019954 |
Injection site swelling | 52.39 | 10.01 | 163 | 441122 | 47409 | 63000328 |
Febrile neutropenia | 52.32 | 10.01 | 548 | 440737 | 117901 | 62929836 |
Gastrointestinal haemorrhage | 51.61 | 10.01 | 822 | 440463 | 80354 | 62967383 |
Renal disorder | 50.88 | 10.01 | 398 | 440887 | 32576 | 63015161 |
Adverse event | 50.76 | 10.01 | 269 | 441016 | 67290 | 62980447 |
Anti-neutrophil cytoplasmic antibody positive vasculitis | 50.46 | 10.01 | 80 | 441205 | 2819 | 63044918 |
Pemphigoid | 50.30 | 10.01 | 138 | 441147 | 7206 | 63040531 |
Affect lability | 50.03 | 10.01 | 181 | 441104 | 10970 | 63036767 |
Respiratory failure | 50.01 | 10.01 | 990 | 440295 | 100868 | 62946869 |
Tenosynovitis | 49.48 | 10.01 | 17 | 441268 | 13778 | 63033959 |
Loss of personal independence in daily activities | 49.38 | 10.01 | 435 | 440850 | 96855 | 62950882 |
Fatigue | 48.75 | 10.01 | 5418 | 435867 | 882610 | 62165127 |
Vasodilatation | 48.63 | 10.01 | 71 | 441214 | 2324 | 63045413 |
Lip swelling | 48.52 | 10.01 | 376 | 440909 | 30687 | 63017050 |
Joint range of motion decreased | 48.34 | 10.01 | 95 | 441190 | 32333 | 63015404 |
Dysphagia | 47.60 | 10.01 | 873 | 440412 | 87712 | 62960025 |
Haemorrhage subcutaneous | 47.42 | 10.01 | 79 | 441206 | 2904 | 63044833 |
Product monitoring error | 47.27 | 10.01 | 100 | 441185 | 4416 | 63043321 |
Inappropriate antidiuretic hormone secretion | 47.27 | 10.01 | 223 | 441062 | 15239 | 63032498 |
Swelling face | 46.67 | 10.01 | 659 | 440626 | 62816 | 62984921 |
Hemiparesis | 46.41 | 10.01 | 299 | 440986 | 22983 | 63024754 |
Infective pulmonary exacerbation of cystic fibrosis | 46.37 | 10.01 | 4 | 441281 | 8813 | 63038924 |
Motor dysfunction | 46.04 | 10.01 | 172 | 441113 | 10589 | 63037148 |
Injection site pruritus | 45.95 | 10.01 | 160 | 441125 | 44956 | 63002781 |
Chest pain | 45.55 | 10.01 | 1885 | 439400 | 214074 | 62833663 |
Dislocation of vertebra | 45.19 | 10.01 | 4 | 441281 | 8631 | 63039106 |
Aortic dissection | 44.17 | 10.01 | 62 | 441223 | 1956 | 63045781 |
Blood creatine phosphokinase increased | 44.07 | 10.01 | 362 | 440923 | 30068 | 63017669 |
Sensory loss | 43.27 | 10.01 | 163 | 441122 | 10075 | 63037662 |
Urine output decreased | 42.37 | 10.01 | 174 | 441111 | 11196 | 63036541 |
Myelosuppression | 42.17 | 10.01 | 62 | 441223 | 23641 | 63024096 |
BRASH syndrome | 42.08 | 10.01 | 31 | 441254 | 438 | 63047299 |
Ear infection | 42.03 | 10.01 | 131 | 441154 | 38082 | 63009655 |
X-ray abnormal | 41.79 | 10.01 | 4 | 441281 | 8106 | 63039631 |
Supraventricular extrasystoles | 41.68 | 10.01 | 96 | 441189 | 4493 | 63043244 |
Arrhythmia | 41.20 | 10.01 | 426 | 440859 | 37714 | 63010023 |
Hypocalcaemia | 41.06 | 10.01 | 368 | 440917 | 31345 | 63016392 |
Lacunar infarction | 40.75 | 10.01 | 78 | 441207 | 3202 | 63044535 |
Pulmonary renal syndrome | 40.72 | 10.01 | 30 | 441255 | 424 | 63047313 |
Hypervolaemia | 40.61 | 10.01 | 337 | 440948 | 28076 | 63019661 |
Inflammation | 39.94 | 10.01 | 372 | 440913 | 81901 | 62965836 |
Gangrene | 39.91 | 10.01 | 113 | 441172 | 6010 | 63041727 |
Diarrhoea | 39.85 | 10.01 | 5611 | 435674 | 709755 | 62337982 |
Injection site bruising | 39.80 | 10.01 | 153 | 441132 | 41757 | 63005980 |
Gingival swelling | 39.66 | 10.01 | 92 | 441193 | 4326 | 63043411 |
Electrocardiogram abnormal | 39.51 | 10.01 | 147 | 441138 | 9032 | 63038705 |
Cough | 39.21 | 10.01 | 2446 | 438839 | 290297 | 62757440 |
Body temperature increased | 39.17 | 10.01 | 130 | 441155 | 37062 | 63010675 |
Injection site warmth | 39.14 | 10.01 | 29 | 441256 | 15166 | 63032571 |
Atrioventricular block second degree | 39.05 | 10.01 | 85 | 441200 | 3829 | 63043908 |
Premature labour | 39.03 | 10.01 | 19 | 441266 | 12485 | 63035252 |
Glomerulonephritis rapidly progressive | 38.89 | 10.01 | 41 | 441244 | 954 | 63046783 |
Gingival bleeding | 38.82 | 10.01 | 182 | 441103 | 12405 | 63035332 |
Maternal exposure before pregnancy | 38.52 | 10.01 | 4 | 441281 | 7599 | 63040138 |
Bundle branch block right | 38.38 | 10.01 | 98 | 441187 | 4900 | 63042837 |
Nocturia | 38.11 | 10.01 | 134 | 441151 | 8007 | 63039730 |
Suicide attempt | 38.02 | 10.01 | 615 | 440670 | 60303 | 62987434 |
Peripheral venous disease | 38.01 | 10.01 | 31 | 441254 | 15446 | 63032291 |
Drug dependence | 38.00 | 10.01 | 70 | 441215 | 24413 | 63023324 |
Lip dry | 37.98 | 10.01 | 31 | 441254 | 15439 | 63032298 |
Autoimmune disorder | 37.90 | 10.01 | 38 | 441247 | 17139 | 63030598 |
Hyperuricaemia | 37.87 | 10.01 | 102 | 441183 | 5268 | 63042469 |
Macular degeneration | 37.56 | 10.01 | 70 | 441215 | 24306 | 63023431 |
Ear pain | 37.52 | 10.01 | 127 | 441158 | 35991 | 63011746 |
Ischaemic stroke | 37.27 | 10.01 | 233 | 441052 | 17724 | 63030013 |
Caesarean section | 37.21 | 10.01 | 38 | 441247 | 16994 | 63030743 |
Plasma cell myeloma | 36.89 | 10.01 | 397 | 440888 | 35508 | 63012229 |
Device dislocation | 36.87 | 10.01 | 77 | 441208 | 25628 | 63022109 |
Disability | 36.71 | 10.01 | 44 | 441241 | 18303 | 63029434 |
Allergic reaction to excipient | 36.54 | 10.01 | 26 | 441259 | 347 | 63047390 |
Blood potassium increased | 36.41 | 10.01 | 235 | 441050 | 18074 | 63029663 |
Haematemesis | 36.40 | 10.01 | 347 | 440938 | 30065 | 63017672 |
Dyspnoea exertional | 36.23 | 10.01 | 605 | 440680 | 59697 | 62988040 |
Hyperdynamic left ventricle | 36.07 | 10.01 | 20 | 441265 | 166 | 63047571 |
Nodal rhythm | 35.87 | 10.01 | 52 | 441233 | 1691 | 63046046 |
Hyperlipidaemia | 35.79 | 10.01 | 246 | 441039 | 19325 | 63028412 |
Nephrosclerosis | 35.23 | 10.01 | 40 | 441245 | 1014 | 63046723 |
Tubulointerstitial nephritis | 35.12 | 10.01 | 248 | 441037 | 19655 | 63028082 |
Drug tolerance decreased | 34.86 | 10.01 | 42 | 441243 | 17431 | 63030306 |
Product substitution issue | 34.74 | 10.01 | 210 | 441075 | 15786 | 63031951 |
Breast cancer stage II | 34.54 | 10.01 | 9 | 441276 | 8727 | 63039010 |
Myalgia | 34.39 | 10.01 | 1294 | 439991 | 145235 | 62902502 |
Angina unstable | 34.27 | 10.01 | 118 | 441167 | 6977 | 63040760 |
Pollakiuria | 34.05 | 10.01 | 320 | 440965 | 27617 | 63020120 |
Neutropenia | 33.92 | 10.01 | 941 | 440344 | 174064 | 62873673 |
Disorientation | 33.73 | 10.01 | 421 | 440864 | 39031 | 63008706 |
Cardiac arrest | 33.63 | 10.01 | 862 | 440423 | 91683 | 62956054 |
Hyperaldosteronism | 33.38 | 10.01 | 21 | 441264 | 225 | 63047512 |
Blood pressure abnormal | 33.31 | 10.01 | 200 | 441085 | 14998 | 63032739 |
Immunodeficiency | 33.16 | 10.01 | 56 | 441229 | 20198 | 63027539 |
Vertigo | 33.15 | 10.01 | 593 | 440692 | 59294 | 62988443 |
Feeling abnormal | 33.06 | 10.01 | 1303 | 439982 | 147089 | 62900648 |
Multiple sclerosis relapse | 32.65 | 10.01 | 200 | 441085 | 48278 | 62999459 |
Therapeutic response decreased | 32.59 | 10.01 | 272 | 441013 | 61253 | 62986484 |
Arteriosclerosis | 32.11 | 10.01 | 147 | 441138 | 9919 | 63037818 |
Retinitis | 32.08 | 10.01 | 3 | 441282 | 6193 | 63041544 |
Unintended pregnancy | 31.97 | 10.01 | 3 | 441282 | 6176 | 63041561 |
Muscle spasms | 31.78 | 10.01 | 1358 | 439927 | 154792 | 62892945 |
Premature delivery | 31.78 | 10.01 | 106 | 441179 | 30175 | 63017562 |
Intestinal malrotation | 31.61 | 10.01 | 24 | 441261 | 356 | 63047381 |
Breast cancer stage I | 31.59 | 10.01 | 5 | 441280 | 6884 | 63040853 |
Premature baby | 31.55 | 10.01 | 60 | 441225 | 20675 | 63027062 |
Myocardial ischaemia | 31.30 | 10.01 | 174 | 441111 | 12685 | 63035052 |
Tongue oedema | 31.24 | 10.01 | 86 | 441199 | 4500 | 63043237 |
Fear of injection | 31.10 | 10.01 | 6 | 441279 | 7158 | 63040579 |
Mitral valve incompetence | 31.06 | 10.01 | 238 | 441047 | 19356 | 63028381 |
Ischaemia | 31.04 | 10.01 | 88 | 441197 | 4684 | 63043053 |
Foetal death | 30.90 | 10.01 | 19 | 441266 | 10961 | 63036776 |
Bladder irritation | 30.82 | 10.01 | 20 | 441265 | 227 | 63047510 |
Drug withdrawal syndrome | 30.78 | 10.01 | 92 | 441193 | 27102 | 63020635 |
Coordination abnormal | 30.67 | 10.01 | 182 | 441103 | 13591 | 63034146 |
Maternal exposure timing unspecified | 30.63 | 10.01 | 6 | 441279 | 7081 | 63040656 |
Night sweats | 30.52 | 10.01 | 206 | 441079 | 48608 | 62999129 |
Therapy non-responder | 30.40 | 10.01 | 359 | 440926 | 75542 | 62972195 |
Rheumatoid nodule | 30.39 | 10.01 | 45 | 441240 | 17110 | 63030627 |
Enthesopathy | 30.24 | 10.01 | 11 | 441274 | 8603 | 63039134 |
Wound infection | 29.98 | 10.01 | 65 | 441220 | 21345 | 63026392 |
Sleep disorder | 29.96 | 10.01 | 393 | 440892 | 81173 | 62966564 |
Joint destruction | 29.92 | 10.01 | 4 | 441281 | 6248 | 63041489 |
Abortion induced | 29.85 | 10.01 | 17 | 441268 | 10225 | 63037512 |
Subdural haematoma | 29.79 | 10.01 | 186 | 441099 | 14142 | 63033595 |
Wrong technique in product usage process | 29.77 | 10.01 | 283 | 441002 | 62057 | 62985680 |
Pulse abnormal | 29.10 | 10.01 | 56 | 441229 | 2308 | 63045429 |
Injection site urticaria | 28.96 | 10.01 | 33 | 441252 | 14040 | 63033697 |
Haemoglobin decreased | 28.88 | 10.01 | 1262 | 440023 | 144223 | 62903514 |
Fibromuscular dysplasia | 28.75 | 10.01 | 19 | 441266 | 223 | 63047514 |
Pleural effusion | 28.73 | 10.01 | 850 | 440435 | 92360 | 62955377 |
Gastrointestinal toxicity | 28.71 | 10.01 | 9 | 441276 | 7732 | 63040005 |
Hypothermia | 28.68 | 10.01 | 177 | 441108 | 13404 | 63034333 |
Stillbirth | 28.58 | 10.01 | 6 | 441279 | 6744 | 63040993 |
Gastric ulcer haemorrhage | 28.57 | 10.01 | 87 | 441198 | 4821 | 63042916 |
Osteoarthritis | 28.57 | 10.01 | 478 | 440807 | 94865 | 62952872 |
Haemodynamic instability | 28.43 | 10.01 | 133 | 441152 | 9057 | 63038680 |
Haematochezia | 28.17 | 10.01 | 526 | 440759 | 53018 | 62994719 |
C-reactive protein increased | 27.99 | 10.01 | 476 | 440809 | 94231 | 62953506 |
Urinary retention | 27.93 | 10.01 | 328 | 440957 | 29973 | 63017764 |
Product label on wrong product | 27.83 | 10.01 | 7 | 441278 | 0 | 63047737 |
Neovascularisation | 27.82 | 10.01 | 37 | 441248 | 1108 | 63046629 |
Heart rate decreased | 27.70 | 10.01 | 458 | 440827 | 45102 | 63002635 |
Myocardial depression | 27.63 | 10.01 | 25 | 441260 | 479 | 63047258 |
Loose tooth | 27.58 | 10.01 | 68 | 441217 | 3326 | 63044411 |
Cerebral ischaemia | 27.51 | 10.01 | 106 | 441179 | 6622 | 63041115 |
Adverse drug reaction | 27.50 | 10.01 | 389 | 440896 | 79325 | 62968412 |
Mental status changes | 27.47 | 10.01 | 407 | 440878 | 39192 | 63008545 |
Device difficult to use | 27.44 | 10.01 | 29 | 441256 | 12767 | 63034970 |
Listless | 27.28 | 10.01 | 61 | 441224 | 2799 | 63044938 |
Faeces discoloured | 27.24 | 10.01 | 221 | 441064 | 18288 | 63029449 |
Ageusia | 27.18 | 10.01 | 176 | 441109 | 13552 | 63034185 |
Protein urine present | 27.17 | 10.01 | 99 | 441186 | 6021 | 63041716 |
Ovarian cyst | 27.12 | 10.01 | 43 | 441242 | 15902 | 63031835 |
Dysgeusia | 27.10 | 10.01 | 466 | 440819 | 46244 | 63001493 |
Glycosylated haemoglobin increased | 27.08 | 10.01 | 163 | 441122 | 12235 | 63035502 |
Red blood cell sedimentation rate increased | 26.81 | 10.01 | 187 | 441098 | 43795 | 63003942 |
Blood aldosterone increased | 26.72 | 10.01 | 17 | 441268 | 186 | 63047551 |
Acute coronary syndrome | 26.67 | 10.01 | 140 | 441145 | 9986 | 63037751 |
Breast cancer female | 26.62 | 10.01 | 33 | 441252 | 13526 | 63034211 |
Therapy partial responder | 26.61 | 10.01 | 21 | 441264 | 10637 | 63037100 |
Parkinsonism | 26.58 | 10.01 | 143 | 441142 | 10296 | 63037441 |
Multiple drug therapy | 26.47 | 10.01 | 70 | 441215 | 3576 | 63044161 |
Labile hypertension | 26.44 | 10.01 | 24 | 441261 | 462 | 63047275 |
Purpura | 26.36 | 10.01 | 152 | 441133 | 11233 | 63036504 |
Rib deformity | 26.30 | 10.01 | 19 | 441266 | 260 | 63047477 |
Sinus arrest | 26.27 | 10.01 | 48 | 441237 | 1901 | 63045836 |
Gravitational oedema | 26.13 | 10.01 | 37 | 441248 | 1177 | 63046560 |
Hypoxia | 26.02 | 10.01 | 571 | 440714 | 59221 | 62988516 |
Uterine perforation | 26.00 | 10.01 | 8 | 441277 | 6955 | 63040782 |
Gingival pain | 25.89 | 10.01 | 119 | 441166 | 8043 | 63039694 |
Periodontitis | 25.61 | 10.01 | 65 | 441220 | 3238 | 63044499 |
Deformity | 25.60 | 10.01 | 26 | 441259 | 11658 | 63036079 |
Blood glucose decreased | 25.54 | 10.01 | 240 | 441045 | 20712 | 63027025 |
Hallucination, visual | 25.53 | 10.01 | 225 | 441060 | 19073 | 63028664 |
Cardiac failure chronic | 25.42 | 10.01 | 78 | 441207 | 4340 | 63043397 |
Device adhesion issue | 25.30 | 10.01 | 3 | 441282 | 5138 | 63042599 |
Contusion | 25.30 | 10.01 | 822 | 440463 | 149222 | 62898515 |
Haemodialysis | 25.17 | 10.01 | 126 | 441159 | 8821 | 63038916 |
Peripheral arterial occlusive disease | 24.95 | 10.01 | 75 | 441210 | 4126 | 63043611 |
Body tinea | 24.87 | 10.01 | 46 | 441239 | 1839 | 63045898 |
Unintentional medical device removal | 24.76 | 10.01 | 6 | 441279 | 6109 | 63041628 |
Hepatocellular carcinoma | 24.63 | 10.01 | 50 | 441235 | 2144 | 63045593 |
Arterial occlusive disease | 24.47 | 10.01 | 94 | 441191 | 5864 | 63041873 |
Scleral discolouration | 24.34 | 10.01 | 22 | 441263 | 421 | 63047316 |
Dementia | 24.28 | 10.01 | 218 | 441067 | 18576 | 63029161 |
Aortic aneurysm | 24.14 | 10.01 | 70 | 441215 | 3774 | 63043963 |
Haematotoxicity | 24.01 | 10.01 | 18 | 441267 | 9358 | 63038379 |
Conjoined twins | 23.99 | 10.01 | 18 | 441267 | 262 | 63047475 |
Nephrogenic systemic fibrosis | 23.98 | 10.01 | 78 | 441207 | 4478 | 63043259 |
Skin candida | 23.90 | 10.01 | 42 | 441243 | 1613 | 63046124 |
Generalised oedema | 23.89 | 10.01 | 190 | 441095 | 15628 | 63032109 |
Cerebral haemorrhage | 23.79 | 10.01 | 322 | 440963 | 30407 | 63017330 |
Joint effusion | 23.72 | 10.01 | 52 | 441233 | 17008 | 63030729 |
C-reactive protein | 23.66 | 10.01 | 3 | 441282 | 4879 | 63042858 |
Hypoglycaemic coma | 23.53 | 10.01 | 54 | 441231 | 2521 | 63045216 |
Acute motor-sensory axonal neuropathy | 23.48 | 10.01 | 18 | 441267 | 271 | 63047466 |
Upper respiratory tract infection | 23.40 | 10.01 | 415 | 440870 | 81632 | 62966105 |
Claustrophobia | 23.37 | 10.01 | 32 | 441253 | 986 | 63046751 |
Heavy menstrual bleeding | 23.23 | 10.01 | 56 | 441229 | 17717 | 63030020 |
Lymphocyte stimulation test positive | 23.22 | 10.01 | 23 | 441262 | 496 | 63047241 |
Obesity | 23.20 | 10.01 | 118 | 441167 | 29834 | 63017903 |
Metastases to bone | 23.15 | 10.01 | 72 | 441213 | 20947 | 63026790 |
Upper gastrointestinal haemorrhage | 23.01 | 10.01 | 216 | 441069 | 18636 | 63029101 |
Anaphylactic reaction | 23.00 | 10.01 | 322 | 440963 | 65778 | 62981959 |
Temperature regulation disorder | 22.98 | 10.01 | 7 | 441278 | 6125 | 63041612 |
Skin exfoliation | 22.87 | 10.01 | 424 | 440861 | 42678 | 63005059 |
Carotid arteriosclerosis | 22.77 | 10.01 | 33 | 441252 | 1073 | 63046664 |
Atrioventricular dissociation | 22.71 | 10.01 | 16 | 441269 | 210 | 63047527 |
Diabetic nephropathy | 22.44 | 10.01 | 38 | 441247 | 1416 | 63046321 |
Vasculitis | 22.40 | 10.01 | 209 | 441076 | 18000 | 63029737 |
Hypophagia | 22.36 | 10.01 | 323 | 440962 | 30936 | 63016801 |
Coeliac disease | 22.25 | 10.01 | 34 | 441251 | 12763 | 63034974 |
Bone erosion | 22.24 | 10.01 | 57 | 441228 | 17660 | 63030077 |
Skin haemorrhage | 22.23 | 10.01 | 133 | 441152 | 9961 | 63037776 |
Oedema | 22.15 | 10.01 | 859 | 440426 | 96763 | 62950974 |
Vision blurred | 22.09 | 10.01 | 814 | 440471 | 91110 | 62956627 |
Inhibitory drug interaction | 22.02 | 10.01 | 56 | 441229 | 2793 | 63044944 |
Schizophrenia | 21.97 | 10.01 | 22 | 441263 | 9930 | 63037807 |
Lethargy | 21.93 | 10.01 | 527 | 440758 | 55480 | 62992257 |
Presyncope | 21.86 | 10.01 | 292 | 440993 | 27493 | 63020244 |
Colitis ulcerative | 21.83 | 10.01 | 100 | 441185 | 25991 | 63021746 |
Sinus congestion | 21.79 | 10.01 | 207 | 441078 | 17916 | 63029821 |
Prescription drug used without a prescription | 21.76 | 10.01 | 50 | 441235 | 2336 | 63045401 |
Medication error | 21.71 | 10.01 | 496 | 440789 | 51788 | 62995949 |
Diabetes mellitus | 21.51 | 10.01 | 524 | 440761 | 55286 | 62992451 |
Acute respiratory distress syndrome | 21.36 | 10.01 | 254 | 441031 | 23280 | 63024457 |
Septic shock | 21.30 | 10.01 | 330 | 440955 | 66299 | 62981438 |
Head discomfort | 21.29 | 10.01 | 163 | 441122 | 13252 | 63034485 |
Hyperkaliuria | 21.28 | 10.01 | 10 | 441275 | 56 | 63047681 |
Intestinal villi atrophy | 21.26 | 10.01 | 16 | 441269 | 234 | 63047503 |
Gingivitis | 21.15 | 10.01 | 115 | 441170 | 8314 | 63039423 |
Reduced facial expression | 21.12 | 10.01 | 44 | 441241 | 1922 | 63045815 |
Pathogen resistance | 21.09 | 10.01 | 9 | 441276 | 6389 | 63041348 |
Harlequin syndrome | 20.99 | 10.01 | 9 | 441276 | 39 | 63047698 |
Finger deformity | 20.98 | 10.01 | 14 | 441271 | 7731 | 63040006 |
Joint injury | 20.97 | 10.01 | 120 | 441165 | 29452 | 63018285 |
Hypertensive encephalopathy | 20.96 | 10.01 | 24 | 441261 | 614 | 63047123 |
Gallbladder adenocarcinoma | 20.92 | 10.01 | 12 | 441273 | 107 | 63047630 |
Hypoperfusion | 20.89 | 10.01 | 37 | 441248 | 1430 | 63046307 |
Joint stiffness | 20.88 | 10.01 | 188 | 441097 | 41681 | 63006056 |
Pericardial effusion | 20.87 | 10.01 | 309 | 440976 | 29749 | 63017988 |
Hypertensive heart disease | 20.86 | 10.01 | 50 | 441235 | 2402 | 63045335 |
Ventricular extrasystoles | 20.84 | 10.01 | 146 | 441139 | 11541 | 63036196 |
Autoimmune enteropathy | 20.82 | 10.01 | 6 | 441279 | 4 | 63047733 |
Lymphocele | 20.78 | 10.01 | 27 | 441258 | 790 | 63046947 |
Acute hepatic failure | 20.74 | 10.01 | 62 | 441223 | 18265 | 63029472 |
Acute respiratory failure | 20.72 | 10.01 | 346 | 440939 | 34139 | 63013598 |
Lichen nitidus | 20.71 | 10.01 | 11 | 441274 | 83 | 63047654 |
Psychotic disorder | 20.66 | 10.01 | 100 | 441185 | 25612 | 63022125 |
Gingival atrophy | 20.64 | 10.01 | 8 | 441277 | 25 | 63047712 |
Hypernatraemia | 20.59 | 10.01 | 106 | 441179 | 7503 | 63040234 |
Drug hypersensitivity | 20.57 | 10.01 | 1869 | 439416 | 308818 | 62738919 |
Cholecystitis chronic | 20.57 | 10.01 | 25 | 441260 | 10336 | 63037401 |
Leukopenia | 20.46 | 10.01 | 396 | 440889 | 76894 | 62970843 |
Urine albumin/creatinine ratio increased | 20.32 | 10.01 | 17 | 441268 | 292 | 63047445 |
Retinal ischaemia | 20.19 | 10.01 | 18 | 441267 | 338 | 63047399 |
Haemorrhage intracranial | 20.17 | 10.01 | 161 | 441124 | 13258 | 63034479 |
Bradyarrhythmia | 20.05 | 10.01 | 45 | 441240 | 2070 | 63045667 |
Cryopyrin associated periodic syndrome | 20.02 | 10.01 | 18 | 441267 | 342 | 63047395 |
Hypoglossal nerve paralysis | 19.92 | 10.01 | 7 | 441278 | 15 | 63047722 |
Renal transplant | 19.90 | 10.01 | 35 | 441250 | 1345 | 63046392 |
Blood uric acid increased | 19.89 | 10.01 | 82 | 441203 | 5285 | 63042452 |
Femoral neck fracture | 19.87 | 10.01 | 114 | 441171 | 8409 | 63039328 |
Sinus rhythm | 19.79 | 10.01 | 27 | 441258 | 829 | 63046908 |
Lecithin-cholesterol acyltransferase deficiency | 19.74 | 10.01 | 6 | 441279 | 6 | 63047731 |
Electrolyte imbalance | 19.71 | 10.01 | 220 | 441065 | 19856 | 63027881 |
Skin discolouration | 19.69 | 10.01 | 371 | 440914 | 37457 | 63010280 |
Injection site rash | 19.63 | 10.01 | 66 | 441219 | 18743 | 63028994 |
Cardiomegaly | 19.62 | 10.01 | 198 | 441087 | 17416 | 63030321 |
Product tampering | 19.59 | 10.01 | 19 | 441266 | 399 | 63047338 |
Oral discharge | 19.57 | 10.01 | 13 | 441272 | 154 | 63047583 |
Cytomegalovirus infection | 19.57 | 10.01 | 77 | 441208 | 20875 | 63026862 |
Pseudolymphoma | 19.56 | 10.01 | 23 | 441262 | 606 | 63047131 |
Blood sodium decreased | 19.55 | 10.01 | 256 | 441029 | 23996 | 63023741 |
Blood loss anaemia | 19.44 | 10.01 | 118 | 441167 | 8883 | 63038854 |
Nephrogenic anaemia | 19.38 | 10.01 | 45 | 441240 | 2117 | 63045620 |
Restlessness | 19.37 | 10.01 | 300 | 440985 | 29153 | 63018584 |
Skin tightness | 19.31 | 10.01 | 70 | 441215 | 4246 | 63043491 |
Multiple-drug resistance | 19.20 | 10.01 | 6 | 441279 | 5164 | 63042573 |
Benign neoplasm of adrenal gland | 19.15 | 10.01 | 8 | 441277 | 32 | 63047705 |
Product dispensing error | 19.12 | 10.01 | 130 | 441155 | 10175 | 63037562 |
Forced vital capacity decreased | 19.09 | 10.01 | 30 | 441255 | 1049 | 63046688 |
Galactorrhoea | 19.09 | 10.01 | 3 | 441282 | 4152 | 63043585 |
Venoocclusive liver disease | 19.08 | 10.01 | 5 | 441280 | 4830 | 63042907 |
Nephrotic syndrome | 18.97 | 10.01 | 83 | 441202 | 5493 | 63042244 |
Kidney transplant rejection | 18.89 | 10.01 | 69 | 441216 | 4202 | 63043535 |
Jaundice | 18.88 | 10.01 | 297 | 440988 | 28954 | 63018783 |
Product storage error | 18.87 | 10.01 | 48 | 441237 | 14908 | 63032829 |
Rectourethral fistula | 18.78 | 10.01 | 8 | 441277 | 34 | 63047703 |
Ballismus | 18.73 | 10.01 | 12 | 441273 | 133 | 63047604 |
Blood lactic acid increased | 18.68 | 10.01 | 98 | 441187 | 6988 | 63040749 |
Dermatitis bullous | 18.67 | 10.01 | 112 | 441173 | 8396 | 63039341 |
Tachypnoea | 18.56 | 10.01 | 193 | 441092 | 17109 | 63030628 |
Congenital bladder anomaly | 18.43 | 10.01 | 13 | 441272 | 171 | 63047566 |
Interstitial lung disease | 18.39 | 10.01 | 562 | 440723 | 61346 | 62986391 |
Gout | 18.22 | 10.01 | 156 | 441129 | 13115 | 63034622 |
Organ failure | 18.10 | 10.01 | 50 | 441235 | 2621 | 63045116 |
Glucose tolerance impaired | 18.06 | 10.01 | 92 | 441193 | 6485 | 63041252 |
Sudden hearing loss | 18.06 | 10.01 | 32 | 441253 | 1237 | 63046500 |
Malpositioned teeth | 18.03 | 10.01 | 7 | 441278 | 22 | 63047715 |
Pulmonary hypertension | 17.93 | 10.01 | 360 | 440925 | 36763 | 63010974 |
Urachal abnormality | 17.93 | 10.01 | 13 | 441272 | 179 | 63047558 |
Fryns syndrome | 17.87 | 10.01 | 9 | 441276 | 60 | 63047677 |
Dialysis | 17.86 | 10.01 | 129 | 441156 | 10298 | 63037439 |
Cardiorenal syndrome | 17.86 | 10.01 | 26 | 441259 | 849 | 63046888 |
Sinus node dysfunction | 17.70 | 10.01 | 72 | 441213 | 4613 | 63043124 |
Adenoma benign | 17.65 | 10.01 | 26 | 441259 | 858 | 63046879 |
Apathy | 17.56 | 10.01 | 113 | 441172 | 8681 | 63039056 |
Diffuse large B-cell lymphoma refractory | 17.48 | 10.01 | 31 | 441254 | 1199 | 63046538 |
Intestinal ischaemia | 17.48 | 10.01 | 100 | 441185 | 7368 | 63040369 |
Full blood count decreased | 17.47 | 10.01 | 266 | 441019 | 25758 | 63021979 |
Gamma-glutamyltransferase increased | 17.45 | 10.01 | 333 | 440952 | 33698 | 63014039 |
Aortic stenosis | 17.29 | 10.01 | 75 | 441210 | 4945 | 63042792 |
Haematoma | 17.27 | 10.01 | 339 | 440946 | 34481 | 63013256 |
Procedural pain | 17.26 | 10.01 | 84 | 441201 | 21485 | 63026252 |
Rectal ulcer haemorrhage | 17.22 | 10.01 | 13 | 441272 | 191 | 63047546 |
Persistent cloaca | 17.17 | 10.01 | 13 | 441272 | 192 | 63047545 |
Putamen haemorrhage | 17.17 | 10.01 | 13 | 441272 | 192 | 63047545 |
Ventricular failure | 17.15 | 10.01 | 17 | 441268 | 367 | 63047370 |
Sneezing | 17.14 | 10.01 | 198 | 441087 | 18020 | 63029717 |
Conduction disorder | 17.14 | 10.01 | 34 | 441251 | 1433 | 63046304 |
Tendonitis | 17.12 | 10.01 | 74 | 441211 | 19541 | 63028196 |
Ankylosing spondylitis | 17.11 | 10.01 | 29 | 441256 | 10445 | 63037292 |
Substance abuse | 17.11 | 10.01 | 6 | 441279 | 4801 | 63042936 |
Labelled drug-drug interaction medication error | 17.10 | 10.01 | 155 | 441130 | 13244 | 63034493 |
Cardiac hypertrophy | 17.05 | 10.01 | 28 | 441257 | 1017 | 63046720 |
Osteoporosis | 17.00 | 10.01 | 288 | 440997 | 57050 | 62990687 |
Product solubility abnormal | 16.97 | 10.01 | 25 | 441260 | 825 | 63046912 |
Drug tolerance | 16.96 | 10.01 | 14 | 441271 | 6935 | 63040802 |
Cardiac disorder | 16.93 | 10.01 | 468 | 440817 | 50348 | 62997389 |
Humerus fracture | 16.86 | 10.01 | 113 | 441172 | 8803 | 63038934 |
Vitello-intestinal duct remnant | 16.85 | 10.01 | 8 | 441277 | 46 | 63047691 |
Irritability | 16.84 | 10.01 | 140 | 441145 | 31554 | 63016183 |
Skin induration | 16.80 | 10.01 | 55 | 441230 | 3168 | 63044569 |
Haemorrhagic diathesis | 16.79 | 10.01 | 68 | 441217 | 4347 | 63043390 |
Vitamin B1 decreased | 16.78 | 10.01 | 13 | 441272 | 199 | 63047538 |
Post transplant lymphoproliferative disorder | 16.71 | 10.01 | 7 | 441278 | 5024 | 63042713 |
Insulin-like growth factor decreased | 16.71 | 10.01 | 17 | 441268 | 379 | 63047358 |
Kidney fibrosis | 16.70 | 10.01 | 39 | 441246 | 1842 | 63045895 |
Acute myeloid leukaemia | 16.67 | 10.01 | 62 | 441223 | 17085 | 63030652 |
Renal cell carcinoma | 16.58 | 10.01 | 56 | 441229 | 3279 | 63044458 |
Adulterated product | 16.56 | 10.01 | 14 | 441271 | 244 | 63047493 |
Haemorrhage subepidermal | 16.45 | 10.01 | 5 | 441280 | 5 | 63047732 |
Cerebrovascular disorder | 16.44 | 10.01 | 49 | 441236 | 2683 | 63045054 |
Congenital acrochordon | 16.44 | 10.01 | 8 | 441277 | 49 | 63047688 |
Hypomania | 16.41 | 10.01 | 12 | 441273 | 6318 | 63041419 |
Confusional state | 16.39 | 10.01 | 1880 | 439405 | 234500 | 62813237 |
Complication of device insertion | 16.38 | 10.01 | 17 | 441268 | 7547 | 63040190 |
Female genital tract fistula | 16.36 | 10.01 | 17 | 441268 | 7542 | 63040195 |
Urinary incontinence | 16.32 | 10.01 | 313 | 440972 | 31701 | 63016036 |
Gingival disorder | 16.32 | 10.01 | 58 | 441227 | 3484 | 63044253 |
Muscular weakness | 16.28 | 10.01 | 1022 | 440263 | 121331 | 62926406 |
Transcription medication error | 16.25 | 10.01 | 13 | 441272 | 209 | 63047528 |
Nodule | 16.19 | 10.01 | 83 | 441202 | 20943 | 63026794 |
Neurotoxicity | 16.15 | 10.01 | 62 | 441223 | 16928 | 63030809 |
Suspected product quality issue | 16.10 | 10.01 | 13 | 441272 | 212 | 63047525 |
Infected dermal cyst | 16.08 | 10.01 | 18 | 441267 | 449 | 63047288 |
Sickle cell anaemia with crisis | 16.06 | 10.01 | 11 | 441274 | 5992 | 63041745 |
Abnormal loss of weight | 15.96 | 10.01 | 81 | 441204 | 5701 | 63042036 |
Hyperparathyroidism secondary | 15.95 | 10.01 | 33 | 441252 | 1434 | 63046303 |
Peritoneal effluent leukocyte count increased | 15.90 | 10.01 | 4 | 441281 | 0 | 63047737 |
Tremor | 15.88 | 10.01 | 1095 | 440190 | 131144 | 62916593 |
Exercise tolerance decreased | 15.88 | 10.01 | 78 | 441207 | 5419 | 63042318 |
Iliac artery occlusion | 15.86 | 10.01 | 12 | 441273 | 177 | 63047560 |
Neurosensory hypoacusis | 15.84 | 10.01 | 13 | 441272 | 217 | 63047520 |
Hypergastrinaemia | 15.83 | 10.01 | 10 | 441275 | 108 | 63047629 |
Dyslalia | 15.77 | 10.01 | 18 | 441267 | 459 | 63047278 |
Lupus-like syndrome | 15.73 | 10.01 | 54 | 441231 | 15241 | 63032496 |
Vulvovaginal pruritus | 15.72 | 10.01 | 54 | 441231 | 3189 | 63044548 |
Essential hypertension | 15.68 | 10.01 | 73 | 441212 | 4960 | 63042777 |
Blood cholinesterase increased | 15.66 | 10.01 | 6 | 441279 | 18 | 63047719 |
Incorrect route of product administration | 15.63 | 10.01 | 119 | 441166 | 27333 | 63020404 |
Nephropathy | 15.57 | 10.01 | 86 | 441199 | 6255 | 63041482 |
Bacteriuria | 15.56 | 10.01 | 27 | 441258 | 1026 | 63046711 |
Saliva discolouration | 15.53 | 10.01 | 7 | 441278 | 35 | 63047702 |
Dystonia | 15.46 | 10.01 | 47 | 441238 | 13772 | 63033965 |
Hyperprolactinaemia | 15.45 | 10.01 | 4 | 441281 | 3896 | 63043841 |
Ischaemic cardiomyopathy | 15.45 | 10.01 | 45 | 441240 | 2432 | 63045305 |
Retroperitoneal haematoma | 15.45 | 10.01 | 50 | 441235 | 2863 | 63044874 |
Dermatitis exfoliative | 15.44 | 10.01 | 77 | 441208 | 5382 | 63042355 |
Burn oesophageal | 15.42 | 10.01 | 12 | 441273 | 185 | 63047552 |
Fluid intake reduced | 15.41 | 10.01 | 58 | 441227 | 3583 | 63044154 |
Apical granuloma | 15.37 | 10.01 | 7 | 441278 | 36 | 63047701 |
Hypertensive angiopathy | 15.35 | 10.01 | 9 | 441276 | 84 | 63047653 |
Blood cholinesterase decreased | 15.23 | 10.01 | 10 | 441275 | 116 | 63047621 |
Albuminuria | 15.22 | 10.01 | 13 | 441272 | 230 | 63047507 |
CD30 expression | 15.22 | 10.01 | 7 | 441278 | 37 | 63047700 |
Synovial cyst | 15.17 | 10.01 | 31 | 441254 | 10402 | 63037335 |
Nasal oedema | 15.12 | 10.01 | 33 | 441252 | 1489 | 63046248 |
Cytokine release syndrome | 15.09 | 10.01 | 50 | 441235 | 14264 | 63033473 |
Sciatica | 15.06 | 10.01 | 159 | 441126 | 34165 | 63013572 |
Generalised tonic-clonic seizure | 15.04 | 10.01 | 129 | 441156 | 28887 | 63018850 |
Crush syndrome | 15.01 | 10.01 | 10 | 441275 | 119 | 63047618 |
Norepinephrine increased | 14.99 | 10.01 | 8 | 441277 | 61 | 63047676 |
Prescribed underdose | 14.94 | 10.01 | 133 | 441152 | 29556 | 63018181 |
Drug use disorder | 14.92 | 10.01 | 8 | 441277 | 4976 | 63042761 |
Chronic pigmented purpura | 14.90 | 10.01 | 11 | 441274 | 156 | 63047581 |
Prerenal failure | 14.88 | 10.01 | 35 | 441250 | 1661 | 63046076 |
Metabolic alkalosis | 14.86 | 10.01 | 51 | 441234 | 3010 | 63044727 |
Sinoatrial block | 14.77 | 10.01 | 24 | 441261 | 864 | 63046873 |
Cerebral atrophy | 14.71 | 10.01 | 72 | 441213 | 4994 | 63042743 |
Dry skin | 14.71 | 10.01 | 508 | 440777 | 56379 | 62991358 |
Subarachnoid haemorrhage | 14.70 | 10.01 | 158 | 441127 | 14125 | 63033612 |
Ventricular septal defect | 14.69 | 10.01 | 6 | 441279 | 4372 | 63043365 |
Epistaxis | 14.68 | 10.01 | 632 | 440653 | 72093 | 62975644 |
Electrocardiogram U wave present | 14.66 | 10.01 | 9 | 441276 | 92 | 63047645 |
Glomerulonephritis acute | 14.66 | 10.01 | 9 | 441276 | 92 | 63047645 |
Normal newborn | 14.66 | 10.01 | 22 | 441263 | 8319 | 63039418 |
Immunosuppressant drug level increased | 14.62 | 10.01 | 57 | 441228 | 3581 | 63044156 |
Myoglobin blood increased | 14.58 | 10.01 | 31 | 441254 | 1374 | 63046363 |
Hallucination, gustatory | 14.57 | 10.01 | 8 | 441277 | 65 | 63047672 |
Diverticulum intestinal haemorrhagic | 14.56 | 10.01 | 33 | 441252 | 1528 | 63046209 |
Aplastic anaemia | 14.48 | 10.01 | 115 | 441170 | 9454 | 63038283 |
Ocular icterus | 14.46 | 10.01 | 57 | 441228 | 3599 | 63044138 |
Lung disorder | 14.42 | 10.01 | 326 | 440959 | 61935 | 62985802 |
Congenital nail disorder | 14.42 | 10.01 | 9 | 441276 | 95 | 63047642 |
Disturbance in social behaviour | 14.19 | 10.01 | 5 | 441280 | 3988 | 63043749 |
Platelet aggregation decreased | 14.18 | 10.01 | 6 | 441279 | 25 | 63047712 |
Lymphocyte count decreased | 14.17 | 10.01 | 138 | 441147 | 30119 | 63017618 |
Sodium retention | 14.14 | 10.01 | 10 | 441275 | 132 | 63047605 |
Oropharyngeal swelling | 14.12 | 10.01 | 24 | 441261 | 897 | 63046840 |
Oxalosis | 14.11 | 10.01 | 7 | 441278 | 45 | 63047692 |
Biopsy kidney | 14.08 | 10.01 | 10 | 441275 | 133 | 63047604 |
Drug ineffective for unapproved indication | 14.07 | 10.01 | 160 | 441125 | 33903 | 63013834 |
Azotaemia | 14.04 | 10.01 | 65 | 441220 | 4406 | 63043331 |
Anorexia nervosa | 14.04 | 10.01 | 13 | 441272 | 257 | 63047480 |
Flatulence | 14.03 | 10.01 | 328 | 440957 | 34374 | 63013363 |
Platelet count decreased | 14.02 | 10.01 | 962 | 440323 | 115160 | 62932577 |
Cytomegalovirus infection reactivation | 14.01 | 10.01 | 5 | 441280 | 3958 | 63043779 |
Acute pulmonary oedema | 14.01 | 10.01 | 101 | 441184 | 8057 | 63039680 |
Pancreatic toxicity | 13.99 | 10.01 | 6 | 441279 | 26 | 63047711 |
Bone marrow failure | 13.97 | 10.01 | 133 | 441152 | 29157 | 63018580 |
Shock haemorrhagic | 13.94 | 10.01 | 117 | 441168 | 9778 | 63037959 |
Peritonitis bacterial | 13.93 | 10.01 | 69 | 441216 | 4810 | 63042927 |
Sensorimotor disorder | 13.85 | 10.01 | 17 | 441268 | 469 | 63047268 |
Thirst | 13.84 | 10.01 | 154 | 441131 | 13887 | 63033850 |
Pulmonary toxicity | 13.83 | 10.01 | 28 | 441257 | 9427 | 63038310 |
Vulvovaginal burning sensation | 13.82 | 10.01 | 39 | 441246 | 2070 | 63045667 |
Cystic fibrosis | 13.81 | 10.01 | 3 | 441282 | 3293 | 63044444 |
Cell marker increased | 13.75 | 10.01 | 13 | 441272 | 264 | 63047473 |
Colitis ischaemic | 13.73 | 10.01 | 124 | 441161 | 10584 | 63037153 |
Renal function test abnormal | 13.69 | 10.01 | 56 | 441229 | 3597 | 63044140 |
Device deployment issue | 13.67 | 10.01 | 5 | 441280 | 3897 | 63043840 |
Polycystic ovaries | 13.64 | 10.01 | 7 | 441278 | 4464 | 63043273 |
Stomatitis haemorrhagic | 13.64 | 10.01 | 6 | 441279 | 28 | 63047709 |
Capillary disorder | 13.61 | 10.01 | 8 | 441277 | 75 | 63047662 |
Status epilepticus | 13.58 | 10.01 | 57 | 441228 | 15176 | 63032561 |
Sinus arrhythmia | 13.58 | 10.01 | 31 | 441254 | 1442 | 63046295 |
Premature rupture of membranes | 13.56 | 10.01 | 9 | 441276 | 4984 | 63042753 |
Concomitant disease progression | 13.54 | 10.01 | 39 | 441246 | 2095 | 63045642 |
Metastatic renal cell carcinoma | 13.53 | 10.01 | 22 | 441263 | 792 | 63046945 |
Maternal drugs affecting foetus | 13.51 | 10.01 | 10 | 441275 | 5232 | 63042505 |
Orthopnoea | 13.47 | 10.01 | 82 | 441203 | 6179 | 63041558 |
Dysphoria | 13.42 | 10.01 | 9 | 441276 | 4957 | 63042780 |
Skin weeping | 13.41 | 10.01 | 21 | 441264 | 732 | 63047005 |
Shock symptom | 13.38 | 10.01 | 7 | 441278 | 51 | 63047686 |
Soft tissue disorder | 13.38 | 10.01 | 7 | 441278 | 4415 | 63043322 |
Peritonitis | 13.38 | 10.01 | 180 | 441105 | 16974 | 63030763 |
Pulmonary arterial hypertension | 13.37 | 10.01 | 226 | 441059 | 22351 | 63025386 |
End stage renal disease | 13.37 | 10.01 | 86 | 441199 | 6607 | 63041130 |
Nail disorder | 13.36 | 10.01 | 46 | 441239 | 12969 | 63034768 |
Gastrointestinal stromal tumour | 13.32 | 10.01 | 26 | 441259 | 1083 | 63046654 |
Hypoacusis | 13.31 | 10.01 | 239 | 441046 | 23912 | 63023825 |
Duodenal ulcer | 13.31 | 10.01 | 96 | 441189 | 7660 | 63040077 |
Atrial pressure increased | 13.30 | 10.01 | 5 | 441280 | 14 | 63047723 |
Chromaturia | 13.28 | 10.01 | 176 | 441109 | 16541 | 63031196 |
Cardiovascular disorder | 13.26 | 10.01 | 133 | 441152 | 11679 | 63036058 |
Accidental exposure to product | 13.26 | 10.01 | 124 | 441161 | 27281 | 63020456 |
Genital haemorrhage | 13.22 | 10.01 | 19 | 441266 | 7313 | 63040424 |
Venous aneurysm | 13.16 | 10.01 | 4 | 441281 | 4 | 63047733 |
Therapeutic drug monitoring analysis not performed | 13.08 | 10.01 | 29 | 441256 | 1323 | 63046414 |
Orbital swelling | 13.05 | 10.01 | 7 | 441278 | 54 | 63047683 |
Renal aneurysm | 13.05 | 10.01 | 5 | 441280 | 15 | 63047722 |
Psychogenic visual disorder | 13.05 | 10.01 | 5 | 441280 | 15 | 63047722 |
Duodenal ulcer repair | 13.05 | 10.01 | 7 | 441278 | 54 | 63047683 |
Sexual dysfunction | 13.04 | 10.01 | 7 | 441278 | 4352 | 63043385 |
Gestational diabetes | 13.03 | 10.01 | 24 | 441261 | 8372 | 63039365 |
Chondroma | 13.00 | 10.01 | 6 | 441279 | 32 | 63047705 |
Renal tubular necrosis | 12.98 | 10.01 | 133 | 441152 | 11745 | 63035992 |
Staphylococcal infection | 12.96 | 10.01 | 205 | 441080 | 41051 | 63006686 |
Metastases to fallopian tube | 12.95 | 10.01 | 7 | 441278 | 55 | 63047682 |
Hospice care | 12.94 | 10.01 | 97 | 441188 | 7835 | 63039902 |
Eye oedema | 12.94 | 10.01 | 31 | 441254 | 1489 | 63046248 |
Retinopathy hypertensive | 12.93 | 10.01 | 12 | 441273 | 238 | 63047499 |
Device malfunction | 12.91 | 10.01 | 72 | 441213 | 17785 | 63029952 |
Yellow skin | 12.88 | 10.01 | 40 | 441245 | 2240 | 63045497 |
Microalbuminuria | 12.88 | 10.01 | 15 | 441270 | 391 | 63047346 |
International normalised ratio increased | 12.88 | 10.01 | 418 | 440867 | 46007 | 63001730 |
Malignant hypertension | 12.86 | 10.01 | 27 | 441258 | 1186 | 63046551 |
Dermatosis | 12.84 | 10.01 | 13 | 441272 | 288 | 63047449 |
Blood sodium increased | 12.82 | 10.01 | 45 | 441240 | 2687 | 63045050 |
Pigmentation disorder | 12.81 | 10.01 | 65 | 441220 | 4574 | 63043163 |
Bladder sphincter atony | 12.80 | 10.01 | 10 | 441275 | 155 | 63047582 |
Small cell carcinoma | 12.75 | 10.01 | 10 | 441275 | 156 | 63047581 |
Enterochromaffin cell hyperplasia | 12.74 | 10.01 | 7 | 441278 | 57 | 63047680 |
Head injury | 12.68 | 10.01 | 264 | 441021 | 27132 | 63020605 |
Device issue | 12.65 | 10.01 | 105 | 441180 | 23676 | 63024061 |
Internal haemorrhage | 12.65 | 10.01 | 70 | 441215 | 5095 | 63042642 |
Chronic graft versus host disease | 12.64 | 10.01 | 3 | 441282 | 3099 | 63044638 |
Anti-erythropoietin antibody positive | 12.64 | 10.01 | 15 | 441270 | 399 | 63047338 |
Mean arterial pressure decreased | 12.64 | 10.01 | 10 | 441275 | 158 | 63047579 |
Osteopenia | 12.61 | 10.01 | 83 | 441202 | 19702 | 63028035 |
Pulmonary alveolar haemorrhage | 12.61 | 10.01 | 65 | 441220 | 4603 | 63043134 |
Myocardial oedema | 12.59 | 10.01 | 11 | 441274 | 201 | 63047536 |
Head banging | 12.59 | 10.01 | 15 | 441270 | 401 | 63047336 |
Ventricular internal diameter abnormal | 12.57 | 10.01 | 6 | 441279 | 35 | 63047702 |
Mucosal inflammation | 12.55 | 10.01 | 240 | 441045 | 46688 | 63001049 |
Heat illness | 12.54 | 10.01 | 11 | 441274 | 202 | 63047535 |
Bifascicular block | 12.53 | 10.01 | 9 | 441276 | 122 | 63047615 |
Dysphonia | 12.52 | 10.01 | 426 | 440859 | 47188 | 63000549 |
Cerebellar haemorrhage | 12.48 | 10.01 | 29 | 441256 | 1365 | 63046372 |
Femoral artery dissection | 12.43 | 10.01 | 6 | 441279 | 36 | 63047701 |
Jaundice hepatocellular | 12.43 | 10.01 | 6 | 441279 | 36 | 63047701 |
Palmar-plantar erythrodysaesthesia syndrome | 12.42 | 10.01 | 227 | 441058 | 22788 | 63024949 |
Lower limb fracture | 12.41 | 10.01 | 108 | 441177 | 24113 | 63023624 |
Urine protein/creatinine ratio increased | 12.37 | 10.01 | 19 | 441266 | 651 | 63047086 |
Oesophageal food impaction | 12.37 | 10.01 | 11 | 441274 | 206 | 63047531 |
Congenital diaphragmatic hernia | 12.32 | 10.01 | 11 | 441274 | 207 | 63047530 |
Dry eye | 12.32 | 10.01 | 204 | 441081 | 40557 | 63007180 |
Brain stem infarction | 12.29 | 10.01 | 21 | 441264 | 788 | 63046949 |
Pernicious anaemia | 12.29 | 10.01 | 19 | 441266 | 655 | 63047082 |
Rheumatoid factor negative | 12.24 | 10.01 | 18 | 441267 | 593 | 63047144 |
Diastolic dysfunction | 12.23 | 10.01 | 82 | 441203 | 6389 | 63041348 |
Blood alkaline phosphatase increased | 12.21 | 10.01 | 388 | 440897 | 42579 | 63005158 |
Blood chloride decreased | 12.19 | 10.01 | 73 | 441212 | 5469 | 63042268 |
Cerebrovascular arteriovenous malformation | 12.17 | 10.01 | 8 | 441277 | 93 | 63047644 |
Zinc deficiency | 12.15 | 10.01 | 7 | 441278 | 63 | 63047674 |
Dilatation ventricular | 12.10 | 10.01 | 41 | 441244 | 2404 | 63045333 |
Cranial nerve disorder | 12.07 | 10.01 | 17 | 441268 | 538 | 63047199 |
Cardiac failure acute | 12.07 | 10.01 | 110 | 441175 | 9413 | 63038324 |
Chest X-ray abnormal | 12.05 | 10.01 | 63 | 441222 | 4486 | 63043251 |
Hip fracture | 12.05 | 10.01 | 279 | 441006 | 29195 | 63018542 |
Extrasystoles | 12.02 | 10.01 | 69 | 441216 | 5091 | 63042646 |
Cataract | 12.01 | 10.01 | 498 | 440787 | 56555 | 62991182 |
Cutaneous vasculitis | 11.97 | 10.01 | 70 | 441215 | 5199 | 63042538 |
Retroperitoneal oedema | 11.97 | 10.01 | 5 | 441280 | 20 | 63047717 |
Leukaemic infiltration renal | 11.97 | 10.01 | 5 | 441280 | 20 | 63047717 |
Colon cancer | 11.96 | 10.01 | 113 | 441172 | 9765 | 63037972 |
Tongue abscess | 11.93 | 10.01 | 3 | 441282 | 0 | 63047737 |
Biliary hamartoma | 11.93 | 10.01 | 3 | 441282 | 0 | 63047737 |
Adrenal gland cancer metastatic | 11.93 | 10.01 | 3 | 441282 | 0 | 63047737 |
Mixed dementia | 11.93 | 10.01 | 3 | 441282 | 0 | 63047737 |
Peripheral nerve paresis | 11.93 | 10.01 | 3 | 441282 | 0 | 63047737 |
Hypovolaemia | 11.90 | 10.01 | 120 | 441165 | 10553 | 63037184 |
Tonsillar inflammation | 11.89 | 10.01 | 8 | 441277 | 97 | 63047640 |
Hepatorenal failure | 11.87 | 10.01 | 19 | 441266 | 675 | 63047062 |
Vomiting | 11.87 | 10.01 | 4196 | 437089 | 555421 | 62492316 |
Road traffic accident | 11.85 | 10.01 | 181 | 441104 | 36451 | 63011286 |
Foot operation | 11.83 | 10.01 | 20 | 441265 | 7211 | 63040526 |
Ultrasound uterus abnormal | 11.79 | 10.01 | 7 | 441278 | 67 | 63047670 |
Congenital syphilitic osteochondritis | 11.78 | 10.01 | 5 | 441280 | 21 | 63047716 |
Blood lactic acid | 11.75 | 10.01 | 8 | 441277 | 99 | 63047638 |
Immune reconstitution inflammatory syndrome | 11.74 | 10.01 | 15 | 441270 | 6069 | 63041668 |
Blood parathyroid hormone increased | 11.72 | 10.01 | 47 | 441238 | 2991 | 63044746 |
Bronchiectasis | 11.72 | 10.01 | 65 | 441220 | 16077 | 63031660 |
Electrocardiogram QT prolonged | 11.71 | 10.01 | 516 | 440769 | 59014 | 62988723 |
Pseudoaldosteronism | 11.70 | 10.01 | 7 | 441278 | 68 | 63047669 |
Therapeutic product effect increased | 11.68 | 10.01 | 26 | 441259 | 1189 | 63046548 |
Vascular access site pain | 11.68 | 10.01 | 8 | 441277 | 100 | 63047637 |
Visual acuity reduced | 11.68 | 10.01 | 215 | 441070 | 21611 | 63026126 |
Carcinoid tumour | 11.67 | 10.01 | 14 | 441271 | 377 | 63047360 |
Mouth haemorrhage | 11.66 | 10.01 | 84 | 441201 | 6699 | 63041038 |
Traumatic haemorrhage | 11.63 | 10.01 | 17 | 441268 | 557 | 63047180 |
Gastric cyst | 11.61 | 10.01 | 8 | 441277 | 101 | 63047636 |
Peritoneal dialysis complication | 11.61 | 10.01 | 26 | 441259 | 1194 | 63046543 |
Thalamus haemorrhage | 11.57 | 10.01 | 19 | 441266 | 690 | 63047047 |
Adrenocortical carcinoma | 11.55 | 10.01 | 6 | 441279 | 43 | 63047694 |
Withdrawal hypertension | 11.55 | 10.01 | 9 | 441276 | 139 | 63047598 |
Hepatic cirrhosis | 11.50 | 10.01 | 113 | 441172 | 24621 | 63023116 |
Glomerulonephritis | 11.45 | 10.01 | 33 | 441252 | 1773 | 63045964 |
Renal injury | 11.44 | 10.01 | 108 | 441177 | 9331 | 63038406 |
Gastric pH increased | 11.44 | 10.01 | 6 | 441279 | 44 | 63047693 |
Tenderness | 11.43 | 10.01 | 101 | 441184 | 22477 | 63025260 |
Acquired porphyria | 11.43 | 10.01 | 5 | 441280 | 23 | 63047714 |
Porphyrins urine increased | 11.43 | 10.01 | 5 | 441280 | 23 | 63047714 |
Faeces hard | 11.42 | 10.01 | 37 | 441248 | 2120 | 63045617 |
Hyperparathyroidism primary | 11.41 | 10.01 | 14 | 441271 | 386 | 63047351 |
Accelerated hypertension | 11.41 | 10.01 | 15 | 441270 | 444 | 63047293 |
Faecal calprotectin increased | 11.40 | 10.01 | 4 | 441281 | 3199 | 63044538 |
Lichen planus | 11.39 | 10.01 | 39 | 441246 | 2299 | 63045438 |
Neurodegenerative disorder | 11.37 | 10.01 | 13 | 441272 | 332 | 63047405 |
Exostosis | 11.35 | 10.01 | 75 | 441210 | 17787 | 63029950 |
Injection site haemorrhage | 11.34 | 10.01 | 111 | 441174 | 24203 | 63023534 |
Device use error | 11.33 | 10.01 | 14 | 441271 | 5747 | 63041990 |
Pulmonary hypoplasia | 11.32 | 10.01 | 12 | 441273 | 281 | 63047456 |
Systemic infection | 11.30 | 10.01 | 63 | 441222 | 4597 | 63043140 |
Gastroenteritis | 11.27 | 10.01 | 253 | 441032 | 26337 | 63021400 |
Cardiac valve sclerosis | 11.26 | 10.01 | 5 | 441280 | 24 | 63047713 |
Hypereosinophilic syndrome | 11.22 | 10.01 | 12 | 441273 | 284 | 63047453 |
Haemorrhagic infarction | 11.19 | 10.01 | 12 | 441273 | 285 | 63047452 |
Uveitis | 11.18 | 10.01 | 47 | 441238 | 12506 | 63035231 |
Aortic occlusion | 11.17 | 10.01 | 8 | 441277 | 108 | 63047629 |
Intermenstrual bleeding | 11.15 | 10.01 | 24 | 441261 | 7902 | 63039835 |
Hypoaesthesia | 11.13 | 10.01 | 1013 | 440272 | 167380 | 62880357 |
Mydriasis | 11.13 | 10.01 | 44 | 441241 | 11912 | 63035825 |
Coronary arterial stent insertion | 11.10 | 10.01 | 44 | 441241 | 2785 | 63044952 |
Product administration error | 11.09 | 10.01 | 218 | 441067 | 22179 | 63025558 |
Fibrosis | 11.07 | 10.01 | 58 | 441227 | 4134 | 63043603 |
Toxic epidermal necrolysis | 11.04 | 10.01 | 242 | 441043 | 25092 | 63022645 |
Blood lactic acid decreased | 11.03 | 10.01 | 9 | 441276 | 149 | 63047588 |
Duodenal ulcer haemorrhage | 11.03 | 10.01 | 40 | 441245 | 2427 | 63045310 |
Wrong drug | 10.99 | 10.01 | 10 | 441275 | 193 | 63047544 |
Nightmare | 10.95 | 10.01 | 191 | 441094 | 19003 | 63028734 |
IgA nephropathy | 10.95 | 10.01 | 17 | 441268 | 588 | 63047149 |
Proctitis | 10.94 | 10.01 | 13 | 441272 | 5428 | 63042309 |
Blood pressure diastolic decreased | 10.90 | 10.01 | 220 | 441065 | 22486 | 63025251 |
Peripheral artery stenosis | 10.89 | 10.01 | 17 | 441268 | 591 | 63047146 |
Abdominal distension | 10.89 | 10.01 | 720 | 440565 | 85895 | 62961842 |
Renal neoplasm | 10.86 | 10.01 | 26 | 441259 | 1248 | 63046489 |
Hyperplastic cholecystopathy | 10.79 | 10.01 | 9 | 441276 | 154 | 63047583 |
Pharyngitis streptococcal | 10.76 | 10.01 | 38 | 441247 | 10634 | 63037103 |
Oesophageal achalasia | 10.74 | 10.01 | 15 | 441270 | 471 | 63047266 |
Neurofibrosarcoma | 10.74 | 10.01 | 9 | 441276 | 155 | 63047582 |
Tinnitus | 10.73 | 10.01 | 324 | 440961 | 35304 | 63012433 |
Erythema multiforme | 10.70 | 10.01 | 113 | 441172 | 10056 | 63037681 |
Bronchial secretion retention | 10.69 | 10.01 | 3 | 441282 | 2770 | 63044967 |
Pneumothorax traumatic | 10.64 | 10.01 | 9 | 441276 | 157 | 63047580 |
Oesophageal carcinoma recurrent | 10.64 | 10.01 | 5 | 441280 | 28 | 63047709 |
Diabetic retinopathy | 10.63 | 10.01 | 38 | 441247 | 2289 | 63045448 |
Oesophageal atresia | 10.62 | 10.01 | 16 | 441269 | 539 | 63047198 |
Periarticular disorder | 10.61 | 10.01 | 6 | 441279 | 52 | 63047685 |
Base excess decreased | 10.60 | 10.01 | 7 | 441278 | 82 | 63047655 |
Musculoskeletal disorder | 10.60 | 10.01 | 92 | 441193 | 20552 | 63027185 |
Carcinoid tumour of the stomach | 10.59 | 10.01 | 9 | 441276 | 158 | 63047579 |
Nasal polyps | 10.54 | 10.01 | 16 | 441269 | 6023 | 63041714 |
Urate nephropathy | 10.52 | 10.01 | 8 | 441277 | 119 | 63047618 |
Retinopathy proliferative | 10.51 | 10.01 | 6 | 441279 | 53 | 63047684 |
Febrile bone marrow aplasia | 10.45 | 10.01 | 22 | 441263 | 7303 | 63040434 |
Blood lactate dehydrogenase increased | 10.45 | 10.01 | 222 | 441063 | 22894 | 63024843 |
Page kidney | 10.44 | 10.01 | 4 | 441281 | 12 | 63047725 |
Osteocalcin decreased | 10.42 | 10.01 | 6 | 441279 | 54 | 63047683 |
No adverse event | 10.40 | 10.01 | 214 | 441071 | 41191 | 63006546 |
Porphyrins stool increased | 10.36 | 10.01 | 5 | 441280 | 30 | 63047707 |
Renal cyst infection | 10.35 | 10.01 | 8 | 441277 | 122 | 63047615 |
Congenital uterine anomaly | 10.35 | 10.01 | 8 | 441277 | 122 | 63047615 |
Facial nerve disorder | 10.32 | 10.01 | 16 | 441269 | 553 | 63047184 |
Unresponsive to stimuli | 10.31 | 10.01 | 308 | 440977 | 33508 | 63014229 |
Gastric ulcer | 10.28 | 10.01 | 229 | 441056 | 23808 | 63023929 |
Cerebrovascular insufficiency | 10.25 | 10.01 | 7 | 441278 | 87 | 63047650 |
Secondary hypertension | 10.23 | 10.01 | 9 | 441276 | 166 | 63047571 |
Varicella zoster virus infection | 10.20 | 10.01 | 3 | 441282 | 2686 | 63045051 |
Anal fistula | 10.20 | 10.01 | 6 | 441279 | 3545 | 63044192 |
Lymphadenopathy | 10.19 | 10.01 | 197 | 441088 | 38261 | 63009476 |
Oculomucocutaneous syndrome | 10.19 | 10.01 | 8 | 441277 | 125 | 63047612 |
Aspergillus infection | 10.19 | 10.01 | 26 | 441259 | 8067 | 63039670 |
Urine flow decreased | 10.16 | 10.01 | 11 | 441274 | 264 | 63047473 |
Normochromic normocytic anaemia | 10.15 | 10.01 | 61 | 441224 | 4575 | 63043162 |
Obsessive-compulsive disorder | 10.14 | 10.01 | 8 | 441277 | 4052 | 63043685 |
Optic nerve injury | 10.13 | 10.01 | 16 | 441269 | 562 | 63047175 |
Blood sodium abnormal | 10.10 | 10.01 | 18 | 441267 | 699 | 63047038 |
Face oedema | 10.10 | 10.01 | 197 | 441088 | 20015 | 63027722 |
Thrombotic thrombocytopenic purpura | 10.08 | 10.01 | 53 | 441232 | 3783 | 63043954 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Completed suicide | 682.31 | 11.16 | 2352 | 348528 | 95816 | 34510235 |
Drug abuse | 477.98 | 11.16 | 198 | 350682 | 98898 | 34507153 |
Off label use | 421.75 | 11.16 | 2481 | 348399 | 417043 | 34189008 |
Gingival hypertrophy | 409.26 | 11.16 | 245 | 350635 | 1576 | 34604475 |
Drug ineffective | 396.72 | 11.16 | 2824 | 348056 | 453927 | 34152124 |
Shock | 267.70 | 11.16 | 684 | 350196 | 23495 | 34582556 |
Blood pressure inadequately controlled | 261.66 | 11.16 | 215 | 350665 | 2425 | 34603626 |
Hypotension | 251.89 | 11.16 | 3360 | 347520 | 218289 | 34387762 |
Intentional overdose | 231.27 | 11.16 | 960 | 349920 | 42714 | 34563337 |
Bradycardia | 228.35 | 11.16 | 1416 | 349464 | 74002 | 34532049 |
Hypertensive crisis | 209.46 | 11.16 | 341 | 350539 | 8410 | 34597641 |
Foetal exposure during pregnancy | 190.34 | 11.16 | 72 | 350808 | 38029 | 34568022 |
Product use in unapproved indication | 188.27 | 11.16 | 580 | 350300 | 116919 | 34489132 |
Distributive shock | 186.14 | 11.16 | 130 | 350750 | 1124 | 34604927 |
Neutropenia | 182.28 | 11.16 | 881 | 349999 | 155897 | 34450154 |
Oedema peripheral | 178.77 | 11.16 | 1914 | 348966 | 117898 | 34488153 |
Acute kidney injury | 171.13 | 11.16 | 4135 | 346745 | 300853 | 34305198 |
Febrile neutropenia | 167.91 | 11.16 | 754 | 350126 | 136095 | 34469956 |
Treatment failure | 158.50 | 11.16 | 141 | 350739 | 46556 | 34559495 |
Blood pressure increased | 157.80 | 11.16 | 1462 | 349418 | 86640 | 34519411 |
Death | 151.52 | 11.16 | 2952 | 347928 | 395097 | 34210954 |
Non-cardiogenic pulmonary oedema | 140.98 | 11.16 | 86 | 350794 | 575 | 34605476 |
Angioedema | 137.37 | 11.16 | 739 | 350141 | 36635 | 34569416 |
Cerebral infarction | 118.51 | 11.16 | 568 | 350312 | 26887 | 34579164 |
Syncope | 116.51 | 11.16 | 1417 | 349463 | 90034 | 34516017 |
Blood creatinine increased | 111.34 | 11.16 | 1449 | 349431 | 93527 | 34512524 |
Angina pectoris | 104.50 | 11.16 | 604 | 350276 | 30759 | 34575292 |
Hyperkalaemia | 102.66 | 11.16 | 1107 | 349773 | 68282 | 34537769 |
Rhabdomyolysis | 96.96 | 11.16 | 1079 | 349801 | 67084 | 34538967 |
Renal impairment | 96.54 | 11.16 | 1407 | 349473 | 93106 | 34512945 |
Drug resistance | 93.23 | 11.16 | 74 | 350806 | 25853 | 34580198 |
Hypokalaemia | 92.84 | 11.16 | 943 | 349937 | 57271 | 34548780 |
Thrombocytopenia | 88.80 | 11.16 | 1072 | 349808 | 155175 | 34450876 |
Swollen tongue | 86.04 | 11.16 | 332 | 350548 | 14273 | 34591778 |
Drug dependence | 85.98 | 11.16 | 70 | 350810 | 24147 | 34581904 |
Premature baby | 85.64 | 11.16 | 45 | 350835 | 19588 | 34586463 |
Cerebrovascular accident | 78.27 | 11.16 | 1241 | 349639 | 83570 | 34522481 |
Metabolic acidosis | 78.20 | 11.16 | 725 | 350155 | 42955 | 34563096 |
Chronic kidney disease | 77.33 | 11.16 | 691 | 350189 | 40519 | 34565532 |
Vasoplegia syndrome | 76.78 | 11.16 | 94 | 350786 | 1762 | 34604289 |
Pancytopenia | 74.97 | 11.16 | 603 | 350277 | 94554 | 34511497 |
Dizziness | 71.80 | 11.16 | 2776 | 348104 | 215745 | 34390306 |
Suspected suicide | 70.81 | 11.16 | 151 | 350729 | 4597 | 34601454 |
Sepsis | 70.63 | 11.16 | 1211 | 349669 | 165350 | 34440701 |
Product use issue | 69.47 | 11.16 | 362 | 350518 | 62854 | 34543197 |
Aggression | 65.45 | 11.16 | 188 | 350692 | 38776 | 34567275 |
Blood pressure systolic increased | 65.07 | 11.16 | 424 | 350456 | 22528 | 34583523 |
Pathogen resistance | 64.96 | 11.16 | 9 | 350871 | 9473 | 34596578 |
Infusion related reaction | 63.38 | 11.16 | 295 | 350585 | 52762 | 34553289 |
Immune reconstitution inflammatory syndrome | 63.21 | 11.16 | 7 | 350873 | 8752 | 34597299 |
Leukopenia | 62.49 | 11.16 | 372 | 350508 | 62484 | 34543567 |
Suicide attempt | 62.04 | 11.16 | 633 | 350247 | 38483 | 34567568 |
Lip swelling | 61.14 | 11.16 | 321 | 350559 | 15759 | 34590292 |
Disease progression | 60.40 | 11.16 | 744 | 350136 | 107333 | 34498718 |
Lactic acidosis | 59.66 | 11.16 | 572 | 350308 | 34200 | 34571851 |
Drug ineffective for unapproved indication | 58.61 | 11.16 | 92 | 350788 | 23623 | 34582428 |
Proteinuria | 56.95 | 11.16 | 351 | 350529 | 18291 | 34587760 |
Rheumatoid arthritis | 56.82 | 11.16 | 195 | 350685 | 38043 | 34568008 |
Myelosuppression | 55.38 | 11.16 | 67 | 350813 | 19198 | 34586853 |
Pyrexia | 55.08 | 11.16 | 2757 | 348123 | 330256 | 34275795 |
Nocturia | 53.66 | 11.16 | 224 | 350656 | 9986 | 34596065 |
C-reactive protein abnormal | 53.63 | 11.16 | 11 | 350869 | 8699 | 34597352 |
Multiple organ dysfunction syndrome | 53.27 | 11.16 | 501 | 350379 | 76065 | 34529986 |
Exposure during pregnancy | 51.58 | 11.16 | 13 | 350867 | 8921 | 34597130 |
Hypertension | 49.73 | 11.16 | 1754 | 349126 | 134689 | 34471362 |
Septic shock | 49.56 | 11.16 | 471 | 350409 | 71363 | 34534688 |
Progressive multifocal leukoencephalopathy | 49.51 | 11.16 | 18 | 350862 | 9746 | 34596305 |
Gastrointestinal tract mucosal pigmentation | 48.76 | 11.16 | 40 | 350840 | 450 | 34605601 |
Synovitis | 48.28 | 11.16 | 42 | 350838 | 14024 | 34592027 |
Cytokine release syndrome | 48.21 | 11.16 | 98 | 350782 | 22779 | 34583272 |
Gingival swelling | 47.63 | 11.16 | 61 | 350819 | 1199 | 34604852 |
Myalgia | 47.06 | 11.16 | 1141 | 349739 | 82969 | 34523082 |
Pemphigoid | 47.02 | 11.16 | 192 | 350688 | 8474 | 34597577 |
Renal failure | 47.00 | 11.16 | 1676 | 349204 | 128881 | 34477170 |
Intentional product use issue | 46.65 | 11.16 | 380 | 350500 | 59436 | 34546615 |
Glycosylated haemoglobin increased | 46.13 | 11.16 | 231 | 350649 | 11129 | 34594922 |
Hyperdynamic left ventricle | 45.94 | 11.16 | 27 | 350853 | 167 | 34605884 |
Pulmonary oedema | 45.53 | 11.16 | 700 | 350180 | 46829 | 34559222 |
Chronic pigmented purpura | 45.15 | 11.16 | 23 | 350857 | 102 | 34605949 |
Myocardial depression | 44.96 | 11.16 | 18 | 350862 | 38 | 34606013 |
Infection | 44.54 | 11.16 | 643 | 350237 | 90272 | 34515779 |
Orthostatic hypotension | 44.28 | 11.16 | 426 | 350454 | 25493 | 34580558 |
Agitation | 44.14 | 11.16 | 366 | 350514 | 57033 | 34549018 |
Cardiac failure congestive | 43.73 | 11.16 | 1120 | 349760 | 82150 | 34523901 |
Sedation | 43.40 | 11.16 | 91 | 350789 | 20915 | 34585136 |
Bronchopulmonary aspergillosis | 43.19 | 11.16 | 50 | 350830 | 14609 | 34591442 |
Renal cell carcinoma | 43.17 | 11.16 | 130 | 350750 | 4918 | 34601133 |
Nephrotic syndrome | 43 | 11.16 | 166 | 350714 | 7137 | 34598914 |
Palmar-plantar erythrodysaesthesia syndrome | 41.52 | 11.16 | 300 | 350580 | 16495 | 34589556 |
Product monitoring error | 41.47 | 11.16 | 117 | 350763 | 4264 | 34601787 |
Asthma | 41.15 | 11.16 | 629 | 350251 | 42027 | 34564024 |
Infective pulmonary exacerbation of cystic fibrosis | 41.03 | 11.16 | 9 | 350871 | 6792 | 34599259 |
Seizure | 41.03 | 11.16 | 773 | 350107 | 104084 | 34501967 |
Multiple-drug resistance | 41.00 | 11.16 | 3 | 350877 | 5236 | 34600815 |
Interstitial lung disease | 40.97 | 11.16 | 900 | 349980 | 64382 | 34541669 |
Mucosal inflammation | 40.84 | 11.16 | 224 | 350656 | 38398 | 34567653 |
Erectile dysfunction | 40.76 | 11.16 | 350 | 350530 | 20287 | 34585764 |
Post transplant lymphoproliferative disorder | 40.71 | 11.16 | 8 | 350872 | 6520 | 34599531 |
Acute graft versus host disease | 40.49 | 11.16 | 8 | 350872 | 6495 | 34599556 |
Gingival bleeding | 40.31 | 11.16 | 158 | 350722 | 6842 | 34599209 |
Carotid artery stenosis | 39.89 | 11.16 | 126 | 350754 | 4893 | 34601158 |
Therapeutic product effect decreased | 39.83 | 11.16 | 196 | 350684 | 34547 | 34571504 |
Haemophagocytic lymphohistiocytosis | 39.58 | 11.16 | 43 | 350837 | 12930 | 34593121 |
Condition aggravated | 39.31 | 11.16 | 1554 | 349326 | 190642 | 34415409 |
Depression | 39.17 | 11.16 | 712 | 350168 | 96386 | 34509665 |
5-hydroxyindolacetic acid in urine increased | 38.98 | 11.16 | 27 | 350853 | 230 | 34605821 |
Haematotoxicity | 38.45 | 11.16 | 17 | 350863 | 8177 | 34597874 |
Atrioventricular block complete | 38.20 | 11.16 | 190 | 350690 | 9129 | 34596922 |
Therapy partial responder | 37.76 | 11.16 | 25 | 350855 | 9591 | 34596460 |
Sinus bradycardia | 37.68 | 11.16 | 241 | 350639 | 12722 | 34593329 |
Suicidal ideation | 37.56 | 11.16 | 244 | 350636 | 40144 | 34565907 |
Thalamus haemorrhage | 36.96 | 11.16 | 48 | 350832 | 957 | 34605094 |
Myocardial infarction | 36.59 | 11.16 | 1525 | 349355 | 119560 | 34486491 |
Contraindicated product administered | 36.54 | 11.16 | 103 | 350777 | 21378 | 34584673 |
Cytomegalovirus infection | 36.35 | 11.16 | 137 | 350743 | 25998 | 34580053 |
Coronary artery disease | 36.28 | 11.16 | 684 | 350196 | 47621 | 34558430 |
Breath sounds abnormal | 36.19 | 11.16 | 151 | 350729 | 6730 | 34599321 |
Renal artery stenosis | 36.16 | 11.16 | 74 | 350806 | 2187 | 34603864 |
Tachycardia | 35.66 | 11.16 | 617 | 350263 | 84155 | 34521896 |
Psychotic disorder | 35.45 | 11.16 | 126 | 350754 | 24326 | 34581725 |
Hypomagnesaemia | 34.82 | 11.16 | 354 | 350526 | 21497 | 34584554 |
Stenosis | 34.71 | 11.16 | 57 | 350823 | 1416 | 34604635 |
Appendicolith | 34.26 | 11.16 | 22 | 350858 | 8579 | 34597472 |
Bone marrow failure | 34.13 | 11.16 | 164 | 350716 | 29089 | 34576962 |
Irritability | 33.97 | 11.16 | 130 | 350750 | 24560 | 34581491 |
Diastolic dysfunction | 33.81 | 11.16 | 138 | 350742 | 6089 | 34599962 |
Wrong technique in product usage process | 33.16 | 11.16 | 218 | 350662 | 35768 | 34570283 |
Aspergillus infection | 32.76 | 11.16 | 45 | 350835 | 12209 | 34593842 |
Tongue oedema | 32.34 | 11.16 | 84 | 350796 | 2913 | 34603138 |
Primary hyperaldosteronism | 32.30 | 11.16 | 16 | 350864 | 66 | 34605985 |
Congenital hiatus hernia | 32.12 | 11.16 | 41 | 350839 | 803 | 34605248 |
Sinusitis | 31.83 | 11.16 | 264 | 350616 | 41138 | 34564913 |
Mucormycosis | 31.79 | 11.16 | 10 | 350870 | 5932 | 34600119 |
Macroglossia | 31.68 | 11.16 | 29 | 350851 | 382 | 34605669 |
Graft versus host disease | 31.19 | 11.16 | 36 | 350844 | 10533 | 34595518 |
Loss of consciousness | 31.16 | 11.16 | 1067 | 349813 | 81600 | 34524451 |
Hypoglycaemia | 31.08 | 11.16 | 743 | 350137 | 53897 | 34552154 |
Acute myocardial infarction | 31.02 | 11.16 | 732 | 350148 | 52987 | 34553064 |
Transient ischaemic attack | 30.94 | 11.16 | 418 | 350462 | 27195 | 34578856 |
Abnormal behaviour | 30.90 | 11.16 | 137 | 350743 | 24832 | 34581219 |
Atrioventricular block first degree | 30.73 | 11.16 | 132 | 350748 | 5960 | 34600091 |
Dermatomyositis | 30.71 | 11.16 | 50 | 350830 | 1233 | 34604818 |
Cytomegalovirus infection reactivation | 30.42 | 11.16 | 7 | 350873 | 5111 | 34600940 |
Chronic graft versus host disease | 30.31 | 11.16 | 4 | 350876 | 4369 | 34601682 |
Palpitations | 30.30 | 11.16 | 567 | 350313 | 39419 | 34566632 |
Overdose | 30.09 | 11.16 | 1158 | 349722 | 89901 | 34516150 |
Injection site pain | 29.85 | 11.16 | 249 | 350631 | 38756 | 34567295 |
Substance abuse | 29.82 | 11.16 | 20 | 350860 | 7621 | 34598430 |
Bone erosion | 29.51 | 11.16 | 3 | 350877 | 4012 | 34602039 |
Acute hepatic failure | 29.05 | 11.16 | 61 | 350819 | 14013 | 34592038 |
Product dose omission issue | 28.96 | 11.16 | 948 | 349932 | 118763 | 34487288 |
Drug withdrawal syndrome | 28.88 | 11.16 | 102 | 350778 | 19732 | 34586319 |
Plasmapheresis | 28.84 | 11.16 | 25 | 350855 | 305 | 34605746 |
Neutrophil count decreased | 28.82 | 11.16 | 351 | 350529 | 50753 | 34555298 |
Candida infection | 28.64 | 11.16 | 87 | 350793 | 17628 | 34588423 |
Immune-mediated myositis | 28.51 | 11.16 | 64 | 350816 | 2019 | 34604032 |
Clear cell renal cell carcinoma | 27.86 | 11.16 | 45 | 350835 | 1102 | 34604949 |
Dyspnoea | 27.68 | 11.16 | 4246 | 346634 | 372536 | 34233515 |
Hypertensive heart disease | 27.55 | 11.16 | 69 | 350811 | 2339 | 34603712 |
Polymyositis | 27.43 | 11.16 | 51 | 350829 | 1402 | 34604649 |
Hepatojugular reflux | 27.43 | 11.16 | 32 | 350848 | 569 | 34605482 |
Arthropathy | 27.39 | 11.16 | 158 | 350722 | 26749 | 34579302 |
Blood mercury abnormal | 27.35 | 11.16 | 21 | 350859 | 213 | 34605838 |
No adverse event | 27.06 | 11.16 | 128 | 350752 | 22799 | 34583252 |
Diabetes mellitus inadequate control | 26.93 | 11.16 | 229 | 350651 | 13235 | 34592816 |
Akathisia | 26.89 | 11.16 | 25 | 350855 | 8084 | 34597967 |
Psoriatic arthropathy | 26.75 | 11.16 | 105 | 350775 | 19693 | 34586358 |
Therapeutic product effect incomplete | 26.69 | 11.16 | 352 | 350528 | 50189 | 34555862 |
Peripheral swelling | 26.63 | 11.16 | 979 | 349901 | 75562 | 34530489 |
Drug use disorder | 26.42 | 11.16 | 5 | 350875 | 4186 | 34601865 |
Hyponatraemia | 26.24 | 11.16 | 1047 | 349833 | 81644 | 34524407 |
Vertebral osteophyte | 26.18 | 11.16 | 13 | 350867 | 54 | 34605997 |
Adenovirus infection | 26.14 | 11.16 | 10 | 350870 | 5247 | 34600804 |
Fall | 26.09 | 11.16 | 2370 | 348510 | 200515 | 34405536 |
Electrocardiogram Q wave abnormal | 25.84 | 11.16 | 27 | 350853 | 422 | 34605629 |
Blood creatine phosphokinase increased | 25.82 | 11.16 | 611 | 350269 | 44246 | 34561805 |
Periodontitis | 25.63 | 11.16 | 59 | 350821 | 1893 | 34604158 |
Hospitalisation | 25.61 | 11.16 | 409 | 350471 | 56493 | 34549558 |
Accelerated hypertension | 25.54 | 11.16 | 21 | 350859 | 237 | 34605814 |
Intentional product misuse | 25.45 | 11.16 | 314 | 350566 | 45297 | 34560754 |
Electrocardiogram QRS complex prolonged | 25.43 | 11.16 | 107 | 350773 | 4787 | 34601264 |
Pelvic mass | 25.26 | 11.16 | 20 | 350860 | 213 | 34605838 |
Gout | 25.21 | 11.16 | 300 | 350580 | 18953 | 34587098 |
Paranoia | 25.17 | 11.16 | 52 | 350828 | 12016 | 34594035 |
Orbital myositis | 24.96 | 11.16 | 16 | 350864 | 118 | 34605933 |
Ventricular septal defect | 24.75 | 11.16 | 5 | 350875 | 3996 | 34602055 |
Metastatic renal cell carcinoma | 24.58 | 11.16 | 60 | 350820 | 2001 | 34604050 |
Gravitational oedema | 24.27 | 11.16 | 32 | 350848 | 648 | 34605403 |
Angina unstable | 24.26 | 11.16 | 200 | 350680 | 11453 | 34594598 |
Dyspnoea exertional | 24.15 | 11.16 | 587 | 350293 | 42692 | 34563359 |
Hyperplasia | 24.04 | 11.16 | 30 | 350850 | 574 | 34605477 |
Myelodysplastic syndrome | 24.00 | 11.16 | 105 | 350775 | 19103 | 34586948 |
Oropharyngeal oedema | 23.90 | 11.16 | 14 | 350866 | 86 | 34605965 |
Staphylococcal infection | 23.79 | 11.16 | 212 | 350668 | 32548 | 34573503 |
Obstructive airways disorder | 23.73 | 11.16 | 249 | 350631 | 15245 | 34590806 |
Intercepted product preparation error | 23.41 | 11.16 | 6 | 350874 | 4072 | 34601979 |
Maternal exposure during pregnancy | 23.40 | 11.16 | 10 | 350870 | 4908 | 34601143 |
Cytomegalovirus chorioretinitis | 23.23 | 11.16 | 4 | 350876 | 3585 | 34602466 |
Alcohol abuse | 23.19 | 11.16 | 9 | 350871 | 4681 | 34601370 |
Ear infection | 23.15 | 11.16 | 42 | 350838 | 10189 | 34595862 |
Carotid arteriosclerosis | 23.13 | 11.16 | 55 | 350825 | 1803 | 34604248 |
Lacunar infarction | 23.13 | 11.16 | 76 | 350804 | 3014 | 34603037 |
Febrile bone marrow aplasia | 23.12 | 11.16 | 29 | 350851 | 8180 | 34597871 |
Carotid sinus syndrome | 23.05 | 11.16 | 10 | 350870 | 28 | 34606023 |
Drug intolerance | 23.02 | 11.16 | 440 | 350440 | 59130 | 34546921 |
Cognitive disorder | 22.95 | 11.16 | 181 | 350699 | 28512 | 34577539 |
Putamen haemorrhage | 22.88 | 11.16 | 20 | 350860 | 247 | 34605804 |
Allergy to animal | 22.48 | 11.16 | 24 | 350856 | 385 | 34605666 |
Dystonia | 22.39 | 11.16 | 47 | 350833 | 10798 | 34595253 |
Skin toxicity | 22.33 | 11.16 | 10 | 350870 | 4774 | 34601277 |
Diabetic nephropathy | 22.31 | 11.16 | 59 | 350821 | 2069 | 34603982 |
Tenosynovitis | 22.22 | 11.16 | 9 | 350871 | 4561 | 34601490 |
Graft versus host disease in skin | 22.11 | 11.16 | 6 | 350874 | 3919 | 34602132 |
Dyskinesia | 22.08 | 11.16 | 133 | 350747 | 22280 | 34583771 |
Lung diffusion test decreased | 21.82 | 11.16 | 29 | 350851 | 592 | 34605459 |
Acidosis | 21.80 | 11.16 | 186 | 350694 | 10759 | 34595292 |
Dyspnoea at rest | 21.72 | 11.16 | 86 | 350794 | 3742 | 34602309 |
Hypoinsulinaemia | 21.67 | 11.16 | 6 | 350874 | 0 | 34606051 |
Lymphadenopathy | 21.64 | 11.16 | 182 | 350698 | 28281 | 34577770 |
Hyperlipidaemia | 21.55 | 11.16 | 232 | 350648 | 14297 | 34591754 |
BRASH syndrome | 21.54 | 11.16 | 27 | 350853 | 519 | 34605532 |
Pseudolymphoma | 21.52 | 11.16 | 30 | 350850 | 642 | 34605409 |
Gait spastic | 21.36 | 11.16 | 39 | 350841 | 1057 | 34604994 |
Intentional self-injury | 21.29 | 11.16 | 69 | 350811 | 13702 | 34592349 |
Pollakiuria | 21.29 | 11.16 | 296 | 350584 | 19378 | 34586673 |
Therapy non-responder | 21.27 | 11.16 | 271 | 350609 | 38875 | 34567176 |
Oesophageal carcinoma | 21.22 | 11.16 | 38 | 350842 | 9266 | 34596785 |
Vomiting | 21.21 | 11.16 | 2169 | 348711 | 245452 | 34360599 |
Red blood cell sedimentation rate abnormal | 21.15 | 11.16 | 5 | 350875 | 3584 | 34602467 |
Obsessive-compulsive disorder | 21.13 | 11.16 | 15 | 350865 | 5549 | 34600502 |
Acute myeloid leukaemia | 20.98 | 11.16 | 103 | 350777 | 18167 | 34587884 |
Haemorrhage subcutaneous | 20.97 | 11.16 | 61 | 350819 | 2263 | 34603788 |
Device leakage | 20.95 | 11.16 | 21 | 350859 | 6554 | 34599497 |
Heart rate decreased | 20.66 | 11.16 | 440 | 350440 | 31305 | 34574746 |
Aortic dissection | 20.65 | 11.16 | 68 | 350812 | 2700 | 34603351 |
Maternal drugs affecting foetus | 20.64 | 11.16 | 7 | 350873 | 3958 | 34602093 |
Eczema | 20.62 | 11.16 | 279 | 350601 | 18157 | 34587894 |
Fungal infection | 20.59 | 11.16 | 86 | 350794 | 15849 | 34590202 |
Brain stem infarction | 20.55 | 11.16 | 42 | 350838 | 1240 | 34604811 |
Lymphoma | 20.52 | 11.16 | 61 | 350819 | 12446 | 34593605 |
Device issue | 20.50 | 11.16 | 42 | 350838 | 9735 | 34596316 |
Epstein-Barr virus infection | 20.40 | 11.16 | 28 | 350852 | 7600 | 34598451 |
Small for dates baby | 20.32 | 11.16 | 7 | 350873 | 3920 | 34602131 |
Lymphocele | 20.06 | 11.16 | 43 | 350837 | 1314 | 34604737 |
Leukaemoid reaction | 20.05 | 11.16 | 13 | 350867 | 98 | 34605953 |
Diffuse large B-cell lymphoma recurrent | 20.04 | 11.16 | 4 | 350876 | 3224 | 34602827 |
Mouth swelling | 20.01 | 11.16 | 52 | 350828 | 1804 | 34604247 |
Cardiogenic shock | 20.01 | 11.16 | 377 | 350503 | 26241 | 34579810 |
Left ventricular hypertrophy | 19.96 | 11.16 | 145 | 350735 | 7985 | 34598066 |
Migraine | 19.80 | 11.16 | 99 | 350781 | 17379 | 34588672 |
Melaena | 19.78 | 11.16 | 480 | 350400 | 34900 | 34571151 |
Apparent death | 19.73 | 11.16 | 6 | 350874 | 3638 | 34602413 |
Appendicitis | 19.71 | 11.16 | 79 | 350801 | 14728 | 34591323 |
Fibrillary glomerulonephritis | 19.69 | 11.16 | 10 | 350870 | 44 | 34606007 |
Hydronephrosis | 19.66 | 11.16 | 174 | 350706 | 10172 | 34595879 |
Ventricular hypertrophy | 19.64 | 11.16 | 95 | 350785 | 4512 | 34601539 |
Venoocclusive liver disease | 19.59 | 11.16 | 31 | 350849 | 7935 | 34598116 |
Blood urea increased | 19.16 | 11.16 | 419 | 350461 | 29945 | 34576106 |
Nausea | 19.09 | 11.16 | 3059 | 347821 | 336849 | 34269202 |
Microalbuminuria | 19.08 | 11.16 | 29 | 350851 | 673 | 34605378 |
Lipodystrophy acquired | 19.05 | 11.16 | 5 | 350875 | 3339 | 34602712 |
Swelling face | 19.04 | 11.16 | 332 | 350548 | 22773 | 34583278 |
Bundle branch block | 18.95 | 11.16 | 33 | 350847 | 861 | 34605190 |
Mydriasis | 18.92 | 11.16 | 27 | 350853 | 7210 | 34598841 |
Blood pressure decreased | 18.92 | 11.16 | 663 | 350217 | 50852 | 34555199 |
Zoonotic bacterial infection | 18.86 | 11.16 | 10 | 350870 | 49 | 34606002 |
Renal disorder | 18.51 | 11.16 | 359 | 350521 | 25121 | 34580930 |
Peripheral artery occlusion | 18.49 | 11.16 | 48 | 350832 | 1664 | 34604387 |
Asphyxia | 18.37 | 11.16 | 25 | 350855 | 6810 | 34599241 |
Duodenal ulcer haemorrhage | 18.32 | 11.16 | 99 | 350781 | 4914 | 34601137 |
Pneumonia | 18.28 | 11.16 | 3283 | 347597 | 359344 | 34246707 |
Nipple inflammation | 18.24 | 11.16 | 10 | 350870 | 53 | 34605998 |
Osteonecrosis | 18.24 | 11.16 | 82 | 350798 | 14808 | 34591243 |
Cytomegalovirus viraemia | 18.19 | 11.16 | 29 | 350851 | 7401 | 34598650 |
Deep vein thrombosis | 18.16 | 11.16 | 507 | 350373 | 64741 | 34541310 |
Euphoric mood | 18.00 | 11.16 | 18 | 350862 | 5623 | 34600428 |
Eyelid oedema | 17.93 | 11.16 | 100 | 350780 | 5024 | 34601027 |
Neuropathy peripheral | 17.91 | 11.16 | 669 | 350211 | 82594 | 34523457 |
Bundle branch block left | 17.90 | 11.16 | 112 | 350768 | 5867 | 34600184 |
Drug eruption | 17.89 | 11.16 | 290 | 350590 | 19608 | 34586443 |
Myopathy | 17.84 | 11.16 | 186 | 350694 | 11368 | 34594683 |
Epiglottic oedema | 17.78 | 11.16 | 15 | 350865 | 176 | 34605875 |
Product substitution issue | 17.77 | 11.16 | 167 | 350713 | 9928 | 34596123 |
Neurotoxicity | 17.67 | 11.16 | 107 | 350773 | 17903 | 34588148 |
Atrioventricular block | 17.66 | 11.16 | 140 | 350740 | 7923 | 34598128 |
Oedema | 17.63 | 11.16 | 592 | 350288 | 45149 | 34560902 |
Presyncope | 17.60 | 11.16 | 279 | 350601 | 18780 | 34587271 |
Micturition urgency | 17.56 | 11.16 | 119 | 350761 | 6406 | 34599645 |
Dysmorphism | 17.45 | 11.16 | 5 | 350875 | 3151 | 34602900 |
Incorrect route of product administration | 17.45 | 11.16 | 83 | 350797 | 14762 | 34591289 |
Anxiety | 17.36 | 11.16 | 818 | 350062 | 98610 | 34507441 |
Pericardial disease | 17.35 | 11.16 | 22 | 350858 | 428 | 34605623 |
Hepatic failure | 17.33 | 11.16 | 243 | 350637 | 34288 | 34571763 |
Chills | 17.24 | 11.16 | 652 | 350228 | 80391 | 34525660 |
Cerebral haemorrhage | 17.19 | 11.16 | 466 | 350414 | 34471 | 34571580 |
Pain | 17.08 | 11.16 | 1796 | 349084 | 202879 | 34403172 |
Discomfort | 17.02 | 11.16 | 276 | 350604 | 18662 | 34587389 |
Hepatic neoplasm | 16.99 | 11.16 | 51 | 350829 | 1926 | 34604125 |
Helicobacter gastritis | 16.94 | 11.16 | 38 | 350842 | 1198 | 34604853 |
Peripheral arterial occlusive disease | 16.94 | 11.16 | 109 | 350771 | 5765 | 34600286 |
Nasal crusting | 16.91 | 11.16 | 20 | 350860 | 361 | 34605690 |
Diabetic neuropathy | 16.80 | 11.16 | 85 | 350795 | 4112 | 34601939 |
Graft versus host disease in gastrointestinal tract | 16.72 | 11.16 | 8 | 350872 | 3675 | 34602376 |
Hypersensitivity vasculitis | 16.62 | 11.16 | 72 | 350808 | 3263 | 34602788 |
Blood glucose increased | 16.59 | 11.16 | 824 | 350056 | 65894 | 34540157 |
Hypertensive emergency | 16.59 | 11.16 | 34 | 350846 | 1006 | 34605045 |
Hepatic function abnormal | 16.55 | 11.16 | 572 | 350308 | 43791 | 34562260 |
Respiratory alkalosis | 16.53 | 11.16 | 46 | 350834 | 1663 | 34604388 |
Pseudomonas infection | 16.52 | 11.16 | 66 | 350814 | 12316 | 34593735 |
Haemodialysis | 16.52 | 11.16 | 170 | 350710 | 10356 | 34595695 |
Milk-alkali syndrome | 16.45 | 11.16 | 25 | 350855 | 580 | 34605471 |
Hepatocellular carcinoma | 16.24 | 11.16 | 130 | 350750 | 7379 | 34598672 |
Hypocalcaemia | 16.24 | 11.16 | 338 | 350542 | 23951 | 34582100 |
Cardiac dysfunction | 16.17 | 11.16 | 56 | 350824 | 2282 | 34603769 |
Atrial septal defect | 16.15 | 11.16 | 31 | 350849 | 7361 | 34598690 |
Renal function test abnormal | 16.13 | 11.16 | 59 | 350821 | 2471 | 34603580 |
Pulmonary embolism | 16.13 | 11.16 | 736 | 350144 | 89010 | 34517041 |
Viral infection | 16.11 | 11.16 | 107 | 350773 | 17516 | 34588535 |
Pharyngeal oedema | 16.11 | 11.16 | 110 | 350770 | 5937 | 34600114 |
Body temperature increased | 16.10 | 11.16 | 105 | 350775 | 17263 | 34588788 |
Alanine aminotransferase abnormal | 16.09 | 11.16 | 14 | 350866 | 4674 | 34601377 |
Muscle rigidity | 16.06 | 11.16 | 53 | 350827 | 10465 | 34595586 |
Blood pressure diastolic decreased | 15.79 | 11.16 | 150 | 350730 | 8944 | 34597107 |
Atheroembolism | 15.78 | 11.16 | 18 | 350862 | 312 | 34605739 |
Liver carcinoma ruptured | 15.75 | 11.16 | 14 | 350866 | 177 | 34605874 |
Blood pressure abnormal | 15.75 | 11.16 | 137 | 350743 | 7969 | 34598082 |
Electrocardiogram P wave abnormal | 15.72 | 11.16 | 13 | 350867 | 148 | 34605903 |
Low birth weight baby | 15.70 | 11.16 | 35 | 350845 | 7870 | 34598181 |
Rheumatoid nodule | 15.69 | 11.16 | 5 | 350875 | 2942 | 34603109 |
Forced vital capacity decreased | 15.62 | 11.16 | 28 | 350852 | 748 | 34605303 |
Enterococcal infection | 15.55 | 11.16 | 45 | 350835 | 9261 | 34596790 |
Psychomotor skills impaired | 15.55 | 11.16 | 10 | 350870 | 3896 | 34602155 |
Therapeutic response decreased | 15.53 | 11.16 | 204 | 350676 | 29109 | 34576942 |
Hepatic fibrosis | 15.52 | 11.16 | 14 | 350866 | 4593 | 34601458 |
Low density lipoprotein decreased | 15.51 | 11.16 | 35 | 350845 | 1108 | 34604943 |
Needle fatigue | 15.49 | 11.16 | 30 | 350850 | 851 | 34605200 |
Hyperglycaemia | 15.48 | 11.16 | 512 | 350368 | 38968 | 34567083 |
Mitral valve incompetence | 15.44 | 11.16 | 223 | 350657 | 14720 | 34591331 |
Chronic obstructive pulmonary disease | 15.42 | 11.16 | 619 | 350261 | 48299 | 34557752 |
Cardiomegaly | 15.41 | 11.16 | 229 | 350651 | 15209 | 34590842 |
COVID-19 | 15.39 | 11.16 | 629 | 350251 | 76921 | 34529130 |
Herbal interaction | 15.36 | 11.16 | 19 | 350861 | 360 | 34605691 |
Giant cell arteritis | 15.28 | 11.16 | 29 | 350851 | 810 | 34605241 |
Kidney small | 15.27 | 11.16 | 9 | 350871 | 56 | 34605995 |
Prostate cancer | 15.27 | 11.16 | 293 | 350587 | 39356 | 34566695 |
Intervertebral disc displacement | 15.22 | 11.16 | 12 | 350868 | 127 | 34605924 |
Pulmonary valve disease | 15.22 | 11.16 | 18 | 350862 | 325 | 34605726 |
Toxic skin eruption | 15.17 | 11.16 | 178 | 350702 | 11207 | 34594844 |
Tricuspid valve calcification | 15.16 | 11.16 | 5 | 350875 | 4 | 34606047 |
Virologic failure | 15.14 | 11.16 | 8 | 350872 | 3472 | 34602579 |
Dermatitis infected | 15.13 | 11.16 | 11 | 350869 | 102 | 34605949 |
Hepatitis | 15.11 | 11.16 | 160 | 350720 | 23744 | 34582307 |
Sprue-like enteropathy | 15.10 | 11.16 | 22 | 350858 | 491 | 34605560 |
Respiratory failure | 15.05 | 11.16 | 914 | 349966 | 107658 | 34498393 |
Haemodynamic instability | 15.04 | 11.16 | 154 | 350726 | 9369 | 34596682 |
Tricuspid valve incompetence | 15.02 | 11.16 | 157 | 350723 | 9603 | 34596448 |
Left ventricular enlargement | 14.99 | 11.16 | 26 | 350854 | 676 | 34605375 |
Cerebellar haemorrhage | 14.91 | 11.16 | 42 | 350838 | 1529 | 34604522 |
Product solubility abnormal | 14.90 | 11.16 | 22 | 350858 | 497 | 34605554 |
Band neutrophil percentage decreased | 14.88 | 11.16 | 6 | 350874 | 13 | 34606038 |
Pericardial haemorrhage | 14.85 | 11.16 | 67 | 350813 | 3091 | 34602960 |
High density lipoprotein decreased | 14.84 | 11.16 | 70 | 350810 | 3290 | 34602761 |
Yellow skin | 14.83 | 11.16 | 51 | 350829 | 2071 | 34603980 |
Osteoporosis | 14.79 | 11.16 | 71 | 350809 | 12597 | 34593454 |
Tremor | 14.70 | 11.16 | 678 | 350202 | 81909 | 34524142 |
Hyperuricaemia | 14.64 | 11.16 | 134 | 350746 | 7909 | 34598142 |
Device use error | 14.62 | 11.16 | 3 | 350877 | 2372 | 34603679 |
Drug level decreased | 14.58 | 11.16 | 36 | 350844 | 7810 | 34598241 |
Hypospadias | 14.46 | 11.16 | 7 | 350873 | 3194 | 34602857 |
Uveitis | 14.45 | 11.16 | 34 | 350846 | 7501 | 34598550 |
Basophil percentage increased | 14.45 | 11.16 | 4 | 350876 | 0 | 34606051 |
Mucosal membrane hyperplasia | 14.45 | 11.16 | 4 | 350876 | 0 | 34606051 |
Ventricular compliance decreased | 14.45 | 11.16 | 4 | 350876 | 0 | 34606051 |
Glomerular filtration rate decreased | 14.43 | 11.16 | 196 | 350684 | 12765 | 34593286 |
Hepatic enzyme increased | 14.38 | 11.16 | 291 | 350589 | 38789 | 34567262 |
Monoparesis | 14.37 | 11.16 | 54 | 350826 | 2292 | 34603759 |
Encephalitis toxic | 14.27 | 11.16 | 16 | 350864 | 272 | 34605779 |
Anal abscess | 14.27 | 11.16 | 27 | 350853 | 6446 | 34599605 |
Atrial fibrillation | 14.26 | 11.16 | 1420 | 349460 | 120973 | 34485078 |
Tubulointerstitial nephritis | 14.20 | 11.16 | 293 | 350587 | 20731 | 34585320 |
Respiratory arrest | 14.19 | 11.16 | 197 | 350683 | 27846 | 34578205 |
Muscle necrosis | 14.17 | 11.16 | 29 | 350851 | 857 | 34605194 |
Chest discomfort | 14.08 | 11.16 | 676 | 350204 | 53854 | 34552197 |
Decreased appetite | 14.07 | 11.16 | 1891 | 348989 | 164501 | 34441550 |
Sickle cell anaemia with crisis | 14.03 | 11.16 | 12 | 350868 | 4041 | 34602010 |
Noninfective gingivitis | 13.97 | 11.16 | 18 | 350862 | 356 | 34605695 |
Blood potassium increased | 13.94 | 11.16 | 238 | 350642 | 16257 | 34589794 |
Acute coronary syndrome | 13.94 | 11.16 | 202 | 350678 | 13343 | 34592708 |
Antipsychotic drug level increased | 13.93 | 11.16 | 11 | 350869 | 3854 | 34602197 |
Abscess | 13.93 | 11.16 | 66 | 350814 | 11751 | 34594300 |
Miosis | 13.91 | 11.16 | 49 | 350831 | 9486 | 34596565 |
Nephrogenic systemic fibrosis | 13.90 | 11.16 | 78 | 350802 | 3927 | 34602124 |
Blood potassium decreased | 13.90 | 11.16 | 255 | 350625 | 17660 | 34588391 |
Neonatal respiratory distress syndrome | 13.90 | 11.16 | 12 | 350868 | 4022 | 34602029 |
Malignant neoplasm progression | 13.88 | 11.16 | 732 | 350148 | 87314 | 34518737 |
Lacrimal disorder | 13.87 | 11.16 | 17 | 350863 | 319 | 34605732 |
Brain abscess | 13.87 | 11.16 | 7 | 350873 | 3118 | 34602933 |
White blood cell count decreased | 13.85 | 11.16 | 800 | 350080 | 94645 | 34511406 |
Hepatic cytolysis | 13.77 | 11.16 | 87 | 350793 | 14409 | 34591642 |
Left atrial enlargement | 13.75 | 11.16 | 29 | 350851 | 876 | 34605175 |
Thrombotic cerebral infarction | 13.74 | 11.16 | 18 | 350862 | 362 | 34605689 |
Strongyloidiasis | 13.74 | 11.16 | 5 | 350875 | 2706 | 34603345 |
Pneumocystis jirovecii pneumonia | 13.68 | 11.16 | 129 | 350751 | 19581 | 34586470 |
Sinus node dysfunction | 13.61 | 11.16 | 81 | 350799 | 4168 | 34601883 |
Hypertensive encephalopathy | 13.60 | 11.16 | 18 | 350862 | 366 | 34605685 |
Full blood count abnormal | 13.55 | 11.16 | 263 | 350617 | 18405 | 34587646 |
Toxic nodular goitre | 13.53 | 11.16 | 6 | 350874 | 18 | 34606033 |
Chest pain | 13.53 | 11.16 | 1462 | 349418 | 125300 | 34480751 |
Neuroleptic malignant syndrome | 13.49 | 11.16 | 115 | 350765 | 17819 | 34588232 |
Prostate cancer stage IV | 13.48 | 11.16 | 4 | 350876 | 2464 | 34603587 |
Histology abnormal | 13.48 | 11.16 | 16 | 350864 | 290 | 34605761 |
Weight increased | 13.46 | 11.16 | 780 | 350100 | 92253 | 34513798 |
Pelvic cyst | 13.41 | 11.16 | 7 | 350873 | 33 | 34606018 |
Hypothyroidism | 13.37 | 11.16 | 289 | 350591 | 20613 | 34585438 |
Polypectomy | 13.35 | 11.16 | 22 | 350858 | 548 | 34605503 |
Cachexia | 13.33 | 11.16 | 33 | 350847 | 7153 | 34598898 |
Pneumonia cytomegaloviral | 13.32 | 11.16 | 7 | 350873 | 3047 | 34603004 |
Inappropriate schedule of product administration | 13.29 | 11.16 | 501 | 350379 | 61795 | 34544256 |
Anal fistula | 13.29 | 11.16 | 21 | 350859 | 5378 | 34600673 |
Cutaneous lupus erythematosus | 13.27 | 11.16 | 26 | 350854 | 744 | 34605307 |
Blood pressure systolic decreased | 13.26 | 11.16 | 84 | 350796 | 4419 | 34601632 |
Splenic cyst | 13.18 | 11.16 | 11 | 350869 | 127 | 34605924 |
Musculoskeletal stiffness | 13.17 | 11.16 | 362 | 350518 | 46318 | 34559733 |
Nodal rhythm | 13.14 | 11.16 | 38 | 350842 | 1405 | 34604646 |
Hyperthermia | 13.11 | 11.16 | 58 | 350822 | 10519 | 34595532 |
Drug interaction | 13.08 | 11.16 | 2515 | 348365 | 223431 | 34382620 |
Blood aldosterone increased | 13.07 | 11.16 | 6 | 350874 | 20 | 34606031 |
Thromboangiitis obliterans | 13.07 | 11.16 | 6 | 350874 | 20 | 34606031 |
Thrombotic stroke | 13.06 | 11.16 | 15 | 350865 | 262 | 34605789 |
Hair colour changes | 13.02 | 11.16 | 45 | 350835 | 1832 | 34604219 |
Sex hormone binding globulin increased | 13 | 11.16 | 5 | 350875 | 9 | 34606042 |
Relapsing-remitting multiple sclerosis | 12.99 | 11.16 | 31 | 350849 | 1019 | 34605032 |
Fracture displacement | 12.98 | 11.16 | 10 | 350870 | 102 | 34605949 |
Intestinal stenosis | 12.97 | 11.16 | 3 | 350877 | 2183 | 34603868 |
Suspected suicide attempt | 12.97 | 11.16 | 11 | 350869 | 130 | 34605921 |
Lymphomatoid papulosis | 12.97 | 11.16 | 13 | 350867 | 193 | 34605858 |
Immunodeficiency | 12.96 | 11.16 | 22 | 350858 | 5476 | 34600575 |
Hand deformity | 12.93 | 11.16 | 11 | 350869 | 3714 | 34602337 |
Hyperthermia malignant | 12.90 | 11.16 | 3 | 350877 | 2174 | 34603877 |
Aortic aneurysm | 12.88 | 11.16 | 114 | 350766 | 6665 | 34599386 |
Status epilepticus | 12.87 | 11.16 | 74 | 350806 | 12540 | 34593511 |
Cardiovascular disorder | 12.86 | 11.16 | 156 | 350724 | 9900 | 34596151 |
Post-traumatic amnestic disorder | 12.82 | 11.16 | 8 | 350872 | 56 | 34605995 |
Hyperammonaemia | 12.80 | 11.16 | 28 | 350852 | 6339 | 34599712 |
Asthma-chronic obstructive pulmonary disease overlap syndrome | 12.80 | 11.16 | 35 | 350845 | 1252 | 34604799 |
Depressed level of consciousness | 12.79 | 11.16 | 539 | 350341 | 42302 | 34563749 |
Generalised oedema | 12.75 | 11.16 | 185 | 350695 | 12223 | 34593828 |
Hyperbilirubinaemia | 12.67 | 11.16 | 108 | 350772 | 16735 | 34589316 |
Coronary artery stenosis | 12.66 | 11.16 | 150 | 350730 | 9466 | 34596585 |
Retinopathy hypertensive | 12.63 | 11.16 | 15 | 350865 | 272 | 34605779 |
Prostate cancer recurrent | 12.63 | 11.16 | 30 | 350850 | 983 | 34605068 |
Ischaemia | 12.61 | 11.16 | 84 | 350796 | 4496 | 34601555 |
Coma scale abnormal | 12.58 | 11.16 | 76 | 350804 | 3932 | 34602119 |
Gastric ulcer haemorrhage | 12.58 | 11.16 | 96 | 350784 | 5370 | 34600681 |
Glomerulonephritis acute | 12.57 | 11.16 | 11 | 350869 | 136 | 34605915 |
Macrophages increased | 12.53 | 11.16 | 12 | 350868 | 168 | 34605883 |
Upper respiratory tract infection | 12.52 | 11.16 | 245 | 350635 | 32814 | 34573237 |
Lymphocyte count decreased | 12.51 | 11.16 | 156 | 350724 | 22466 | 34583585 |
Lung operation | 12.50 | 11.16 | 9 | 350871 | 82 | 34605969 |
Ventricular hyperkinesia | 12.45 | 11.16 | 13 | 350867 | 203 | 34605848 |
Crying | 12.44 | 11.16 | 25 | 350855 | 5837 | 34600214 |
Toxicity to various agents | 12.41 | 11.16 | 2238 | 348642 | 198124 | 34407927 |
Intraventricular haemorrhage | 12.41 | 11.16 | 69 | 350811 | 3462 | 34602589 |
Hypertonic bladder | 12.34 | 11.16 | 44 | 350836 | 1820 | 34604231 |
Renal mass | 12.30 | 11.16 | 43 | 350837 | 1761 | 34604290 |
Respiratory depression | 12.29 | 11.16 | 104 | 350776 | 16141 | 34589910 |
Flour sensitivity | 12.25 | 11.16 | 6 | 350874 | 24 | 34606027 |
Occult blood | 12.25 | 11.16 | 27 | 350853 | 841 | 34605210 |
Blood cholinesterase decreased | 12.19 | 11.16 | 11 | 350869 | 142 | 34605909 |
Stomatitis | 12.17 | 11.16 | 329 | 350551 | 42185 | 34563866 |
Snoring | 12.17 | 11.16 | 66 | 350814 | 3280 | 34602771 |
Peripheral artery stenosis | 12.17 | 11.16 | 27 | 350853 | 845 | 34605206 |
Blister | 12.14 | 11.16 | 308 | 350572 | 22550 | 34583501 |
Seronegative arthritis | 12.13 | 11.16 | 30 | 350850 | 1009 | 34605042 |
Metastases to central nervous system | 12.08 | 11.16 | 42 | 350838 | 8163 | 34597888 |
Oliguria | 12.06 | 11.16 | 133 | 350747 | 8247 | 34597804 |
Tardive dyskinesia | 12.03 | 11.16 | 25 | 350855 | 5765 | 34600286 |
Injection site reaction | 11.98 | 11.16 | 79 | 350801 | 12954 | 34593097 |
Drug dispensed to wrong patient | 11.97 | 11.16 | 20 | 350860 | 504 | 34605547 |
Prerenal failure | 11.97 | 11.16 | 47 | 350833 | 2037 | 34604014 |
Lung hernia | 11.96 | 11.16 | 8 | 350872 | 64 | 34605987 |
Arterial stenosis | 11.89 | 11.16 | 32 | 350848 | 1134 | 34604917 |
Multiple sclerosis relapse | 11.87 | 11.16 | 80 | 350800 | 13053 | 34592998 |
Pain in extremity | 11.86 | 11.16 | 1447 | 349433 | 125066 | 34480985 |
Somnolence | 11.85 | 11.16 | 957 | 349923 | 110159 | 34495892 |
Mean platelet volume increased | 11.81 | 11.16 | 20 | 350860 | 510 | 34605541 |
Pericarditis uraemic | 11.78 | 11.16 | 5 | 350875 | 13 | 34606038 |
Altered state of consciousness | 11.73 | 11.16 | 307 | 350573 | 22586 | 34583465 |
Wheezing | 11.71 | 11.16 | 518 | 350362 | 40884 | 34565167 |
Renal transplant | 11.69 | 11.16 | 43 | 350837 | 1806 | 34604245 |
Hypercholesterolaemia | 11.67 | 11.16 | 137 | 350743 | 8625 | 34597426 |
Transaminases increased | 11.66 | 11.16 | 194 | 350686 | 26629 | 34579422 |
Mean arterial pressure decreased | 11.66 | 11.16 | 11 | 350869 | 151 | 34605900 |
Lipoma | 11.64 | 11.16 | 41 | 350839 | 1685 | 34604366 |
Ventricular tachycardia | 11.64 | 11.16 | 192 | 350688 | 26387 | 34579664 |
Bile duct stone | 11.61 | 11.16 | 54 | 350826 | 2523 | 34603528 |
Joint swelling | 11.61 | 11.16 | 723 | 350157 | 59167 | 34546884 |
Ultrafiltration failure | 11.60 | 11.16 | 11 | 350869 | 152 | 34605899 |
Serotonin syndrome | 11.58 | 11.16 | 136 | 350744 | 19797 | 34586254 |
Hypertensive nephropathy | 11.57 | 11.16 | 19 | 350861 | 472 | 34605579 |
Blood pressure orthostatic | 11.56 | 11.16 | 8 | 350872 | 68 | 34605983 |
Infusion site extravasation | 11.56 | 11.16 | 16 | 350864 | 4328 | 34601723 |
Dysgeusia | 11.53 | 11.16 | 348 | 350532 | 26149 | 34579902 |
Cold sweat | 11.52 | 11.16 | 152 | 350728 | 9835 | 34596216 |
Renal artery thrombosis | 11.52 | 11.16 | 15 | 350865 | 300 | 34605751 |
Polyomavirus-associated nephropathy | 11.44 | 11.16 | 13 | 350867 | 3831 | 34602220 |
Sinonasal obstruction | 11.38 | 11.16 | 8 | 350872 | 70 | 34605981 |
Renin increased | 11.36 | 11.16 | 9 | 350871 | 96 | 34605955 |
Electrocardiogram T wave amplitude decreased | 11.35 | 11.16 | 16 | 350864 | 346 | 34605705 |
Malaise | 11.33 | 11.16 | 2074 | 348806 | 183751 | 34422300 |
Physical examination abnormal | 11.33 | 11.16 | 15 | 350865 | 305 | 34605746 |
Retinal vascular thrombosis | 11.28 | 11.16 | 8 | 350872 | 71 | 34605980 |
Rhinovirus infection | 11.28 | 11.16 | 16 | 350864 | 4283 | 34601768 |
Diabetic retinopathy | 11.27 | 11.16 | 42 | 350838 | 1775 | 34604276 |
Epilepsy | 11.24 | 11.16 | 150 | 350730 | 21345 | 34584706 |
Phaeochromocytoma malignant | 11.19 | 11.16 | 8 | 350872 | 72 | 34605979 |
Polymyalgia rheumatica | 11.18 | 11.16 | 37 | 350843 | 1473 | 34604578 |
Acute lung injury | 11.18 | 11.16 | 37 | 350843 | 1473 | 34604578 |
Periodontal disease | 11.17 | 11.16 | 25 | 350855 | 787 | 34605264 |
Angiopathy | 11.17 | 11.16 | 76 | 350804 | 4097 | 34601954 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Completed suicide | 1494.01 | 10.06 | 4996 | 664001 | 240771 | 78834620 |
Hypotension | 1007.48 | 10.06 | 6729 | 662268 | 433588 | 78641803 |
Drug ineffective | 989.91 | 10.06 | 5196 | 663801 | 1075717 | 77999674 |
Off label use | 763.00 | 10.06 | 4482 | 664515 | 902733 | 78172658 |
Shock | 733.95 | 10.06 | 1314 | 667683 | 42234 | 79033157 |
Synovitis | 728.69 | 10.06 | 183 | 668814 | 150551 | 78924840 |
Acute kidney injury | 711.78 | 10.06 | 7064 | 661933 | 512340 | 78563051 |
Gingival hypertrophy | 706.18 | 10.06 | 397 | 668600 | 2745 | 79072646 |
Anti-cyclic citrullinated peptide antibody positive | 649.71 | 10.06 | 9 | 668988 | 83134 | 78992257 |
Hand deformity | 641.15 | 10.06 | 64 | 668933 | 103855 | 78971536 |
Pemphigus | 625.84 | 10.06 | 57 | 668940 | 99525 | 78975866 |
Maternal exposure during pregnancy | 614.80 | 10.06 | 190 | 668807 | 136348 | 78939043 |
Contraindicated product administered | 606.38 | 10.06 | 281 | 668716 | 157257 | 78918134 |
Bradycardia | 603.92 | 10.06 | 2495 | 666502 | 133062 | 78942329 |
Treatment failure | 589.85 | 10.06 | 349 | 668648 | 170137 | 78905254 |
Drug intolerance | 574.18 | 10.06 | 828 | 668169 | 263291 | 78812100 |
Infusion related reaction | 536.55 | 10.06 | 686 | 668311 | 229551 | 78845840 |
Systemic lupus erythematosus | 525.29 | 10.06 | 180 | 668817 | 120969 | 78954422 |
Intentional overdose | 518.96 | 10.06 | 2009 | 666988 | 103951 | 78971440 |
Arthropathy | 509.97 | 10.06 | 441 | 668556 | 176670 | 78898721 |
Pericarditis | 506.72 | 10.06 | 125 | 668872 | 104111 | 78971280 |
Therapeutic product effect decreased | 499.15 | 10.06 | 386 | 668611 | 163477 | 78911914 |
Drug abuse | 475.85 | 10.06 | 399 | 668598 | 162292 | 78913099 |
Glossodynia | 473.88 | 10.06 | 139 | 668858 | 103198 | 78972193 |
Oedema peripheral | 444.86 | 10.06 | 3627 | 665370 | 248661 | 78826730 |
Non-cardiogenic pulmonary oedema | 433.71 | 10.06 | 224 | 668773 | 1275 | 79074116 |
Blood pressure inadequately controlled | 423.04 | 10.06 | 377 | 668620 | 5800 | 79069591 |
Blood pressure increased | 385.74 | 10.06 | 3063 | 665934 | 208297 | 78867094 |
Duodenal ulcer perforation | 385.26 | 10.06 | 50 | 668947 | 66161 | 79009230 |
Helicobacter infection | 381.60 | 10.06 | 63 | 668934 | 69641 | 79005750 |
Alopecia | 380.94 | 10.06 | 861 | 668136 | 230494 | 78844897 |
Hyponatraemia | 369.89 | 10.06 | 2658 | 666339 | 175190 | 78900201 |
Distributive shock | 364.51 | 10.06 | 246 | 668751 | 2441 | 79072950 |
Orthostatic hypotension | 350.34 | 10.06 | 1153 | 667844 | 55011 | 79020380 |
Cerebrovascular accident | 347.03 | 10.06 | 2362 | 666635 | 152930 | 78922461 |
Wound | 347.03 | 10.06 | 279 | 668718 | 115900 | 78959491 |
Renal impairment | 346.73 | 10.06 | 2390 | 666607 | 155393 | 78919998 |
Hepatic enzyme increased | 340.99 | 10.06 | 632 | 668365 | 181978 | 78893413 |
C-reactive protein abnormal | 338.15 | 10.06 | 16 | 668981 | 48351 | 79027040 |
Fall | 337.82 | 10.06 | 5856 | 663141 | 481773 | 78593618 |
Folliculitis | 334.12 | 10.06 | 37 | 668960 | 55343 | 79020048 |
Vasoplegia syndrome | 330.21 | 10.06 | 261 | 668736 | 3369 | 79072022 |
Hyperkalaemia | 326.45 | 10.06 | 1853 | 667144 | 112545 | 78962846 |
Rheumatoid arthritis | 325.45 | 10.06 | 798 | 668199 | 207672 | 78867719 |
Sleep disorder due to general medical condition, insomnia type | 323.16 | 10.06 | 9 | 668988 | 43547 | 79031844 |
Angioedema | 311.72 | 10.06 | 1365 | 667632 | 74670 | 79000721 |
Hypersensitivity | 311.37 | 10.06 | 1140 | 667857 | 261099 | 78814292 |
Hypertensive crisis | 307.64 | 10.06 | 593 | 668404 | 20177 | 79055214 |
Rheumatoid factor positive | 302.24 | 10.06 | 66 | 668931 | 59773 | 79015618 |
Product use issue | 294.29 | 10.06 | 847 | 668150 | 208975 | 78866416 |
Metabolic acidosis | 290.60 | 10.06 | 1417 | 667580 | 81112 | 78994279 |
Lactic acidosis | 280.01 | 10.06 | 1252 | 667745 | 69107 | 79006284 |
Exposure during pregnancy | 280.00 | 10.06 | 261 | 668736 | 100871 | 78974520 |
Muscle injury | 274.66 | 10.06 | 40 | 668957 | 48521 | 79026870 |
Product use in unapproved indication | 265.63 | 10.06 | 1138 | 667859 | 249221 | 78826170 |
Hypokalaemia | 249.92 | 10.06 | 2064 | 666933 | 141976 | 78933415 |
Sinusitis | 244.61 | 10.06 | 831 | 668166 | 194670 | 78880721 |
Irritable bowel syndrome | 244.09 | 10.06 | 108 | 668889 | 62133 | 79013258 |
Toxicity to various agents | 239.10 | 10.06 | 4910 | 664087 | 416630 | 78658761 |
Syncope | 235.75 | 10.06 | 2422 | 666575 | 177027 | 78898364 |
Discomfort | 223.75 | 10.06 | 447 | 668550 | 125170 | 78950221 |
Rheumatic fever | 223.21 | 10.06 | 3 | 668994 | 28522 | 79046869 |
Blood creatinine increased | 221.70 | 10.06 | 2130 | 666867 | 152927 | 78922464 |
Infection | 220.46 | 10.06 | 1160 | 667837 | 240552 | 78834839 |
Rhabdomyolysis | 215.79 | 10.06 | 1544 | 667453 | 101587 | 78973804 |
Impaired healing | 212.59 | 10.06 | 253 | 668744 | 87402 | 78987989 |
Cerebral infarction | 210.56 | 10.06 | 850 | 668147 | 44826 | 79030565 |
Pain | 208.84 | 10.06 | 4411 | 664586 | 699391 | 78376000 |
Fibromyalgia | 205.61 | 10.06 | 144 | 668853 | 64196 | 79011195 |
Psoriatic arthropathy | 202.44 | 10.06 | 213 | 668784 | 77786 | 78997605 |
Cardiac failure congestive | 198.57 | 10.06 | 1946 | 667051 | 140456 | 78934935 |
Hypoglycaemia | 191.56 | 10.06 | 1484 | 667513 | 100110 | 78975281 |
Arthralgia | 179.17 | 10.06 | 3551 | 665446 | 568252 | 78507139 |
Angina pectoris | 179.05 | 10.06 | 884 | 668113 | 50848 | 79024543 |
Therapeutic product effect incomplete | 178.55 | 10.06 | 600 | 668397 | 141045 | 78934346 |
Condition aggravated | 178.23 | 10.06 | 3044 | 665953 | 498080 | 78577311 |
Dizziness | 178.15 | 10.06 | 5724 | 663273 | 520717 | 78554674 |
Abdominal discomfort | 176.90 | 10.06 | 1303 | 667694 | 249424 | 78825967 |
Renal failure | 175.31 | 10.06 | 2510 | 666487 | 198458 | 78876933 |
Musculoskeletal stiffness | 172.04 | 10.06 | 818 | 668179 | 174190 | 78901201 |
Intentional product use issue | 171.50 | 10.06 | 675 | 668322 | 151437 | 78923954 |
Neutropenia | 169.86 | 10.06 | 1568 | 667429 | 286142 | 78789249 |
Overdose | 167.23 | 10.06 | 2317 | 666680 | 181889 | 78893502 |
Swelling | 166.74 | 10.06 | 1098 | 667899 | 215613 | 78859778 |
Febrile neutropenia | 165.59 | 10.06 | 1195 | 667802 | 229804 | 78845587 |
Depressed level of consciousness | 163.86 | 10.06 | 1378 | 667619 | 95274 | 78980117 |
Pregnancy | 159.31 | 10.06 | 19 | 668978 | 26832 | 79048559 |
Swollen joint count increased | 158.93 | 10.06 | 8 | 668989 | 22919 | 79052472 |
Myocardial infarction | 157.53 | 10.06 | 2292 | 666705 | 181837 | 78893554 |
Lower respiratory tract infection | 156.36 | 10.06 | 557 | 668440 | 128663 | 78946728 |
Red blood cell sedimentation rate abnormal | 153.09 | 10.06 | 5 | 668992 | 20958 | 79054433 |
Creatinine renal clearance decreased | 149.26 | 10.06 | 423 | 668574 | 18579 | 79056812 |
Chronic kidney disease | 148.10 | 10.06 | 1007 | 667990 | 65147 | 79010244 |
Swollen tongue | 147.00 | 10.06 | 727 | 668270 | 41843 | 79033548 |
Coronary artery disease | 143.81 | 10.06 | 992 | 668005 | 64482 | 79010909 |
Stomatitis | 143.61 | 10.06 | 687 | 668310 | 146070 | 78929321 |
Abortion spontaneous | 136.50 | 10.06 | 39 | 668958 | 29468 | 79045923 |
Suspected suicide | 135.17 | 10.06 | 284 | 668713 | 10292 | 79065099 |
Suicide attempt | 135.10 | 10.06 | 1172 | 667825 | 81760 | 78993631 |
Ill-defined disorder | 134.75 | 10.06 | 215 | 668782 | 65660 | 79009731 |
Atrial fibrillation | 132.44 | 10.06 | 2365 | 666632 | 195521 | 78879870 |
Device expulsion | 127.63 | 10.06 | 30 | 668967 | 25831 | 79049560 |
Proteinuria | 126.01 | 10.06 | 574 | 668423 | 31928 | 79043463 |
Atrioventricular block complete | 125.86 | 10.06 | 365 | 668632 | 16245 | 79059146 |
Pulmonary oedema | 124.91 | 10.06 | 1210 | 667787 | 87044 | 78988347 |
Pyrexia | 123.78 | 10.06 | 4553 | 664444 | 674156 | 78401235 |
Drug resistance | 122.75 | 10.06 | 104 | 668893 | 42109 | 79033282 |
Hypomagnesaemia | 120.91 | 10.06 | 740 | 668257 | 46171 | 79029220 |
Drug interaction | 120.30 | 10.06 | 4435 | 664562 | 410748 | 78664643 |
Sedation complication | 119.38 | 10.06 | 345 | 668652 | 15324 | 79060067 |
Sinus bradycardia | 118.88 | 10.06 | 473 | 668524 | 24774 | 79050617 |
Injection site erythema | 117.52 | 10.06 | 305 | 668692 | 77892 | 78997499 |
Injection site reaction | 116.66 | 10.06 | 174 | 668823 | 54611 | 79020780 |
Joint swelling | 116.29 | 10.06 | 1712 | 667285 | 286934 | 78788457 |
Gastrointestinal disorder | 114.98 | 10.06 | 580 | 668417 | 121625 | 78953766 |
Balance disorder | 114.75 | 10.06 | 1302 | 667695 | 97555 | 78977836 |
Acute myocardial infarction | 113.38 | 10.06 | 1065 | 667932 | 75971 | 78999420 |
Neurologic neglect syndrome | 111.95 | 10.06 | 130 | 668867 | 2777 | 79072614 |
Hip arthroplasty | 110.36 | 10.06 | 83 | 668914 | 35673 | 79039718 |
Injection site pain | 108.00 | 10.06 | 642 | 668355 | 129196 | 78946195 |
Myelosuppression | 104.59 | 10.06 | 110 | 668887 | 40186 | 79035205 |
Cardiogenic shock | 104.15 | 10.06 | 655 | 668342 | 41259 | 79034132 |
Drug dependence | 101.72 | 10.06 | 115 | 668882 | 40654 | 79034737 |
Blood pressure systolic increased | 101.56 | 10.06 | 932 | 668065 | 66054 | 79009337 |
Carotid artery thrombosis | 100.36 | 10.06 | 126 | 668871 | 2927 | 79072464 |
Live birth | 100.25 | 10.06 | 18 | 668979 | 18726 | 79056665 |
Atrioventricular block first degree | 99.02 | 10.06 | 279 | 668718 | 12212 | 79063179 |
Rash | 98.25 | 10.06 | 3912 | 665085 | 574446 | 78500945 |
Sprue-like enteropathy | 93.36 | 10.06 | 82 | 668915 | 1236 | 79074155 |
Dyspnoea | 91.79 | 10.06 | 8362 | 660635 | 848663 | 78226728 |
Weight increased | 91.72 | 10.06 | 1706 | 667291 | 275680 | 78799711 |
Pemphigoid | 91.55 | 10.06 | 310 | 668687 | 15005 | 79060386 |
Anuria | 90.99 | 10.06 | 383 | 668614 | 20580 | 79054811 |
Product monitoring error | 89.10 | 10.06 | 217 | 668780 | 8689 | 79066702 |
Blood calcium decreased | 87.15 | 10.06 | 510 | 668487 | 31309 | 79044082 |
Migraine | 86.49 | 10.06 | 408 | 668589 | 87085 | 78988306 |
Diabetes mellitus inadequate control | 86.36 | 10.06 | 418 | 668579 | 23846 | 79051545 |
Decreased appetite | 85.79 | 10.06 | 3601 | 665396 | 338817 | 78736574 |
Hypertensive emergency | 85.34 | 10.06 | 111 | 668886 | 2674 | 79072717 |
Palpitations | 84.95 | 10.06 | 1514 | 667483 | 125096 | 78950295 |
Transient ischaemic attack | 84.40 | 10.06 | 742 | 668255 | 51953 | 79023438 |
Loss of consciousness | 83.05 | 10.06 | 1919 | 667078 | 166024 | 78909367 |
Facet joint syndrome | 81.46 | 10.06 | 3 | 668994 | 11299 | 79064092 |
Hyperglycaemia | 81.00 | 10.06 | 925 | 668072 | 69410 | 79005981 |
Renin increased | 80.95 | 10.06 | 40 | 668957 | 204 | 79075187 |
Blood pressure decreased | 78.72 | 10.06 | 1222 | 667775 | 98244 | 78977147 |
Hemiplegia | 78.64 | 10.06 | 290 | 668707 | 14649 | 79060742 |
Lip swelling | 78.41 | 10.06 | 600 | 668397 | 40311 | 79035080 |
Nasopharyngitis | 77.36 | 10.06 | 1583 | 667414 | 252298 | 78823093 |
Intentional self-injury | 77.07 | 10.06 | 95 | 668902 | 32324 | 79043067 |
Asthenia | 76.98 | 10.06 | 5128 | 663869 | 506561 | 78568830 |
Blister | 76.21 | 10.06 | 638 | 668359 | 118838 | 78956553 |
Carotid artery stenosis | 75.78 | 10.06 | 202 | 668795 | 8556 | 79066835 |
Nocturia | 74.91 | 10.06 | 269 | 668728 | 13412 | 79061979 |
Hyperdynamic left ventricle | 74.87 | 10.06 | 45 | 668952 | 358 | 79075033 |
Pathogen resistance | 74.10 | 10.06 | 15 | 668982 | 14327 | 79061064 |
Deep vein thrombosis postoperative | 73.74 | 10.06 | 4 | 668993 | 10748 | 79064643 |
Knee arthroplasty | 73.50 | 10.06 | 158 | 668839 | 43090 | 79032301 |
Wrong technique in product usage process | 72.13 | 10.06 | 346 | 668651 | 73529 | 79001862 |
Renal artery stenosis | 71.81 | 10.06 | 115 | 668882 | 3367 | 79072024 |
Atrioventricular block | 70.95 | 10.06 | 269 | 668728 | 13772 | 79061619 |
Erectile dysfunction | 70.87 | 10.06 | 277 | 668720 | 14387 | 79061004 |
Cytomegalovirus infection | 70.66 | 10.06 | 158 | 668839 | 42486 | 79032905 |
Hypertension | 69.85 | 10.06 | 3421 | 665576 | 327571 | 78747820 |
Blood creatine phosphokinase increased | 69.84 | 10.06 | 855 | 668142 | 65235 | 79010156 |
Gingival bleeding | 69.58 | 10.06 | 296 | 668701 | 15980 | 79059411 |
Breast cancer stage III | 69.50 | 10.06 | 3 | 668994 | 9823 | 79065568 |
Infective pulmonary exacerbation of cystic fibrosis | 69.47 | 10.06 | 12 | 668985 | 12839 | 79062552 |
Tenosynovitis | 69.33 | 10.06 | 22 | 668975 | 15532 | 79059859 |
Oliguria | 68.49 | 10.06 | 295 | 668702 | 16014 | 79059377 |
Dehydration | 68.36 | 10.06 | 2637 | 666360 | 245550 | 78829841 |
Dysarthria | 68.11 | 10.06 | 867 | 668130 | 66755 | 79008636 |
Melaena | 67.09 | 10.06 | 794 | 668203 | 60096 | 79015295 |
Product prescribing error | 66.16 | 10.06 | 620 | 668377 | 44193 | 79031198 |
Glycosylated haemoglobin increased | 65.83 | 10.06 | 328 | 668669 | 18932 | 79056459 |
Angina unstable | 65.65 | 10.06 | 294 | 668703 | 16233 | 79059158 |
Interstitial lung disease | 65.40 | 10.06 | 1317 | 667680 | 111283 | 78964108 |
Circulatory collapse | 65.38 | 10.06 | 540 | 668457 | 37128 | 79038263 |
Cardiac failure | 65.11 | 10.06 | 1731 | 667266 | 153111 | 78922280 |
Left ventricular hypertrophy | 64.68 | 10.06 | 224 | 668773 | 10967 | 79064424 |
Hepatic function abnormal | 64.03 | 10.06 | 914 | 668083 | 72193 | 79003198 |
Gingival swelling | 63.90 | 10.06 | 128 | 668869 | 4481 | 79070910 |
Drug ineffective for unapproved indication | 63.87 | 10.06 | 218 | 668779 | 51020 | 79024371 |
BRASH syndrome | 63.62 | 10.06 | 59 | 668938 | 958 | 79074433 |
Aortic dissection | 62.80 | 10.06 | 120 | 668877 | 4055 | 79071336 |
Immune reconstitution inflammatory syndrome | 62.73 | 10.06 | 19 | 668978 | 13822 | 79061569 |
Ear infection | 62.59 | 10.06 | 121 | 668876 | 34311 | 79041080 |
Disability | 62.10 | 10.06 | 33 | 668964 | 17087 | 79058304 |
Blood urea increased | 61.84 | 10.06 | 654 | 668343 | 48136 | 79027255 |
Hyperlipidaemia | 61.28 | 10.06 | 402 | 668595 | 25691 | 79049700 |
Chronic pigmented purpura | 61.05 | 10.06 | 33 | 668964 | 209 | 79075182 |
Personality disorder | 60.69 | 10.06 | 149 | 668848 | 5997 | 79069394 |
Myalgia | 60.60 | 10.06 | 2011 | 666986 | 183630 | 78891761 |
Adjustment disorder | 60.21 | 10.06 | 115 | 668882 | 3885 | 79071506 |
Grip strength decreased | 59.85 | 10.06 | 57 | 668940 | 21812 | 79053579 |
Myocardial depression | 59.09 | 10.06 | 43 | 668954 | 486 | 79074905 |
Urticaria | 58.42 | 10.06 | 1148 | 667849 | 184053 | 78891338 |
Injection site pruritus | 58.25 | 10.06 | 172 | 668825 | 42111 | 79033280 |
Therapy partial responder | 58.18 | 10.06 | 37 | 668960 | 17360 | 79058031 |
Hypocalcaemia | 57.22 | 10.06 | 656 | 668341 | 49268 | 79026123 |
Liver injury | 57.13 | 10.06 | 262 | 668735 | 56352 | 79019039 |
Septic shock | 56.36 | 10.06 | 709 | 668288 | 122092 | 78953299 |
Injection site bruising | 56.33 | 10.06 | 167 | 668830 | 40835 | 79034556 |
Nephrotic syndrome | 55.57 | 10.06 | 213 | 668784 | 10961 | 79064430 |
Body temperature increased | 55.37 | 10.06 | 189 | 668808 | 44231 | 79031160 |
Immunodeficiency | 54.74 | 10.06 | 61 | 668936 | 21707 | 79053684 |
Haematotoxicity | 54.71 | 10.06 | 31 | 668966 | 15488 | 79059903 |
Leukopenia | 54.49 | 10.06 | 670 | 668327 | 115843 | 78959548 |
Bursitis | 54.46 | 10.06 | 139 | 668858 | 35705 | 79039686 |
Hemiparesis | 54.02 | 10.06 | 475 | 668522 | 33258 | 79042133 |
Injection site swelling | 53.82 | 10.06 | 208 | 668789 | 46924 | 79028467 |
Foot deformity | 53.68 | 10.06 | 74 | 668923 | 24000 | 79051391 |
Hepatotoxicity | 53.41 | 10.06 | 235 | 668762 | 51117 | 79024274 |
Post transplant lymphoproliferative disorder | 53.31 | 10.06 | 15 | 668982 | 11449 | 79063942 |
Lacunar infarction | 53.17 | 10.06 | 139 | 668858 | 5818 | 79069573 |
Hypertensive heart disease | 52.65 | 10.06 | 112 | 668885 | 4094 | 79071297 |
Altered state of consciousness | 52.57 | 10.06 | 581 | 668416 | 43241 | 79032150 |
Prescribed overdose | 52.26 | 10.06 | 154 | 668843 | 37729 | 79037662 |
Therapeutic response decreased | 52.23 | 10.06 | 337 | 668660 | 66516 | 79008875 |
Tongue oedema | 51.63 | 10.06 | 154 | 668843 | 6963 | 79068428 |
Renal cell carcinoma | 51.24 | 10.06 | 146 | 668851 | 6432 | 79068959 |
Dislocation of vertebra | 50.89 | 10.06 | 4 | 668993 | 7876 | 79067515 |
Bone marrow failure | 50.69 | 10.06 | 238 | 668759 | 50869 | 79024522 |
Cytokine release syndrome | 50.63 | 10.06 | 145 | 668852 | 35853 | 79039538 |
Adjustment disorder with depressed mood | 50.19 | 10.06 | 8 | 668989 | 9078 | 79066313 |
Haemorrhage subcutaneous | 50.07 | 10.06 | 119 | 668878 | 4690 | 79070701 |
Anaemia | 50.01 | 10.06 | 4359 | 664638 | 440656 | 78634735 |
Blood glucose increased | 49.68 | 10.06 | 1290 | 667707 | 113685 | 78961706 |
Eating disorder | 48.68 | 10.06 | 319 | 668678 | 20378 | 79055013 |
Glomerular filtration rate decreased | 48.68 | 10.06 | 342 | 668655 | 22360 | 79053031 |
Anti-neutrophil cytoplasmic antibody positive vasculitis | 48.66 | 10.06 | 101 | 668896 | 3628 | 79071763 |
Bone erosion | 48.28 | 10.06 | 47 | 668950 | 17800 | 79057591 |
Rheumatoid nodule | 48.25 | 10.06 | 45 | 668952 | 17393 | 79057998 |
Thrombocytopenia | 48.02 | 10.06 | 1780 | 667217 | 263479 | 78811912 |
Injury | 47.99 | 10.06 | 417 | 668580 | 77079 | 78998312 |
Renal disorder | 47.69 | 10.06 | 552 | 668445 | 41553 | 79033838 |
Breast cancer stage II | 47.55 | 10.06 | 6 | 668991 | 8114 | 79067277 |
Injection site warmth | 47.48 | 10.06 | 33 | 668964 | 14774 | 79060617 |
Device adhesion issue | 47.40 | 10.06 | 3 | 668994 | 7072 | 79068319 |
Lip dry | 47.31 | 10.06 | 36 | 668961 | 15382 | 79060009 |
Blood cholesterol increased | 47.30 | 10.06 | 461 | 668536 | 83259 | 78992132 |
Subacute cutaneous lupus erythematosus | 47.12 | 10.06 | 97 | 668900 | 3464 | 79071927 |
Blood potassium decreased | 46.69 | 10.06 | 596 | 668401 | 45916 | 79029475 |
Haemodynamic instability | 46.57 | 10.06 | 277 | 668720 | 17105 | 79058286 |
Lung diffusion test abnormal | 46.54 | 10.06 | 33 | 668964 | 357 | 79075034 |
Disease progression | 46.13 | 10.06 | 1185 | 667812 | 183177 | 78892214 |
Multiple-drug resistance | 45.95 | 10.06 | 9 | 668988 | 8799 | 79066592 |
Carotid arteriosclerosis | 45.83 | 10.06 | 81 | 668916 | 2575 | 79072816 |
Nodal rhythm | 45.80 | 10.06 | 89 | 668908 | 3046 | 79072345 |
Inflammation | 45.40 | 10.06 | 535 | 668462 | 93218 | 78982173 |
Gravitational oedema | 45.36 | 10.06 | 66 | 668931 | 1773 | 79073618 |
Tubulointerstitial nephritis | 44.99 | 10.06 | 505 | 668492 | 37730 | 79037661 |
Acute graft versus host disease | 44.23 | 10.06 | 15 | 668982 | 10152 | 79065239 |
Acute hepatic failure | 44.06 | 10.06 | 119 | 668878 | 29994 | 79045397 |
Haemophagocytic lymphohistiocytosis | 43.97 | 10.06 | 72 | 668925 | 21765 | 79053626 |
Haemodialysis | 43.94 | 10.06 | 282 | 668715 | 17886 | 79057505 |
Aggression | 43.94 | 10.06 | 249 | 668748 | 50709 | 79024682 |
Cerebral haemorrhage | 43.90 | 10.06 | 704 | 668293 | 56969 | 79018422 |
Swelling face | 43.38 | 10.06 | 839 | 668158 | 70373 | 79005018 |
Dyspnoea exertional | 43.34 | 10.06 | 996 | 668001 | 86077 | 78989314 |
Periodontitis | 43.34 | 10.06 | 108 | 668889 | 4388 | 79071003 |
Pseudolymphoma | 43.28 | 10.06 | 52 | 668945 | 1153 | 79074238 |
5-hydroxyindolacetic acid in urine increased | 43.21 | 10.06 | 27 | 668970 | 232 | 79075159 |
Mucosal inflammation | 43.19 | 10.06 | 415 | 668582 | 75165 | 79000226 |
Adverse event | 42.84 | 10.06 | 312 | 668685 | 59902 | 79015489 |
Haematemesis | 42.84 | 10.06 | 646 | 668351 | 51618 | 79023773 |
Product substitution issue | 42.76 | 10.06 | 304 | 668693 | 19952 | 79055439 |
Joint range of motion decreased | 42.58 | 10.06 | 140 | 668857 | 33142 | 79042249 |
Hepatocellular carcinoma | 42.46 | 10.06 | 169 | 668828 | 8852 | 79066539 |
Gastrointestinal tract mucosal pigmentation | 42.19 | 10.06 | 48 | 668949 | 1002 | 79074389 |
Osteoporosis | 42.15 | 10.06 | 273 | 668724 | 53839 | 79021552 |
Mitral valve incompetence | 42.06 | 10.06 | 395 | 668602 | 28170 | 79047221 |
Aspergillus infection | 41.63 | 10.06 | 60 | 668937 | 19101 | 79056290 |
Autoimmune disorder | 41.28 | 10.06 | 47 | 668950 | 16565 | 79058826 |
Pollakiuria | 41.27 | 10.06 | 487 | 668510 | 36830 | 79038561 |
Therapy non-responder | 41.21 | 10.06 | 536 | 668461 | 91769 | 78983622 |
Arteriosclerosis | 41.10 | 10.06 | 278 | 668719 | 17949 | 79057442 |
Hyperuricaemia | 41.08 | 10.06 | 202 | 668795 | 11597 | 79063794 |
Peripheral arterial occlusive disease | 40.73 | 10.06 | 157 | 668840 | 8101 | 79067290 |
Palmar-plantar erythrodysaesthesia syndrome | 40.53 | 10.06 | 441 | 668556 | 32693 | 79042698 |
Graft versus host disease | 40.15 | 10.06 | 40 | 668957 | 14986 | 79060405 |
Caesarean section | 40.11 | 10.06 | 28 | 668969 | 12507 | 79062884 |
Faeces discoloured | 39.56 | 10.06 | 396 | 668601 | 28731 | 79046660 |
Cytomegalovirus infection reactivation | 39.44 | 10.06 | 12 | 668985 | 8704 | 79066687 |
Aphasia | 39.23 | 10.06 | 580 | 668417 | 46152 | 79029239 |
Breast cancer stage I | 39.11 | 10.06 | 5 | 668992 | 6695 | 79068696 |
Presyncope | 39.08 | 10.06 | 521 | 668476 | 40533 | 79034858 |
Multiple sclerosis relapse | 38.72 | 10.06 | 230 | 668767 | 46303 | 79029088 |
Ischaemic stroke | 38.71 | 10.06 | 437 | 668560 | 32694 | 79042697 |
Drug hypersensitivity | 38.69 | 10.06 | 2081 | 666916 | 296835 | 78778556 |
Diabetic nephropathy | 38.67 | 10.06 | 80 | 668917 | 2867 | 79072524 |
Thalamus haemorrhage | 38.33 | 10.06 | 60 | 668937 | 1722 | 79073669 |
Diastolic dysfunction | 38.29 | 10.06 | 186 | 668811 | 10625 | 79064766 |
Cardiomegaly | 38.10 | 10.06 | 363 | 668634 | 25989 | 79049402 |
Upper respiratory tract infection | 37.96 | 10.06 | 537 | 668460 | 90631 | 78984760 |
Hypoinsulinaemia | 37.89 | 10.06 | 10 | 668987 | 0 | 79075391 |
Mydriasis | 37.59 | 10.06 | 56 | 668941 | 17587 | 79057804 |
Psychotic disorder | 37.51 | 10.06 | 199 | 668798 | 41203 | 79034188 |
Hyperaldosteronism | 37.45 | 10.06 | 31 | 668966 | 429 | 79074962 |
Cognitive disorder | 37.36 | 10.06 | 808 | 668189 | 69118 | 79006273 |
Loss of personal independence in daily activities | 37.33 | 10.06 | 620 | 668377 | 101960 | 78973431 |
Drug use disorder | 37.22 | 10.06 | 13 | 668984 | 8638 | 79066753 |
Osteoarthritis | 37.16 | 10.06 | 512 | 668485 | 86797 | 78988594 |
Congenital hiatus hernia | 37.13 | 10.06 | 40 | 668957 | 784 | 79074607 |
Hypervolaemia | 37.08 | 10.06 | 533 | 668464 | 42157 | 79033234 |
Ovarian cyst | 37.01 | 10.06 | 31 | 668966 | 12624 | 79062767 |
Progressive multifocal leukoencephalopathy | 36.92 | 10.06 | 73 | 668924 | 20527 | 79054864 |
Gout | 36.82 | 10.06 | 343 | 668654 | 24406 | 79050985 |
Gastric ulcer haemorrhage | 36.17 | 10.06 | 161 | 668836 | 8866 | 79066525 |
Breast cancer female | 36.15 | 10.06 | 26 | 668971 | 11435 | 79063956 |
Atrioventricular block second degree | 36.05 | 10.06 | 139 | 668858 | 7173 | 79068218 |
Urine output decreased | 36.05 | 10.06 | 267 | 668730 | 17755 | 79057636 |
Haematochezia | 36.02 | 10.06 | 977 | 668020 | 86668 | 78988723 |
Type 2 diabetes mellitus | 35.98 | 10.06 | 306 | 668691 | 56816 | 79018575 |
Chest pain | 35.95 | 10.06 | 2792 | 666205 | 279512 | 78795879 |
Bundle branch block right | 35.93 | 10.06 | 188 | 668809 | 11063 | 79064328 |
Primary hyperaldosteronism | 35.84 | 10.06 | 20 | 668977 | 136 | 79075255 |
Metastatic renal cell carcinoma | 35.81 | 10.06 | 68 | 668929 | 2287 | 79073104 |
Substance abuse | 35.73 | 10.06 | 22 | 668975 | 10504 | 79064887 |
Acute coronary syndrome | 35.63 | 10.06 | 301 | 668696 | 20832 | 79054559 |
Irritability | 35.50 | 10.06 | 201 | 668796 | 40943 | 79034448 |
Drug withdrawal syndrome | 35.43 | 10.06 | 160 | 668837 | 34558 | 79040833 |
Chronic graft versus host disease | 35.22 | 10.06 | 7 | 668990 | 6774 | 79068617 |
Agitation | 34.89 | 10.06 | 607 | 668390 | 99108 | 78976283 |
Glomerulonephritis rapidly progressive | 34.77 | 10.06 | 55 | 668942 | 1593 | 79073798 |
X-ray abnormal | 34.77 | 10.06 | 4 | 668993 | 5809 | 79069582 |
Bronchopulmonary aspergillosis | 34.22 | 10.06 | 86 | 668911 | 22208 | 79053183 |
Unintentional medical device removal | 34.21 | 10.06 | 11 | 668986 | 7701 | 79067690 |
Coeliac disease | 34.20 | 10.06 | 27 | 668970 | 11324 | 79064067 |
Acute myeloid leukaemia | 34.18 | 10.06 | 138 | 668859 | 30747 | 79044644 |
Arrhythmia | 34.03 | 10.06 | 712 | 668285 | 60560 | 79014831 |
Device issue | 34.01 | 10.06 | 115 | 668882 | 26993 | 79048398 |
Ischaemia | 33.86 | 10.06 | 146 | 668851 | 7929 | 79067462 |
Neurotoxicity | 33.70 | 10.06 | 149 | 668848 | 32369 | 79043022 |
Heart rate decreased | 33.66 | 10.06 | 800 | 668197 | 69516 | 79005875 |
Blood lactic acid increased | 33.44 | 10.06 | 202 | 668795 | 12542 | 79062849 |
Peripheral venous disease | 33.41 | 10.06 | 51 | 668946 | 15858 | 79059533 |
Pulse abnormal | 33.37 | 10.06 | 82 | 668915 | 3302 | 79072089 |
Vasodilatation | 33.26 | 10.06 | 79 | 668918 | 3112 | 79072279 |
Affect lability | 33.16 | 10.06 | 184 | 668813 | 11075 | 79064316 |
Foetal death | 33.08 | 10.06 | 13 | 668984 | 8031 | 79067360 |
Red blood cell sedimentation rate | 32.86 | 10.06 | 4 | 668993 | 5561 | 79069830 |
Duodenal ulcer haemorrhage | 32.76 | 10.06 | 133 | 668864 | 7030 | 79068361 |
Dystonia | 32.50 | 10.06 | 83 | 668914 | 21316 | 79054075 |
Putamen haemorrhage | 32.36 | 10.06 | 30 | 668967 | 487 | 79074904 |
Pulmonary renal syndrome | 32.29 | 10.06 | 33 | 668964 | 607 | 79074784 |
Immune-mediated myositis | 32.08 | 10.06 | 82 | 668915 | 3385 | 79072006 |
Nephrosclerosis | 31.82 | 10.06 | 56 | 668941 | 1774 | 79073617 |
Urinary retention | 31.76 | 10.06 | 659 | 668338 | 55971 | 79019420 |
Uterine perforation | 31.73 | 10.06 | 7 | 668990 | 6296 | 79069095 |
Allergic reaction to excipient | 31.36 | 10.06 | 25 | 668972 | 327 | 79075064 |
Diabetic neuropathy | 31.33 | 10.06 | 119 | 668878 | 6097 | 79069294 |
Malaise | 31.12 | 10.06 | 4624 | 664373 | 485245 | 78590146 |
Injection site urticaria | 31.11 | 10.06 | 37 | 668960 | 12789 | 79062602 |
Generalised oedema | 31.08 | 10.06 | 320 | 668677 | 23389 | 79052002 |
Device difficult to use | 31.01 | 10.06 | 40 | 668957 | 13345 | 79062046 |
Linear IgA disease | 31.00 | 10.06 | 76 | 668921 | 3056 | 79072335 |
Blood mercury abnormal | 30.73 | 10.06 | 21 | 668976 | 213 | 79075178 |
Inappropriate antidiuretic hormone secretion | 30.71 | 10.06 | 347 | 668650 | 25966 | 79049425 |
Premature labour | 30.69 | 10.06 | 16 | 668981 | 8374 | 79067017 |
Ischaemic cardiomyopathy | 30.65 | 10.06 | 137 | 668860 | 7558 | 79067833 |
Supraventricular extrasystoles | 30.59 | 10.06 | 128 | 668869 | 6859 | 79068532 |
Incorrect route of product administration | 30.48 | 10.06 | 170 | 668827 | 34759 | 79040632 |
Myocardial ischaemia | 30.45 | 10.06 | 338 | 668659 | 25181 | 79050210 |
Chronic obstructive pulmonary disease | 30.37 | 10.06 | 935 | 668062 | 84484 | 78990907 |
Ear pain | 30.33 | 10.06 | 157 | 668840 | 32712 | 79042679 |
Hepatojugular reflux | 30.16 | 10.06 | 32 | 668965 | 616 | 79074775 |
Pancytopenia | 30.02 | 10.06 | 1112 | 667885 | 164633 | 78910758 |
Anaphylactic reaction | 29.87 | 10.06 | 508 | 668489 | 83235 | 78992156 |
Breath sounds abnormal | 29.83 | 10.06 | 233 | 668764 | 15751 | 79059640 |
Adverse drug reaction | 29.83 | 10.06 | 385 | 668612 | 66007 | 79009384 |
Premature delivery | 29.82 | 10.06 | 99 | 668898 | 23368 | 79052023 |
Gastrointestinal haemorrhage | 29.70 | 10.06 | 1520 | 667477 | 146199 | 78929192 |
Fibromuscular dysplasia | 29.63 | 10.06 | 21 | 668976 | 227 | 79075164 |
Adenovirus infection | 29.60 | 10.06 | 17 | 668980 | 8430 | 79066961 |
Venoocclusive liver disease | 29.58 | 10.06 | 33 | 668964 | 11738 | 79063653 |
Heavy menstrual bleeding | 29.34 | 10.06 | 45 | 668952 | 13966 | 79061425 |
Wound infection | 29.27 | 10.06 | 103 | 668894 | 23888 | 79051503 |
Red blood cell sedimentation rate increased | 28.98 | 10.06 | 246 | 668751 | 45696 | 79029695 |
Coordination abnormal | 28.88 | 10.06 | 246 | 668751 | 17066 | 79058325 |
Gastrointestinal toxicity | 28.87 | 10.06 | 16 | 668981 | 8093 | 79067298 |
Blood aldosterone increased | 28.86 | 10.06 | 20 | 668977 | 208 | 79075183 |
Drug tolerance decreased | 28.83 | 10.06 | 40 | 668957 | 12938 | 79062453 |
Sinus arrest | 28.81 | 10.06 | 81 | 668916 | 3541 | 79071850 |
Forced vital capacity decreased | 28.60 | 10.06 | 52 | 668945 | 1691 | 79073700 |
Yellow skin | 28.48 | 10.06 | 79 | 668918 | 3426 | 79071965 |
Blood potassium increased | 28.48 | 10.06 | 373 | 668624 | 28902 | 79046489 |
Constipation | 28.48 | 10.06 | 2751 | 666246 | 280299 | 78795092 |
Bradyarrhythmia | 28.47 | 10.06 | 88 | 668909 | 4058 | 79071333 |
Temperature regulation disorder | 28.47 | 10.06 | 7 | 668990 | 5846 | 79069545 |
C-reactive protein | 28.39 | 10.06 | 4 | 668993 | 4975 | 79070416 |
Drug tolerance | 28.26 | 10.06 | 19 | 668978 | 8656 | 79066735 |
Gangrene | 28.09 | 10.06 | 149 | 668848 | 8815 | 79066576 |
Accelerated hypertension | 28.05 | 10.06 | 32 | 668965 | 670 | 79074721 |
Sensory loss | 28.02 | 10.06 | 196 | 668801 | 12795 | 79062596 |
Nodule | 27.87 | 10.06 | 99 | 668898 | 22895 | 79052496 |
Gingival pain | 27.81 | 10.06 | 149 | 668848 | 8849 | 79066542 |
Venoocclusive disease | 27.72 | 10.06 | 3 | 668994 | 4570 | 79070821 |
Fear of injection | 27.71 | 10.06 | 14 | 668983 | 7460 | 79067931 |
Sickle cell anaemia with crisis | 27.68 | 10.06 | 16 | 668981 | 7906 | 79067485 |
Arterial occlusive disease | 27.49 | 10.06 | 142 | 668855 | 8314 | 79067077 |
Staphylococcal infection | 27.33 | 10.06 | 335 | 668662 | 57960 | 79017431 |
Brain stem infarction | 27.06 | 10.06 | 55 | 668942 | 1946 | 79073445 |
Mucormycosis | 26.99 | 10.06 | 19 | 668978 | 8450 | 79066941 |
Gingivitis | 26.95 | 10.06 | 148 | 668849 | 8873 | 79066518 |
Sinus node dysfunction | 26.92 | 10.06 | 132 | 668865 | 7569 | 79067822 |
Fatigue | 26.86 | 10.06 | 7165 | 661832 | 922562 | 78152829 |
Prostatic specific antigen increased | 26.86 | 10.06 | 164 | 668833 | 10222 | 79065169 |
Micturition urgency | 26.85 | 10.06 | 190 | 668807 | 12451 | 79062940 |
Hypertensive encephalopathy | 26.82 | 10.06 | 37 | 668960 | 945 | 79074446 |
Device use error | 26.79 | 10.06 | 13 | 668984 | 7088 | 79068303 |
Blood glucose decreased | 26.68 | 10.06 | 337 | 668660 | 25897 | 79049494 |
Joint effusion | 26.49 | 10.06 | 71 | 668926 | 17943 | 79057448 |
Lymphocyte count decreased | 26.45 | 10.06 | 261 | 668736 | 47028 | 79028363 |
Stenosis | 26.38 | 10.06 | 61 | 668936 | 2361 | 79073030 |
Graft versus host disease in skin | 26.35 | 10.06 | 9 | 668988 | 6064 | 79069327 |
Skin toxicity | 26.04 | 10.06 | 19 | 668978 | 8295 | 79067096 |
Subdural haematoma | 25.94 | 10.06 | 389 | 668608 | 31045 | 79044346 |
Bladder irritation | 25.70 | 10.06 | 20 | 668977 | 252 | 79075139 |
Prescription drug used without a prescription | 25.58 | 10.06 | 84 | 668913 | 4001 | 79071390 |
Dialysis | 25.55 | 10.06 | 252 | 668745 | 18210 | 79057181 |
Lymphadenopathy | 25.34 | 10.06 | 305 | 668692 | 52942 | 79022449 |
Retinitis | 25.12 | 10.06 | 8 | 668989 | 5635 | 79069756 |
Protein urine present | 25.10 | 10.06 | 158 | 668839 | 9954 | 79065437 |
Prerenal failure | 24.94 | 10.06 | 78 | 668919 | 3620 | 79071771 |
Schizophrenia | 24.93 | 10.06 | 58 | 668939 | 15382 | 79060009 |
Cardiovascular disorder | 24.93 | 10.06 | 246 | 668751 | 17779 | 79057612 |
Diffuse large B-cell lymphoma recurrent | 24.90 | 10.06 | 3 | 668994 | 4204 | 79071187 |
Lymphocele | 24.90 | 10.06 | 48 | 668949 | 1633 | 79073758 |
Candida infection | 24.84 | 10.06 | 203 | 668794 | 38011 | 79037380 |
Sedation | 24.71 | 10.06 | 590 | 668407 | 51305 | 79024086 |
Dyspnoea at rest | 24.70 | 10.06 | 124 | 668873 | 7178 | 79068213 |
Sciatica | 24.68 | 10.06 | 170 | 668827 | 33052 | 79042339 |
Acidosis | 24.62 | 10.06 | 264 | 668733 | 19498 | 79055893 |
Muscle necrosis | 24.56 | 10.06 | 44 | 668953 | 1414 | 79073977 |
Bundle branch block left | 24.43 | 10.06 | 173 | 668824 | 11340 | 79064051 |
Ventricular hypertrophy | 24.31 | 10.06 | 119 | 668878 | 6819 | 79068572 |
Pericardial effusion | 24.29 | 10.06 | 533 | 668464 | 45704 | 79029687 |
Diabetes mellitus | 24.24 | 10.06 | 844 | 668153 | 77546 | 78997845 |
Peripheral artery occlusion | 24.20 | 10.06 | 61 | 668936 | 2496 | 79072895 |
Glomerulonephritis acute | 24.15 | 10.06 | 20 | 668977 | 277 | 79075114 |
Clear cell renal cell carcinoma | 23.91 | 10.06 | 61 | 668936 | 2515 | 79072876 |
Maternal exposure before pregnancy | 23.82 | 10.06 | 4 | 668993 | 4369 | 79071022 |
Hepatic neoplasm | 23.79 | 10.06 | 73 | 668924 | 3353 | 79072038 |
Appendicolith | 23.74 | 10.06 | 22 | 668975 | 8529 | 79066862 |
Lower limb fracture | 23.68 | 10.06 | 107 | 668890 | 23108 | 79052283 |
Lethargy | 23.60 | 10.06 | 869 | 668128 | 80423 | 78994968 |
Blood pressure abnormal | 23.59 | 10.06 | 234 | 668763 | 16935 | 79058456 |
Mean arterial pressure decreased | 23.59 | 10.06 | 22 | 668975 | 360 | 79075031 |
Fungal infection | 23.53 | 10.06 | 230 | 668767 | 41518 | 79033873 |
Finger deformity | 23.52 | 10.06 | 17 | 668980 | 7457 | 79067934 |
Ageusia | 23.50 | 10.06 | 228 | 668769 | 16404 | 79058987 |
Epstein-Barr virus infection | 23.40 | 10.06 | 54 | 668943 | 14362 | 79061029 |
Oedema | 23.33 | 10.06 | 1227 | 667770 | 118353 | 78957038 |
C-reactive protein increased | 23.28 | 10.06 | 866 | 668131 | 128161 | 78947230 |
Medication error | 23.25 | 10.06 | 747 | 668250 | 67895 | 79007496 |
Human herpesvirus 6 infection | 23.23 | 10.06 | 8 | 668989 | 5362 | 79070029 |
Sinoatrial block | 23.05 | 10.06 | 41 | 668956 | 1310 | 79074081 |
Orbital myositis | 23.04 | 10.06 | 16 | 668981 | 167 | 79075224 |
Multiple drug therapy | 23.03 | 10.06 | 81 | 668916 | 3997 | 79071394 |
Deformity | 22.98 | 10.06 | 28 | 668969 | 9577 | 79065814 |
Hypoperfusion | 22.97 | 10.06 | 61 | 668936 | 2578 | 79072813 |
Diverticulum intestinal haemorrhagic | 22.93 | 10.06 | 80 | 668917 | 3931 | 79071460 |
Intestinal ischaemia | 22.90 | 10.06 | 190 | 668807 | 13080 | 79062311 |
Status epilepticus | 22.89 | 10.06 | 120 | 668877 | 24921 | 79050470 |
Oesophageal carcinoma | 22.83 | 10.06 | 36 | 668961 | 11048 | 79064343 |
Unintended pregnancy | 22.80 | 10.06 | 3 | 668994 | 3930 | 79071461 |
Lymphocyte stimulation test positive | 22.79 | 10.06 | 37 | 668960 | 1096 | 79074295 |
Peripheral artery stenosis | 22.64 | 10.06 | 40 | 668957 | 1271 | 79074120 |
Plasmapheresis | 22.62 | 10.06 | 28 | 668969 | 641 | 79074750 |
Febrile bone marrow aplasia | 22.60 | 10.06 | 47 | 668950 | 12973 | 79062418 |
Viral infection | 22.59 | 10.06 | 241 | 668756 | 42775 | 79032616 |
Upper gastrointestinal haemorrhage | 22.38 | 10.06 | 479 | 668518 | 40901 | 79034490 |
Femoral neck fracture | 22.35 | 10.06 | 152 | 668845 | 9832 | 79065559 |
Diabetic retinopathy | 22.33 | 10.06 | 67 | 668930 | 3039 | 79072352 |
Motor dysfunction | 22.33 | 10.06 | 205 | 668792 | 14528 | 79060863 |
Electrocardiogram Q wave abnormal | 22.32 | 10.06 | 27 | 668970 | 603 | 79074788 |
Dry eye | 22.30 | 10.06 | 200 | 668797 | 36731 | 79038660 |
Renal transplant | 22.29 | 10.06 | 59 | 668938 | 2488 | 79072903 |
Hypothermia | 22.21 | 10.06 | 290 | 668707 | 22456 | 79052935 |
Serotonin syndrome | 22.16 | 10.06 | 256 | 668741 | 44771 | 79030620 |
Alanine aminotransferase abnormal | 22.13 | 10.06 | 25 | 668972 | 8842 | 79066549 |
Joint destruction | 22.12 | 10.06 | 11 | 668986 | 5914 | 79069477 |
Low density lipoprotein decreased | 22.06 | 10.06 | 38 | 668959 | 1183 | 79074208 |
Cerebellar haemorrhage | 21.96 | 10.06 | 64 | 668933 | 2856 | 79072535 |
Thirst | 21.94 | 10.06 | 246 | 668751 | 18373 | 79057018 |
Labile hypertension | 21.90 | 10.06 | 25 | 668972 | 524 | 79074867 |
Blood uric acid increased | 21.84 | 10.06 | 189 | 668808 | 13171 | 79062220 |
Kidney transplant rejection | 21.76 | 10.06 | 154 | 668843 | 10092 | 79065299 |
Tricuspid valve incompetence | 21.69 | 10.06 | 257 | 668740 | 19455 | 79055936 |
Contusion | 21.69 | 10.06 | 1023 | 667974 | 147753 | 78927638 |
Rib deformity | 21.66 | 10.06 | 17 | 668980 | 217 | 79075174 |
Myelodysplastic syndrome | 21.55 | 10.06 | 157 | 668840 | 30144 | 79045247 |
Dyslalia | 21.55 | 10.06 | 35 | 668962 | 1037 | 79074354 |
Intestinal villi atrophy | 21.55 | 10.06 | 23 | 668974 | 446 | 79074945 |
Neovascularisation | 21.52 | 10.06 | 38 | 668959 | 1207 | 79074184 |
Injection site haemorrhage | 21.51 | 10.06 | 141 | 668856 | 27729 | 79047662 |
Hypersensitivity vasculitis | 21.48 | 10.06 | 115 | 668882 | 6828 | 79068563 |
Large intestine polyp | 21.42 | 10.06 | 181 | 668816 | 12527 | 79062864 |
Uveitis | 21.39 | 10.06 | 71 | 668926 | 16759 | 79058632 |
Haemoglobin decreased | 21.34 | 10.06 | 2152 | 666845 | 219967 | 78855424 |
Tendonitis | 21.33 | 10.06 | 115 | 668882 | 23715 | 79051676 |
Abortion induced | 21.30 | 10.06 | 17 | 668980 | 7092 | 79068299 |
Aplastic anaemia | 21.29 | 10.06 | 237 | 668760 | 17668 | 79057723 |
Scleral discolouration | 21.28 | 10.06 | 26 | 668971 | 587 | 79074804 |
Myopathy | 21.28 | 10.06 | 265 | 668732 | 20298 | 79055093 |
Device dislocation | 21.27 | 10.06 | 129 | 668868 | 25841 | 79049550 |
Sepsis | 21.25 | 10.06 | 1958 | 667039 | 267470 | 78807921 |
Metastases to bone | 21.25 | 10.06 | 119 | 668878 | 24308 | 79051083 |
Aortic stenosis | 21.09 | 10.06 | 121 | 668876 | 7374 | 79068017 |
Urine albumin/creatinine ratio increased | 21.03 | 10.06 | 25 | 668972 | 548 | 79074843 |
Chromaturia | 21.01 | 10.06 | 318 | 668679 | 25428 | 79049963 |
Blood cholinesterase decreased | 20.95 | 10.06 | 18 | 668979 | 263 | 79075128 |
Joint stiffness | 20.94 | 10.06 | 230 | 668767 | 40600 | 79034791 |
Night sweats | 20.93 | 10.06 | 309 | 668688 | 51786 | 79023605 |
Enthesopathy | 20.92 | 10.06 | 41 | 668956 | 11567 | 79063824 |
Traumatic haemorrhage | 20.90 | 10.06 | 39 | 668958 | 1294 | 79074097 |
Cardiac dysfunction | 20.83 | 10.06 | 79 | 668918 | 4045 | 79071346 |
Purpura | 20.79 | 10.06 | 253 | 668744 | 19274 | 79056117 |
CD30 expression | 20.72 | 10.06 | 10 | 668987 | 48 | 79075343 |
Vertigo | 20.67 | 10.06 | 741 | 668256 | 68341 | 79007050 |
Obsessive-compulsive disorder | 20.67 | 10.06 | 12 | 668985 | 5915 | 79069476 |
Dilatation ventricular | 20.61 | 10.06 | 79 | 668918 | 4065 | 79071326 |
Headache | 20.61 | 10.06 | 5018 | 663979 | 648754 | 78426637 |
Seizure | 20.59 | 10.06 | 1336 | 667661 | 187498 | 78887893 |
Body tinea | 20.53 | 10.06 | 47 | 668950 | 1807 | 79073584 |
Glucose tolerance impaired | 20.50 | 10.06 | 127 | 668870 | 7957 | 79067434 |
Bundle branch block | 20.49 | 10.06 | 43 | 668954 | 1557 | 79073834 |
Ocular icterus | 20.48 | 10.06 | 96 | 668901 | 5404 | 79069987 |
Synovial cyst | 20.44 | 10.06 | 33 | 668964 | 10032 | 79065359 |
Nipple inflammation | 20.39 | 10.06 | 10 | 668987 | 50 | 79075341 |
Hyperplasia | 20.29 | 10.06 | 37 | 668960 | 1206 | 79074185 |
Skin tightness | 20.28 | 10.06 | 96 | 668901 | 5426 | 79069965 |
Product dose omission issue | 20.23 | 10.06 | 1794 | 667203 | 245743 | 78829648 |
Left ventricular enlargement | 20.21 | 10.06 | 28 | 668969 | 718 | 79074673 |
Pleural effusion | 20.04 | 10.06 | 1446 | 667551 | 143816 | 78931575 |
Cytomegalovirus viraemia | 20.04 | 10.06 | 49 | 668948 | 12772 | 79062619 |
Colon cancer | 19.99 | 10.06 | 198 | 668799 | 14325 | 79061066 |
Alcohol abuse | 19.95 | 10.06 | 10 | 668987 | 5353 | 79070038 |
Carcinoid tumour | 19.94 | 10.06 | 24 | 668973 | 533 | 79074858 |
Fibrillary glomerulonephritis | 19.93 | 10.06 | 10 | 668987 | 53 | 79075338 |
Nephrogenic anaemia | 19.92 | 10.06 | 75 | 668922 | 3827 | 79071564 |
Left atrial enlargement | 19.88 | 10.06 | 36 | 668961 | 1167 | 79074224 |
Normal newborn | 19.86 | 10.06 | 18 | 668979 | 7054 | 79068337 |
Polypectomy | 19.85 | 10.06 | 36 | 668961 | 1168 | 79074223 |
Foetal exposure during pregnancy | 19.80 | 10.06 | 12 | 668985 | 5778 | 79069613 |
Procedural pain | 19.79 | 10.06 | 113 | 668884 | 22971 | 79052420 |
Azotaemia | 19.73 | 10.06 | 128 | 668869 | 8148 | 79067243 |
Nephrogenic systemic fibrosis | 19.72 | 10.06 | 103 | 668894 | 6057 | 79069334 |
Ballismus | 19.62 | 10.06 | 18 | 668979 | 288 | 79075103 |
Liver carcinoma ruptured | 19.60 | 10.06 | 15 | 668982 | 184 | 79075207 |
Pulmonary valve disease | 19.52 | 10.06 | 18 | 668979 | 290 | 79075101 |
Injection site rash | 19.38 | 10.06 | 81 | 668916 | 17873 | 79057518 |
Graft versus host disease in gastrointestinal tract | 19.30 | 10.06 | 15 | 668982 | 6341 | 79069050 |
Hypertonic bladder | 19.21 | 10.06 | 78 | 668919 | 4123 | 79071268 |
Hypovolaemic shock | 19.21 | 10.06 | 172 | 668825 | 12104 | 79063287 |
Mucosal membrane hyperplasia | 19.19 | 10.06 | 9 | 668988 | 40 | 79075351 |
Hypergastrinaemia | 19.14 | 10.06 | 15 | 668982 | 191 | 79075200 |
Zoonotic bacterial infection | 19.07 | 10.06 | 10 | 668987 | 59 | 79075332 |
Benign neoplasm of adrenal gland | 19.01 | 10.06 | 9 | 668988 | 41 | 79075350 |
Device leakage | 19 | 10.06 | 39 | 668958 | 10817 | 79064574 |
Enterochromaffin cell hyperplasia | 19.00 | 10.06 | 11 | 668986 | 81 | 79075310 |
Haemorrhage subepidermal | 18.95 | 10.06 | 7 | 668990 | 14 | 79075377 |
Blood loss anaemia | 18.83 | 10.06 | 206 | 668791 | 15292 | 79060099 |
COVID-19 | 18.68 | 10.06 | 1107 | 667890 | 156567 | 78918824 |
Blood sodium decreased | 18.65 | 10.06 | 387 | 668610 | 32868 | 79042523 |
Chondroma | 18.63 | 10.06 | 6 | 668991 | 6 | 79075385 |
Lecithin-cholesterol acyltransferase deficiency | 18.63 | 10.06 | 6 | 668991 | 6 | 79075385 |
Multiple sclerosis | 18.61 | 10.06 | 110 | 668887 | 22172 | 79053219 |
Flushing | 18.58 | 10.06 | 581 | 668416 | 87687 | 78987704 |
Herpes zoster | 18.57 | 10.06 | 617 | 668380 | 92466 | 78982925 |
Varicella zoster virus infection | 18.55 | 10.06 | 7 | 668990 | 4434 | 79070957 |
Osteopenia | 18.52 | 10.06 | 85 | 668912 | 18279 | 79057112 |
Lichen nitidus | 18.46 | 10.06 | 11 | 668986 | 86 | 79075305 |
Dysgeusia | 18.28 | 10.06 | 618 | 668379 | 56559 | 79018832 |
Electrocardiogram P wave abnormal | 18.27 | 10.06 | 19 | 668978 | 357 | 79075034 |
Female genital tract fistula | 18.27 | 10.06 | 14 | 668983 | 5961 | 79069430 |
Type I hypersensitivity | 18.26 | 10.06 | 7 | 668990 | 4391 | 79071000 |
Prostate cancer recurrent | 18.24 | 10.06 | 28 | 668969 | 790 | 79074601 |
Eczema | 18.21 | 10.06 | 460 | 668537 | 40358 | 79035033 |
Dyskinesia | 18.18 | 10.06 | 265 | 668732 | 44508 | 79030883 |
Systemic infection | 18.11 | 10.06 | 142 | 668855 | 9610 | 79065781 |
Cerebral ischaemia | 18.11 | 10.06 | 158 | 668839 | 11037 | 79064354 |
Mycobacterium marinum infection | 18.10 | 10.06 | 21 | 668976 | 448 | 79074943 |
Epiglottic oedema | 18.10 | 10.06 | 18 | 668979 | 320 | 79075071 |
Toxic skin eruption | 18.05 | 10.06 | 275 | 668722 | 22018 | 79053373 |
Ventricular hyperkinesia | 18.04 | 10.06 | 17 | 668980 | 282 | 79075109 |
Sleep disorder | 18.03 | 10.06 | 564 | 668433 | 85113 | 78990278 |
Aortic aneurysm | 17.97 | 10.06 | 127 | 668870 | 8319 | 79067072 |
Product tampering | 17.94 | 10.06 | 20 | 668977 | 408 | 79074983 |
Cardiac disorder | 17.91 | 10.06 | 698 | 668299 | 65059 | 79010332 |
Carotid sinus syndrome | 17.88 | 10.06 | 14 | 668983 | 178 | 79075213 |
Renal injury | 17.88 | 10.06 | 219 | 668778 | 16708 | 79058683 |
Hyperparathyroidism secondary | 17.84 | 10.06 | 56 | 668941 | 2604 | 79072787 |
Portal hypertension | 17.78 | 10.06 | 20 | 668977 | 7088 | 79068303 |
Lipodystrophy acquired | 17.77 | 10.06 | 7 | 668990 | 4318 | 79071073 |
Atrioventricular dissociation | 17.75 | 10.06 | 18 | 668979 | 328 | 79075063 |
Polymyositis | 17.75 | 10.06 | 61 | 668936 | 2975 | 79072416 |
Gingival disorder | 17.67 | 10.06 | 69 | 668928 | 3582 | 79071809 |
Gallbladder adenocarcinoma | 17.62 | 10.06 | 12 | 668985 | 121 | 79075270 |
Bladder sphincter atony | 17.62 | 10.06 | 12 | 668985 | 121 | 79075270 |
Pulmonary hypoplasia | 17.60 | 10.06 | 9 | 668988 | 50 | 79075341 |
End stage renal disease | 17.50 | 10.06 | 168 | 668829 | 12052 | 79063339 |
Gamma-glutamyltransferase increased | 17.48 | 10.06 | 591 | 668406 | 54089 | 79021302 |
Duodenal ulcer | 17.39 | 10.06 | 212 | 668785 | 16157 | 79059234 |
Pericardial disease | 17.37 | 10.06 | 23 | 668974 | 564 | 79074827 |
Dysphonia | 17.25 | 10.06 | 611 | 668386 | 56261 | 79019130 |
Herpes simplex | 17.20 | 10.06 | 49 | 668948 | 12138 | 79063253 |
Electrolyte imbalance | 17.19 | 10.06 | 359 | 668638 | 30522 | 79044869 |
Sexual dysfunction | 17.17 | 10.06 | 24 | 668973 | 7739 | 79067652 |
Drug level increased | 17.15 | 10.06 | 445 | 668552 | 39206 | 79036185 |
Fine motor skill dysfunction | 17.10 | 10.06 | 12 | 668985 | 5345 | 79070046 |
Cardiac arrest | 17.05 | 10.06 | 1671 | 667326 | 170425 | 78904966 |
Hypoglossal nerve paralysis | 17.00 | 10.06 | 7 | 668990 | 21 | 79075370 |
Cholecystitis chronic | 16.99 | 10.06 | 36 | 668961 | 9870 | 79065521 |
Labelled drug-drug interaction medication error | 16.91 | 10.06 | 326 | 668671 | 27324 | 79048067 |
Fulminant type 1 diabetes mellitus | 16.87 | 10.06 | 38 | 668959 | 1445 | 79073946 |
Virologic failure | 16.86 | 10.06 | 7 | 668990 | 4184 | 79071207 |
Complication of device insertion | 16.86 | 10.06 | 17 | 668980 | 6333 | 79069058 |
Retinopathy hypertensive | 16.79 | 10.06 | 21 | 668976 | 486 | 79074905 |
Orthopnoea | 16.73 | 10.06 | 143 | 668854 | 9930 | 79065461 |
Nasal crusting | 16.71 | 10.06 | 23 | 668974 | 586 | 79074805 |
Cardiac failure acute | 16.70 | 10.06 | 237 | 668760 | 18692 | 79056699 |
Cytomegalovirus chorioretinitis | 16.61 | 10.06 | 13 | 668984 | 5477 | 79069914 |
Angiopathy | 16.56 | 10.06 | 109 | 668888 | 6973 | 79068418 |
Intraventricular haemorrhage | 16.54 | 10.06 | 83 | 668914 | 4804 | 79070587 |
Pleuritic pain | 16.50 | 10.06 | 38 | 668959 | 10114 | 79065277 |
Hyperthyroidism | 16.49 | 10.06 | 270 | 668727 | 21939 | 79053452 |
Cystic fibrosis | 16.41 | 10.06 | 6 | 668991 | 3874 | 79071517 |
Neoplasm progression | 16.39 | 10.06 | 320 | 668677 | 51362 | 79024029 |
Injection site discolouration | 16.38 | 10.06 | 24 | 668973 | 7590 | 79067801 |
Cough | 16.36 | 10.06 | 3399 | 665598 | 363390 | 78712001 |
Renal function test abnormal | 16.30 | 10.06 | 84 | 668913 | 4914 | 79070477 |
Suspected suicide attempt | 16.28 | 10.06 | 17 | 668980 | 321 | 79075070 |
Vascular device infection | 16.28 | 10.06 | 39 | 668958 | 10237 | 79065154 |
Harlequin syndrome | 16.27 | 10.06 | 9 | 668988 | 60 | 79075331 |
Embolic stroke | 16.26 | 10.06 | 117 | 668880 | 7709 | 79067682 |
Needle fatigue | 16.20 | 10.06 | 28 | 668969 | 874 | 79074517 |
Appendicitis | 16.15 | 10.06 | 105 | 668892 | 20689 | 79054702 |
Coronary artery stenosis | 16.13 | 10.06 | 168 | 668829 | 12316 | 79063075 |
Ultrasound uterus abnormal | 16.10 | 10.06 | 7 | 668990 | 25 | 79075366 |
Drug abuser | 16.07 | 10.06 | 16 | 668981 | 5997 | 79069394 |
Vasculitis | 16.06 | 10.06 | 298 | 668699 | 24804 | 79050587 |
Tricuspid valve calcification | 16.04 | 10.06 | 5 | 668992 | 4 | 79075387 |
Disturbance in social behaviour | 16.04 | 10.06 | 11 | 668986 | 4959 | 79070432 |
Atheroembolism | 16.03 | 10.06 | 17 | 668980 | 327 | 79075064 |
Band neutrophil percentage decreased | 15.93 | 10.06 | 6 | 668991 | 13 | 79075378 |
Essential hypertension | 15.92 | 10.06 | 96 | 668901 | 5957 | 79069434 |
Rales | 15.92 | 10.06 | 246 | 668751 | 19755 | 79055636 |
Helicobacter gastritis | 15.92 | 10.06 | 51 | 668946 | 2398 | 79072993 |
Acute pulmonary oedema | 15.86 | 10.06 | 186 | 668811 | 14044 | 79061347 |
Femoral artery dissection | 15.86 | 10.06 | 8 | 668989 | 43 | 79075348 |
Panniculitis | 15.85 | 10.06 | 52 | 668945 | 12319 | 79063072 |
Accidental exposure to product | 15.84 | 10.06 | 177 | 668820 | 31145 | 79044246 |
Benign prostatic hyperplasia | 15.83 | 10.06 | 158 | 668839 | 11454 | 79063937 |
Cutaneous vasculitis | 15.79 | 10.06 | 121 | 668876 | 8131 | 79067260 |
Blood parathyroid hormone increased | 15.78 | 10.06 | 64 | 668933 | 3381 | 79072010 |
Colitis ulcerative | 15.78 | 10.06 | 201 | 668796 | 34541 | 79040850 |
Sensitivity to weather change | 15.77 | 10.06 | 27 | 668970 | 8020 | 79067371 |
Eyelid oedema | 15.75 | 10.06 | 180 | 668817 | 13507 | 79061884 |
Glucose urine present | 15.70 | 10.06 | 41 | 668956 | 1715 | 79073676 |
Obstructive airways disorder | 15.69 | 10.06 | 360 | 668637 | 31099 | 79044292 |
Coronary artery occlusion | 15.69 | 10.06 | 197 | 668800 | 15118 | 79060273 |
Acute graft versus host disease in skin | 15.65 | 10.06 | 25 | 668972 | 7633 | 79067758 |
Cryopyrin associated periodic syndrome | 15.63 | 10.06 | 18 | 668979 | 381 | 79075010 |
Hyperthermia | 15.62 | 10.06 | 88 | 668909 | 17949 | 79057442 |
Listless | 15.57 | 10.06 | 69 | 668928 | 3792 | 79071599 |
Hyperprolactinaemia | 15.56 | 10.06 | 10 | 668987 | 4666 | 79070725 |
Fistula | 15.49 | 10.06 | 56 | 668941 | 12884 | 79062507 |
Suicidal ideation | 15.47 | 10.06 | 505 | 668492 | 75835 | 78999556 |
Extrasystoles | 15.46 | 10.06 | 111 | 668886 | 7308 | 79068083 |
Noninfective gingivitis | 15.46 | 10.06 | 39 | 668958 | 1597 | 79073794 |
Coma scale abnormal | 15.38 | 10.06 | 125 | 668872 | 8553 | 79066838 |
Intestinal angioedema | 15.33 | 10.06 | 27 | 668970 | 856 | 79074535 |
Hepatosplenomegaly | 15.27 | 10.06 | 17 | 668980 | 6052 | 79069339 |
Product storage error | 15.26 | 10.06 | 77 | 668920 | 16149 | 79059242 |
Hypertensive urgency | 15.20 | 10.06 | 21 | 668976 | 537 | 79074854 |
Ventricular extrasystoles | 15.17 | 10.06 | 241 | 668756 | 19463 | 79055928 |
Idiopathic pulmonary fibrosis | 15.16 | 10.06 | 73 | 668924 | 4155 | 79071236 |
Ventricular compliance decreased | 15.16 | 10.06 | 4 | 668993 | 0 | 79075391 |
Aortic valve incompetence | 15.16 | 10.06 | 134 | 668863 | 9396 | 79065995 |
Cardiorenal syndrome | 15.14 | 10.06 | 38 | 668959 | 1551 | 79073840 |
Klebsiella infection | 15.12 | 10.06 | 74 | 668923 | 15646 | 79059745 |
Tongue disorder | 15.11 | 10.06 | 63 | 668934 | 13912 | 79061479 |
Hypertensive nephropathy | 15.07 | 10.06 | 29 | 668968 | 985 | 79074406 |
Craniectomy | 15.05 | 10.06 | 5 | 668992 | 6 | 79075385 |
Hypovolaemia | 15.01 | 10.06 | 220 | 668777 | 17471 | 79057920 |
Nephropathy | 15.01 | 10.06 | 136 | 668861 | 9602 | 79065789 |
Inappropriate schedule of product administration | 14.98 | 10.06 | 943 | 668054 | 132685 | 78942706 |
Pericardial haemorrhage | 14.97 | 10.06 | 76 | 668921 | 4419 | 79070972 |
Claustrophobia | 14.96 | 10.06 | 33 | 668964 | 1237 | 79074154 |
Jaundice | 14.93 | 10.06 | 568 | 668429 | 52781 | 79022610 |
Food allergy | 14.93 | 10.06 | 44 | 668953 | 10780 | 79064611 |
Walking aid user | 14.92 | 10.06 | 40 | 668957 | 10108 | 79065283 |
Gastric pH increased | 14.89 | 10.06 | 8 | 668989 | 50 | 79075341 |
Galactorrhoea | 14.82 | 10.06 | 6 | 668991 | 3640 | 79071751 |
Arthritis | 14.80 | 10.06 | 800 | 668197 | 114080 | 78961311 |
Hepatitis | 14.79 | 10.06 | 355 | 668642 | 55372 | 79020019 |
Rectal ulcer haemorrhage | 14.76 | 10.06 | 15 | 668982 | 274 | 79075117 |
Sinonasal obstruction | 14.76 | 10.06 | 16 | 668981 | 316 | 79075075 |
Adenoma benign | 14.69 | 10.06 | 31 | 668966 | 1127 | 79074264 |
Wrong patient received product | 14.63 | 10.06 | 77 | 668920 | 4541 | 79070850 |
Pelvic cyst | 14.63 | 10.06 | 8 | 668989 | 52 | 79075339 |
Inhibitory drug interaction | 14.63 | 10.06 | 75 | 668922 | 4378 | 79071013 |
Sex hormone binding globulin increased | 14.63 | 10.06 | 5 | 668992 | 7 | 79075384 |
Mitochondrial toxicity | 14.62 | 10.06 | 4 | 668993 | 3110 | 79072281 |
Encephalitis toxic | 14.59 | 10.06 | 15 | 668982 | 278 | 79075113 |
Road traffic accident | 14.57 | 10.06 | 268 | 668729 | 43396 | 79031995 |
Premature rupture of membranes | 14.53 | 10.06 | 8 | 668989 | 4061 | 79071330 |
Faecal calprotectin increased | 14.52 | 10.06 | 15 | 668982 | 5526 | 79069865 |
Pharyngitis streptococcal | 14.45 | 10.06 | 44 | 668953 | 10670 | 79064721 |
Haemorrhagic diathesis | 14.45 | 10.06 | 94 | 668903 | 5990 | 79069401 |
Hypertensive cardiomyopathy | 14.44 | 10.06 | 16 | 668981 | 324 | 79075067 |
Base excess decreased | 14.43 | 10.06 | 17 | 668980 | 369 | 79075022 |
Haemorrhage intracranial | 14.42 | 10.06 | 304 | 668693 | 25889 | 79049502 |
Haematuria | 14.38 | 10.06 | 711 | 668286 | 68125 | 79007266 |
Neuropathy peripheral | 14.35 | 10.06 | 1006 | 667991 | 140299 | 78935092 |
Enterococcal infection | 14.34 | 10.06 | 75 | 668922 | 15585 | 79059806 |
Macroglossia | 14.27 | 10.06 | 31 | 668966 | 1150 | 79074241 |
Intercepted product preparation error | 14.24 | 10.06 | 6 | 668991 | 3554 | 79071837 |
Rheumatoid lung | 14.23 | 10.06 | 9 | 668988 | 4236 | 79071155 |
Genital haemorrhage | 14.17 | 10.06 | 19 | 668978 | 6236 | 79069155 |
Transplant rejection | 14.17 | 10.06 | 100 | 668897 | 19337 | 79056054 |
Giant cell arteritis | 14.14 | 10.06 | 53 | 668944 | 2698 | 79072693 |
Blood cholinesterase increased | 14.12 | 10.06 | 7 | 668990 | 36 | 79075355 |
Coronary arterial stent insertion | 14.12 | 10.06 | 93 | 668904 | 5951 | 79069440 |
Cell marker increased | 14.12 | 10.06 | 22 | 668975 | 629 | 79074762 |
Anal fissure | 14.06 | 10.06 | 27 | 668970 | 7676 | 79067715 |
Skin candida | 14.06 | 10.06 | 44 | 668953 | 2043 | 79073348 |
Lip oedema | 14.04 | 10.06 | 96 | 668901 | 6220 | 79069171 |
Continuous haemodiafiltration | 14.04 | 10.06 | 43 | 668954 | 1973 | 79073418 |
Drug level below therapeutic | 14.00 | 10.06 | 39 | 668958 | 9731 | 79065660 |
Blood urea abnormal | 13.99 | 10.06 | 33 | 668964 | 1294 | 79074097 |
Vascular resistance systemic decreased | 13.97 | 10.06 | 13 | 668984 | 212 | 79075179 |
Malpositioned teeth | 13.97 | 10.06 | 7 | 668990 | 37 | 79075354 |
Eosinophilia | 13.96 | 10.06 | 488 | 668509 | 44857 | 79030534 |
Physical examination abnormal | 13.93 | 10.06 | 15 | 668982 | 294 | 79075097 |
Poor venous access | 13.91 | 10.06 | 92 | 668905 | 18057 | 79057334 |
Generalised tonic-clonic seizure | 13.88 | 10.06 | 272 | 668725 | 43638 | 79031753 |
Tenderness | 13.85 | 10.06 | 129 | 668868 | 23513 | 79051878 |
Myositis | 13.85 | 10.06 | 232 | 668765 | 18936 | 79056455 |
Full blood count abnormal | 13.85 | 10.06 | 441 | 668556 | 40033 | 79035358 |
Cold sweat | 13.76 | 10.06 | 227 | 668770 | 18472 | 79056919 |
Cross sensitivity reaction | 13.69 | 10.06 | 7 | 668990 | 3705 | 79071686 |
Cellulitis of male external genital organ | 13.67 | 10.06 | 7 | 668990 | 39 | 79075352 |
Metabolic disorder | 13.59 | 10.06 | 36 | 668961 | 9134 | 79066257 |
Device breakage | 13.59 | 10.06 | 45 | 668952 | 10630 | 79064761 |
Lung hernia | 13.59 | 10.06 | 8 | 668989 | 61 | 79075330 |
Drug eruption | 13.57 | 10.06 | 473 | 668524 | 43462 | 79031929 |
Coronary artery surgery | 13.55 | 10.06 | 12 | 668985 | 183 | 79075208 |
Herbal interaction | 13.55 | 10.06 | 19 | 668978 | 493 | 79074898 |
IgA nephropathy | 13.54 | 10.06 | 39 | 668958 | 1729 | 79073662 |
Device deployment issue | 13.53 | 10.06 | 5 | 668992 | 3207 | 79072184 |
Peritoneal dialysis complication | 13.50 | 10.06 | 47 | 668950 | 2307 | 79073084 |
Product administered to patient of inappropriate age | 13.49 | 10.06 | 16 | 668981 | 5537 | 79069854 |
Product solubility abnormal | 13.48 | 10.06 | 27 | 668970 | 945 | 79074446 |
Sodium retention | 13.44 | 10.06 | 12 | 668985 | 185 | 79075206 |
Bone cyst | 13.39 | 10.06 | 6 | 668991 | 3427 | 79071964 |
Electrocardiogram abnormal | 13.37 | 10.06 | 206 | 668791 | 16531 | 79058860 |
Brain abscess | 13.35 | 10.06 | 13 | 668984 | 4923 | 79070468 |
Carcinoid tumour of the stomach | 13.34 | 10.06 | 12 | 668985 | 187 | 79075204 |
Microalbuminuria | 13.34 | 10.06 | 26 | 668971 | 892 | 79074499 |
Sinus rhythm | 13.33 | 10.06 | 25 | 668972 | 833 | 79074558 |
Analgesic drug level increased | 13.29 | 10.06 | 5 | 668992 | 3173 | 79072218 |
Hydronephrosis | 13.26 | 10.06 | 213 | 668784 | 17241 | 79058150 |
Disorientation | 13.24 | 10.06 | 649 | 668348 | 62127 | 79013264 |
Vaginal haemorrhage | 13.24 | 10.06 | 118 | 668879 | 21699 | 79053692 |
Device related infection | 13.23 | 10.06 | 205 | 668792 | 34089 | 79041302 |
Iliac artery occlusion | 13.23 | 10.06 | 15 | 668982 | 312 | 79075079 |
Intermenstrual bleeding | 13.20 | 10.06 | 18 | 668979 | 5866 | 79069525 |
Tardive dyskinesia | 13.16 | 10.06 | 45 | 668952 | 10526 | 79064865 |
Drug screen positive | 13.16 | 10.06 | 19 | 668978 | 6044 | 79069347 |
Intentional product misuse | 13.15 | 10.06 | 658 | 668339 | 94507 | 78980884 |
Electrocardiogram T wave amplitude decreased | 13.11 | 10.06 | 23 | 668974 | 727 | 79074664 |
Gait inability | 13.09 | 10.06 | 385 | 668612 | 58532 | 79016859 |
Hallucination, gustatory | 13.07 | 10.06 | 8 | 668989 | 66 | 79075325 |
Musculoskeletal disorder | 13.01 | 10.06 | 116 | 668881 | 21332 | 79054059 |
Head injury | 13.00 | 10.06 | 408 | 668589 | 36961 | 79038430 |
Liver function test increased | 13.00 | 10.06 | 245 | 668752 | 39528 | 79035863 |
Acute motor-sensory axonal neuropathy | 12.99 | 10.06 | 17 | 668980 | 412 | 79074979 |
Osteonecrosis | 12.99 | 10.06 | 183 | 668814 | 30912 | 79044479 |
Metabolic alkalosis | 12.98 | 10.06 | 73 | 668924 | 4416 | 79070975 |
Exposure via ingestion | 12.94 | 10.06 | 81 | 668916 | 5093 | 79070298 |
Pericarditis uraemic | 12.93 | 10.06 | 5 | 668992 | 12 | 79075379 |
Vision blurred | 12.91 | 10.06 | 1044 | 667953 | 104854 | 78970537 |
Vasculitic rash | 12.87 | 10.06 | 44 | 668953 | 2140 | 79073251 |
Toxic nodular goitre | 12.87 | 10.06 | 7 | 668990 | 45 | 79075346 |
Streptococcal infection | 12.84 | 10.06 | 35 | 668962 | 8795 | 79066596 |
Loose tooth | 12.80 | 10.06 | 56 | 668941 | 3061 | 79072330 |
Drug dispensed to wrong patient | 12.79 | 10.06 | 22 | 668975 | 684 | 79074707 |
Adulterated product | 12.77 | 10.06 | 14 | 668983 | 280 | 79075111 |
Paranoia | 12.73 | 10.06 | 103 | 668894 | 19329 | 79056062 |
Chronic sinusitis | 12.72 | 10.06 | 61 | 668936 | 12965 | 79062426 |
Tuberculosis | 12.71 | 10.06 | 75 | 668922 | 15123 | 79060268 |
Brain oedema | 12.68 | 10.06 | 143 | 668854 | 25120 | 79050271 |
Ulcer | 12.66 | 10.06 | 176 | 668821 | 29796 | 79045595 |
Neuroendocrine tumour | 12.66 | 10.06 | 32 | 668965 | 1312 | 79074079 |
Kidney fibrosis | 12.65 | 10.06 | 61 | 668936 | 3474 | 79071917 |
Cardiac failure chronic | 12.61 | 10.06 | 146 | 668851 | 10989 | 79064402 |
Dermatomyositis | 12.59 | 10.06 | 62 | 668935 | 3561 | 79071830 |
Anosognosia | 12.59 | 10.06 | 8 | 668989 | 3756 | 79071635 |
Nipple disorder | 12.59 | 10.06 | 12 | 668985 | 202 | 79075189 |
Hypertensive angiopathy | 12.57 | 10.06 | 9 | 668988 | 99 | 79075292 |
Periarticular disorder | 12.56 | 10.06 | 6 | 668991 | 28 | 79075363 |
Cardiac myxoma | 12.53 | 10.06 | 10 | 668987 | 131 | 79075260 |
Dermatosis | 12.53 | 10.06 | 20 | 668977 | 584 | 79074807 |
Muscle twitching | 12.50 | 10.06 | 140 | 668857 | 24624 | 79050767 |
Phaeochromocytoma malignant | 12.50 | 10.06 | 8 | 668989 | 72 | 79075319 |
Apathy | 12.48 | 10.06 | 165 | 668832 | 12812 | 79062579 |
Flatulence | 12.47 | 10.06 | 457 | 668540 | 42267 | 79033124 |
Nail disorder | 12.47 | 10.06 | 54 | 668943 | 11798 | 79063593 |
Hypogammaglobulinaemia | 12.44 | 10.06 | 61 | 668936 | 12890 | 79062501 |
Gestational diabetes | 12.44 | 10.06 | 21 | 668976 | 6272 | 79069119 |
Venous aneurysm | 12.42 | 10.06 | 4 | 668993 | 4 | 79075387 |
Product label on wrong product | 12.40 | 10.06 | 6 | 668991 | 29 | 79075362 |
Dermatitis infected | 12.39 | 10.06 | 14 | 668983 | 290 | 79075101 |
Venous oxygen saturation decreased | 12.39 | 10.06 | 5 | 668992 | 14 | 79075377 |
Blood parathyroid hormone decreased | 12.35 | 10.06 | 46 | 668951 | 10490 | 79064901 |
Mouth swelling | 12.30 | 10.06 | 90 | 668907 | 5961 | 79069430 |
Beta 2 microglobulin urine increased | 12.28 | 10.06 | 10 | 668987 | 135 | 79075256 |
Brain stem haemorrhage | 12.25 | 10.06 | 36 | 668961 | 1614 | 79073777 |
Carbohydrate metabolism disorder | 12.24 | 10.06 | 6 | 668991 | 30 | 79075361 |
Guillain-Barre syndrome | 12.23 | 10.06 | 122 | 668875 | 8843 | 79066548 |
Leukaemoid reaction | 12.20 | 10.06 | 15 | 668982 | 341 | 79075050 |
Tachyarrhythmia | 12.18 | 10.06 | 100 | 668897 | 6862 | 79068529 |
Adrenal neoplasm | 12.17 | 10.06 | 18 | 668979 | 491 | 79074900 |
Diarrhoea | 12.15 | 10.06 | 7812 | 661185 | 872677 | 78202714 |
Monoparesis | 12.15 | 10.06 | 60 | 668937 | 3451 | 79071940 |
Stent placement | 12.14 | 10.06 | 95 | 668902 | 6425 | 79068966 |
Pelvi-ureteric obstruction | 12.14 | 10.06 | 8 | 668989 | 76 | 79075315 |
Atrial natriuretic peptide increased | 12.14 | 10.06 | 5 | 668992 | 15 | 79075376 |
Gingival atrophy | 12.14 | 10.06 | 8 | 668989 | 76 | 79075315 |
Lung diffusion test decreased | 12.14 | 10.06 | 31 | 668966 | 1279 | 79074112 |
Anal fistula | 12.11 | 10.06 | 25 | 668972 | 6919 | 79068472 |
Skin weeping | 12.10 | 10.06 | 27 | 668970 | 1020 | 79074371 |
Peripheral ischaemia | 12.09 | 10.06 | 127 | 668870 | 9330 | 79066061 |
Oral discharge | 12.06 | 10.06 | 13 | 668984 | 255 | 79075136 |
Benign gastrointestinal neoplasm | 12.04 | 10.06 | 10 | 668987 | 139 | 79075252 |
Autoimmune enteropathy | 12.04 | 10.06 | 7 | 668990 | 52 | 79075339 |
Blood pressure systolic decreased | 12.01 | 10.06 | 144 | 668853 | 10932 | 79064459 |
Pulmonary alveolar haemorrhage | 12.00 | 10.06 | 148 | 668849 | 11309 | 79064082 |
Optic nerve injury | 12.00 | 10.06 | 20 | 668977 | 606 | 79074785 |
Osteoma | 11.99 | 10.06 | 9 | 668988 | 107 | 79075284 |
Renal artery occlusion | 11.99 | 10.06 | 10 | 668987 | 140 | 79075251 |
Rhinovirus infection | 11.96 | 10.06 | 31 | 668966 | 7922 | 79067469 |
Urine flow decreased | 11.95 | 10.06 | 28 | 668969 | 1093 | 79074298 |
Thrombotic cerebral infarction | 11.95 | 10.06 | 19 | 668978 | 553 | 79074838 |
Post-traumatic amnestic disorder | 11.93 | 10.06 | 7 | 668990 | 53 | 79075338 |
Blood sodium increased | 11.93 | 10.06 | 75 | 668922 | 4723 | 79070668 |
Cardiac valve sclerosis | 11.92 | 10.06 | 9 | 668988 | 108 | 79075283 |
Epididymal cyst | 11.91 | 10.06 | 5 | 668992 | 16 | 79075375 |
Surfactant protein increased | 11.91 | 10.06 | 5 | 668992 | 16 | 79075375 |
No adverse event | 11.88 | 10.06 | 230 | 668767 | 36962 | 79038429 |
Therapy interrupted | 11.87 | 10.06 | 188 | 668809 | 31153 | 79044238 |
Q fever | 11.86 | 10.06 | 13 | 668984 | 260 | 79075131 |
Neurosensory hypoacusis | 11.86 | 10.06 | 12 | 668985 | 218 | 79075173 |
Splenic rupture | 11.83 | 10.06 | 46 | 668951 | 2383 | 79073008 |
Dermatitis exfoliative | 11.83 | 10.06 | 141 | 668856 | 10688 | 79064703 |
Hyperparathyroidism | 11.80 | 10.06 | 56 | 668941 | 3168 | 79072223 |
Pleural mass | 11.80 | 10.06 | 8 | 668989 | 80 | 79075311 |
Gait spastic | 11.80 | 10.06 | 29 | 668968 | 1168 | 79074223 |
Lupus-like syndrome | 11.79 | 10.06 | 68 | 668929 | 13789 | 79061602 |
Vulvovaginal burning sensation | 11.74 | 10.06 | 35 | 668962 | 1582 | 79073809 |
Vagus nerve disorder | 11.72 | 10.06 | 7 | 668990 | 55 | 79075336 |
Metastases to fallopian tube | 11.72 | 10.06 | 7 | 668990 | 55 | 79075336 |
Menstruation irregular | 11.72 | 10.06 | 15 | 668982 | 5021 | 79070370 |
Ventricular drainage | 11.68 | 10.06 | 5 | 668992 | 17 | 79075374 |
Exostosis | 11.68 | 10.06 | 88 | 668909 | 16770 | 79058621 |
Malignant hypertension | 11.67 | 10.06 | 35 | 668962 | 1587 | 79073804 |
Orbital swelling | 11.61 | 10.06 | 7 | 668990 | 56 | 79075335 |
Conjunctivitis | 11.59 | 10.06 | 149 | 668848 | 25566 | 79049825 |
Neuroleptic malignant syndrome | 11.58 | 10.06 | 162 | 668835 | 27397 | 79047994 |
Mobility decreased | 11.57 | 10.06 | 875 | 668122 | 121300 | 78954091 |
Pleuroperitoneal communication | 11.54 | 10.06 | 4 | 668993 | 6 | 79075385 |
Gingival hypoplasia | 11.54 | 10.06 | 4 | 668993 | 6 | 79075385 |
Hypothyroidism | 11.54 | 10.06 | 544 | 668453 | 51848 | 79023543 |
Tumour rupture | 11.54 | 10.06 | 17 | 668980 | 462 | 79074929 |
Leukocytosis | 11.53 | 10.06 | 460 | 668537 | 42995 | 79032396 |
Joint injury | 11.52 | 10.06 | 189 | 668808 | 31146 | 79044245 |
Anal abscess | 11.52 | 10.06 | 40 | 668957 | 9315 | 79066076 |
Hepatitis B reactivation | 11.51 | 10.06 | 21 | 668976 | 6087 | 79069304 |
Norepinephrine increased | 11.48 | 10.06 | 8 | 668989 | 84 | 79075307 |
Incorrect dose administered by device | 11.46 | 10.06 | 15 | 668982 | 4974 | 79070417 |
Peripheral coldness | 11.43 | 10.06 | 193 | 668804 | 15777 | 79059614 |
Neutrophil count decreased | 11.42 | 10.06 | 658 | 668339 | 93301 | 78982090 |
Head discomfort | 11.40 | 10.06 | 178 | 668819 | 14324 | 79061067 |
Palatal oedema | 11.38 | 10.06 | 32 | 668965 | 1399 | 79073992 |
Electrocardiogram QRS complex prolonged | 11.38 | 10.06 | 140 | 668857 | 10693 | 79064698 |
Glucose tolerance increased | 11.37 | 10.06 | 3 | 668994 | 0 | 79075391 |
Oesophageal adenocarcinoma stage III | 11.37 | 10.06 | 3 | 668994 | 0 | 79075391 |
Tear discolouration | 11.37 | 10.06 | 3 | 668994 | 0 | 79075391 |
Diabetic enteropathy | 11.37 | 10.06 | 3 | 668994 | 0 | 79075391 |
Protein albumin ratio decreased | 11.37 | 10.06 | 3 | 668994 | 0 | 79075391 |
Secondary hypertension | 11.36 | 10.06 | 15 | 668982 | 367 | 79075024 |
Interstitial granulomatous dermatitis | 11.35 | 10.06 | 12 | 668985 | 230 | 79075161 |
Colorectal cancer | 11.32 | 10.06 | 36 | 668961 | 8611 | 79066780 |
Renovascular hypertension | 11.31 | 10.06 | 7 | 668990 | 59 | 79075332 |
Depression | 11.30 | 10.06 | 1620 | 667377 | 215170 | 78860221 |
Nasal oedema | 11.29 | 10.06 | 36 | 668961 | 1688 | 79073703 |
Vaginal infection | 11.27 | 10.06 | 20 | 668977 | 5860 | 79069531 |
Ventricular failure | 11.24 | 10.06 | 18 | 668979 | 527 | 79074864 |
Primary hypoparathyroidism | 11.23 | 10.06 | 6 | 668991 | 37 | 79075354 |
Urine protein/creatinine ratio increased | 11.23 | 10.06 | 29 | 668968 | 1205 | 79074186 |
Acute respiratory failure | 11.22 | 10.06 | 609 | 668388 | 58932 | 79016459 |
Cerebrovascular disorder | 11.21 | 10.06 | 61 | 668936 | 3644 | 79071747 |
Myasthenia gravis | 11.18 | 10.06 | 135 | 668862 | 10264 | 79065127 |
Cerebral toxoplasmosis | 11.15 | 10.06 | 3 | 668994 | 2359 | 79073032 |
Cerebrovascular arteriovenous malformation | 11.15 | 10.06 | 9 | 668988 | 120 | 79075271 |
Immune effector cell-associated neurotoxicity syndrome | 11.12 | 10.06 | 20 | 668977 | 5828 | 79069563 |
Muscular weakness | 11.11 | 10.06 | 1525 | 667472 | 159204 | 78916187 |
Shock haemorrhagic | 11.10 | 10.06 | 233 | 668764 | 19827 | 79055564 |
Abnormal behaviour | 11.10 | 10.06 | 227 | 668770 | 36194 | 79039197 |
Tumour haemorrhage | 11.07 | 10.06 | 66 | 668931 | 4078 | 79071313 |
Deafness neurosensory | 11.07 | 10.06 | 26 | 668971 | 6872 | 79068519 |
Retroperitoneal oedema | 11.07 | 10.06 | 5 | 668992 | 20 | 79075371 |
Flour sensitivity | 11.07 | 10.06 | 5 | 668992 | 20 | 79075371 |
Tenosynovitis stenosans | 11.07 | 10.06 | 6 | 668991 | 3072 | 79072319 |
Retinal ischaemia | 11.06 | 10.06 | 22 | 668975 | 766 | 79074625 |
Renal artery thrombosis | 11.01 | 10.06 | 17 | 668980 | 482 | 79074909 |
Lymphopenia | 11.01 | 10.06 | 185 | 668812 | 30372 | 79045019 |
Hepatic failure | 11.00 | 10.06 | 411 | 668586 | 60801 | 79014590 |
Crush syndrome | 11.00 | 10.06 | 11 | 668986 | 197 | 79075194 |
Prostatomegaly | 10.99 | 10.06 | 58 | 668939 | 3425 | 79071966 |
Thromboangiitis obliterans | 10.97 | 10.06 | 6 | 668991 | 39 | 79075352 |
Ureteric cancer | 10.97 | 10.06 | 13 | 668984 | 284 | 79075107 |
Peritoneal dialysis | 10.95 | 10.06 | 23 | 668974 | 833 | 79074558 |
Basal ganglia stroke | 10.95 | 10.06 | 10 | 668987 | 159 | 79075232 |
Abnormal loss of weight | 10.95 | 10.06 | 113 | 668884 | 8263 | 79067128 |
Bone density abnormal | 10.95 | 10.06 | 6 | 668991 | 3054 | 79072337 |
Cardiac pacemaker insertion | 10.94 | 10.06 | 85 | 668912 | 5737 | 79069654 |
Skin exfoliation | 10.87 | 10.06 | 566 | 668431 | 54534 | 79020857 |
Malignant neoplasm of renal pelvis | 10.85 | 10.06 | 9 | 668988 | 125 | 79075266 |
Hyperhidrosis | 10.80 | 10.06 | 1109 | 667888 | 150383 | 78925008 |
Renal mass | 10.80 | 10.06 | 56 | 668941 | 3284 | 79072107 |
Anorexia nervosa | 10.79 | 10.06 | 12 | 668985 | 244 | 79075147 |
Respiratory failure | 10.79 | 10.06 | 1702 | 667295 | 179209 | 78896182 |
Electrocardiogram U wave present | 10.79 | 10.06 | 9 | 668988 | 126 | 79075265 |
Breast cancer | 10.76 | 10.06 | 209 | 668788 | 33572 | 79041819 |
Lacrimal disorder | 10.76 | 10.06 | 17 | 668980 | 492 | 79074899 |
Polycystic liver disease | 10.75 | 10.06 | 10 | 668987 | 163 | 79075228 |
Necrotising myositis | 10.72 | 10.06 | 29 | 668968 | 1239 | 79074152 |
Leukaemic infiltration renal | 10.70 | 10.06 | 5 | 668992 | 22 | 79075369 |
Biopsy kidney | 10.65 | 10.06 | 10 | 668987 | 165 | 79075226 |
Affective disorder | 10.64 | 10.06 | 35 | 668962 | 8284 | 79067107 |
Nausea | 10.63 | 10.06 | 7623 | 661374 | 949573 | 78125818 |
Henoch-Schonlein purpura | 10.61 | 10.06 | 48 | 668949 | 2662 | 79072729 |
Leukaemia recurrent | 10.58 | 10.06 | 5 | 668992 | 2769 | 79072622 |
Stent malfunction | 10.58 | 10.06 | 7 | 668990 | 67 | 79075324 |
Vulvovaginal pruritus | 10.58 | 10.06 | 47 | 668950 | 2586 | 79072805 |
Foot operation | 10.55 | 10.06 | 20 | 668977 | 5713 | 79069678 |
Hyperkaliuria | 10.51 | 10.06 | 10 | 668987 | 168 | 79075223 |
Apical granuloma | 10.50 | 10.06 | 6 | 668991 | 43 | 79075348 |
Splenic cyst | 10.49 | 10.06 | 12 | 668985 | 252 | 79075139 |
Drug dose omission by device | 10.48 | 10.06 | 23 | 668974 | 6227 | 79069164 |
Tic | 10.48 | 10.06 | 6 | 668991 | 2980 | 79072411 |
Dactylitis | 10.47 | 10.06 | 5 | 668992 | 2752 | 79072639 |
Acute respiratory distress syndrome | 10.45 | 10.06 | 461 | 668536 | 43606 | 79031785 |
Erysipelas | 10.45 | 10.06 | 138 | 668859 | 10712 | 79064679 |
Microscopic polyangiitis | 10.45 | 10.06 | 15 | 668982 | 398 | 79074993 |
Occult blood | 10.41 | 10.06 | 35 | 668962 | 1688 | 79073703 |
Pneumonia cytomegaloviral | 10.37 | 10.06 | 16 | 668981 | 4953 | 79070438 |
Hyperplastic cholecystopathy | 10.36 | 10.06 | 11 | 668986 | 212 | 79075179 |
Pneumothorax traumatic | 10.35 | 10.06 | 12 | 668985 | 256 | 79075135 |
Back pain | 10.34 | 10.06 | 2326 | 666671 | 301854 | 78773537 |
Chest discomfort | 10.33 | 10.06 | 1316 | 667681 | 136728 | 78938663 |
Transaminases increased | 10.31 | 10.06 | 343 | 668654 | 51400 | 79023991 |
Fluid intake reduced | 10.30 | 10.06 | 89 | 668908 | 6199 | 79069192 |
Post procedural pneumonia | 10.28 | 10.06 | 9 | 668988 | 135 | 79075256 |
Prostatic operation | 10.27 | 10.06 | 12 | 668985 | 258 | 79075133 |
Hallucination, visual | 10.27 | 10.06 | 353 | 668644 | 32376 | 79043015 |
Pyelonephritis acute | 10.27 | 10.06 | 86 | 668911 | 5937 | 79069454 |
Blepharospasm | 10.26 | 10.06 | 21 | 668976 | 5830 | 79069561 |
Acute myeloid leukaemia recurrent | 10.25 | 10.06 | 8 | 668989 | 3375 | 79072016 |
Rebound effect | 10.24 | 10.06 | 29 | 668968 | 7197 | 79068194 |
Brain contusion | 10.24 | 10.06 | 30 | 668967 | 1343 | 79074048 |
Large cell lung cancer metastatic | 10.23 | 10.06 | 4 | 668993 | 10 | 79075381 |
Bifascicular block | 10.22 | 10.06 | 14 | 668983 | 355 | 79075036 |
Extremity necrosis | 10.22 | 10.06 | 53 | 668944 | 3108 | 79072283 |
Lichenification | 10.22 | 10.06 | 22 | 668975 | 811 | 79074580 |
Crying | 10.21 | 10.06 | 134 | 668863 | 22909 | 79052482 |
Blood pressure difference of extremities | 10.20 | 10.06 | 5 | 668992 | 25 | 79075366 |
Systemic candida | 10.19 | 10.06 | 26 | 668971 | 6680 | 79068711 |
Metastases to central nervous system | 10.18 | 10.06 | 88 | 668909 | 16287 | 79059104 |
Skin haemorrhage | 10.17 | 10.06 | 149 | 668848 | 11832 | 79063559 |
Granuloma skin | 10.14 | 10.06 | 41 | 668956 | 9133 | 79066258 |
Water intoxication | 10.14 | 10.06 | 21 | 668976 | 753 | 79074638 |
Foaming at mouth | 10.13 | 10.06 | 37 | 668960 | 1860 | 79073531 |
Product dispensing error | 10.13 | 10.06 | 162 | 668835 | 13101 | 79062290 |
Laryngeal cancer | 10.12 | 10.06 | 21 | 668976 | 754 | 79074637 |
Duodenal ulcer repair | 10.08 | 10.06 | 7 | 668990 | 73 | 79075318 |
Mitral valve thickening | 10.06 | 10.06 | 15 | 668982 | 412 | 79074979 |
None
Source | Code | Description |
---|---|---|
ATC | C07FB07 | CARDIOVASCULAR SYSTEM BETA BLOCKING AGENTS BETA BLOCKING AGENTS, OTHER COMBINATIONS Beta blocking agents and calcium channel blockers |
ATC | C07FB12 | CARDIOVASCULAR SYSTEM BETA BLOCKING AGENTS BETA BLOCKING AGENTS, OTHER COMBINATIONS Beta blocking agents and calcium channel blockers |
ATC | C07FB13 | CARDIOVASCULAR SYSTEM BETA BLOCKING AGENTS BETA BLOCKING AGENTS, OTHER COMBINATIONS Beta blocking agents and calcium channel blockers |
ATC | C08CA01 | CARDIOVASCULAR SYSTEM CALCIUM CHANNEL BLOCKERS SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS Dihydropyridine derivatives |
ATC | C08CA51 | CARDIOVASCULAR SYSTEM CALCIUM CHANNEL BLOCKERS SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS Dihydropyridine derivatives |
ATC | C08GA02 | CARDIOVASCULAR SYSTEM CALCIUM CHANNEL BLOCKERS CALCIUM CHANNEL BLOCKERS AND DIURETICS Calcium channel blockers and diuretics |
ATC | C09BB03 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ACE INHIBITORS, COMBINATIONS ACE inhibitors and calcium channel blockers |
ATC | C09BB04 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ACE INHIBITORS, COMBINATIONS ACE inhibitors and calcium channel blockers |
ATC | C09BB07 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ACE INHIBITORS, COMBINATIONS ACE inhibitors and calcium channel blockers |
ATC | C09BB13 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ACE INHIBITORS, COMBINATIONS ACE inhibitors and calcium channel blockers |
ATC | C09BX01 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ACE INHIBITORS, COMBINATIONS ACE inhibitors, other combinations |
ATC | C09BX03 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ACE INHIBITORS, COMBINATIONS ACE inhibitors, other combinations |
ATC | C09BX04 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ACE INHIBITORS, COMBINATIONS ACE inhibitors, other combinations |
ATC | C09DB01 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
ATC | C09DB02 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
ATC | C09DB04 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
ATC | C09DB05 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
ATC | C09DB06 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
ATC | C09DB07 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
ATC | C09DB09 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
ATC | C09DX01 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs), other combinations |
ATC | C09DX03 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs), other combinations |
ATC | C09DX06 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs), other combinations |
ATC | C09DX07 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs), other combinations |
ATC | C09DX08 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS Angiotensin II receptor blockers (ARBs), other combinations |
ATC | C09XA53 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM Renin-inhibitors |
ATC | C09XA54 | CARDIOVASCULAR SYSTEM AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM Renin-inhibitors |
ATC | C10BX03 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, COMBINATIONS Lipid modifying agents in combination with other drugs |
ATC | C10BX07 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, COMBINATIONS Lipid modifying agents in combination with other drugs |
ATC | C10BX09 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, COMBINATIONS Lipid modifying agents in combination with other drugs |
ATC | C10BX11 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, COMBINATIONS Lipid modifying agents in combination with other drugs |
ATC | C10BX14 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, COMBINATIONS Lipid modifying agents in combination with other drugs |
ATC | C10BX18 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, COMBINATIONS Lipid modifying agents in combination with other drugs |
ATC | C10BX19 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, COMBINATIONS Lipid modifying agents in combination with other drugs |
FDA CS | M0006414 | Dihydropyridines |
FDA MoA | N0000000069 | Calcium Channel Antagonists |
FDA EPC | N0000175421 | Dihydropyridine Calcium Channel Blocker |
FDA EPC | N0000175566 | Calcium Channel Blocker |
CHEBI has role | CHEBI:35620 | vasodilator agents |
CHEBI has role | CHEBI:35674 | antihypertensive drugs |
CHEBI has role | CHEBI:38215 | calcium channel blockers |
FDA MoA | N0000190114 | Cytochrome P450 3A Inhibitors |
MeSH PA | D000959 | Antihypertensive Agents |
MeSH PA | D002121 | Calcium Channel Blockers |
MeSH PA | D000077264 | Calcium-Regulating Hormones and Agents |
MeSH PA | D002317 | Cardiovascular Agents |
MeSH PA | D049990 | Membrane Transport Modulators |
MeSH PA | D014665 | Vasodilator Agents |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Hypertensive disorder | indication | 38341003 | DOID:10763 |
Prinzmetal angina | indication | 87343002 | |
Angina pectoris | indication | 194828000 | |
Cerebrovascular accident | indication | 230690007 | |
Primary Prevention of Coronary Heart Disease | indication | ||
Myocardial Infarction Prevention | indication | ||
Anuria | contraindication | 2472002 | DOID:2983 |
Alcoholism | contraindication | 7200002 | |
Hyperkalemia | contraindication | 14140009 | |
Jaundice | contraindication | 18165001 | |
Secondary angle-closure glaucoma | contraindication | 21571006 | |
Hypovolemia | contraindication | 28560003 | |
Obstruction of bile duct | contraindication | 30144000 | |
Dehydration | contraindication | 34095006 | |
Hyperuricemia | contraindication | 35885006 | DOID:1920 |
Hypothyroidism | contraindication | 40930008 | DOID:1459 |
Angioedema | contraindication | 41291007 | DOID:1558 |
Hypokalemia | contraindication | 43339004 | |
Diabetes mellitus type 2 | contraindication | 44054006 | DOID:9352 |
Low blood pressure | contraindication | 45007003 | |
Systemic lupus erythematosus | contraindication | 55464009 | DOID:9074 |
Sympathectomy | contraindication | 57071006 | |
Acute nephropathy | contraindication | 58574008 | |
Hepatic failure | contraindication | 59927004 | |
Hypercalcemia | contraindication | 66931009 | DOID:12678 |
Hyperparathyroidism | contraindication | 66999008 | DOID:13543 |
Hypochloremic alkalosis | contraindication | 70134007 | |
Hepatic coma | contraindication | 72836002 | DOID:12550 |
Diabetes mellitus | contraindication | 73211009 | DOID:9351 |
Chronic idiopathic constipation | contraindication | 82934008 | |
Hereditary angioneurotic edema | contraindication | 82966003 | DOID:14735 |
Hyponatremia | contraindication | 89627008 | |
Gout | contraindication | 90560007 | DOID:13189 |
Kidney disease | contraindication | 90708001 | DOID:557 |
Disorder of connective tissue | contraindication | 105969002 | DOID:65 |
Disorder of muscle | contraindication | 129565002 | DOID:423 |
Liver function tests abnormal | contraindication | 166603001 | |
Hypomagnesemia | contraindication | 190855004 | |
Acute pancreatitis | contraindication | 197456007 | DOID:2913 |
Impaired renal function disorder | contraindication | 197663003 | |
Hemorrhagic cerebral infarction | contraindication | 230706003 | |
Disease of liver | contraindication | 235856003 | DOID:409 |
Rhabdomyolysis | contraindication | 240131006 | |
Neonatal hyperbilirubinemia | contraindication | 281610001 | |
Pregnancy, function | contraindication | 289908002 | |
Renal artery stenosis | contraindication | 302233006 | |
Neutropenic disorder | contraindication | 303011007 | DOID:1227 |
Bone marrow depression | contraindication | 307762000 | |
Surgical procedure | contraindication | 387713003 | |
Breastfeeding (mother) | contraindication | 413712001 | |
Traumatic injury | contraindication | 417746004 | |
Azotemia | contraindication | 445009001 | |
Head and Neck Angioedema | contraindication | ||
Hemodialysis with High-Flux Membrane | contraindication | ||
Severe Aortic Valve Stenosis | contraindication | ||
Intestinal Angioedema | contraindication |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 9.0 | Basic |
pKa2 | 1.55 | Basic |
Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Patent number | Patent expiration date | Patent use |
---|---|---|---|---|---|---|---|---|---|---|
EQ 10MG BASE;14MG | PRESTALIA | ADHERA | N205003 | Jan. 21, 2015 | RX | TABLET | ORAL | 6696481 | April 15, 2023 | TREATMENT OF HYPERTENSION |
EQ 2.5MG BASE;3.5MG | PRESTALIA | ADHERA | N205003 | Jan. 21, 2015 | RX | TABLET | ORAL | 6696481 | April 15, 2023 | TREATMENT OF HYPERTENSION |
EQ 5MG BASE;7MG | PRESTALIA | ADHERA | N205003 | Jan. 21, 2015 | RX | TABLET | ORAL | 6696481 | April 15, 2023 | TREATMENT OF HYPERTENSION |
EQ 10MG BASE;200MG | CONSENSI | PURPLE BIOTECH | N210045 | May 31, 2018 | DISCN | TABLET | ORAL | 9662315 | May 22, 2029 | TREATMENT OF ADULT PATIENTS FOR WHOM TREATMENT WITH BOTH AMLODIPINE FOR HYPERTENSION AND CELECOXIB FOR OSTEOARTHRITIS ARE APPROPRIATE |
EQ 2.5MG BASE;200MG | CONSENSI | PURPLE BIOTECH | N210045 | May 31, 2018 | DISCN | TABLET | ORAL | 9662315 | May 22, 2029 | TREATMENT OF ADULT PATIENTS FOR WHOM TREATMENT WITH BOTH AMLODIPINE FOR HYPERTENSION AND CELECOXIB FOR OSTEOARTHRITIS ARE APPROPRIATE |
EQ 5MG BASE;200MG | CONSENSI | PURPLE BIOTECH | N210045 | May 31, 2018 | DISCN | TABLET | ORAL | 9662315 | May 22, 2029 | TREATMENT OF ADULT PATIENTS FOR WHOM TREATMENT WITH BOTH AMLODIPINE FOR HYPERTENSION AND CELECOXIB FOR OSTEOARTHRITIS ARE APPROPRIATE |
EQ 10MG BASE;14MG | PRESTALIA | ADHERA | N205003 | Jan. 21, 2015 | RX | TABLET | ORAL | 7846961 | Oct. 5, 2029 | TREATMENT OF HYPERTENSION |
EQ 2.5MG BASE;3.5MG | PRESTALIA | ADHERA | N205003 | Jan. 21, 2015 | RX | TABLET | ORAL | 7846961 | Oct. 5, 2029 | TREATMENT OF HYPERTENSION |
EQ 5MG BASE;7MG | PRESTALIA | ADHERA | N205003 | Jan. 21, 2015 | RX | TABLET | ORAL | 7846961 | Oct. 5, 2029 | TREATMENT OF HYPERTENSION |
EQ 10MG BASE;200MG | CONSENSI | PURPLE BIOTECH | N210045 | May 31, 2018 | DISCN | TABLET | ORAL | 9408837 | Feb. 28, 2030 | TREATMENT OF ADULT PATIENTS FOR WHOM TREATMENT WITH BOTH AMLODIPINE FOR HYPERTENSION AND CELECOXIB FOR OSTEOARTHRITIS ARE APPROPRIATE |
EQ 2.5MG BASE;200MG | CONSENSI | PURPLE BIOTECH | N210045 | May 31, 2018 | DISCN | TABLET | ORAL | 9408837 | Feb. 28, 2030 | TREATMENT OF ADULT PATIENTS FOR WHOM TREATMENT WITH BOTH AMLODIPINE FOR HYPERTENSION AND CELECOXIB FOR OSTEOARTHRITIS ARE APPROPRIATE |
EQ 5MG BASE;200MG | CONSENSI | PURPLE BIOTECH | N210045 | May 31, 2018 | DISCN | TABLET | ORAL | 9408837 | Feb. 28, 2030 | TREATMENT OF ADULT PATIENTS FOR WHOM TREATMENT WITH BOTH AMLODIPINE FOR HYPERTENSION AND CELECOXIB FOR OSTEOARTHRITIS ARE APPROPRIATE |
EQ 10MG BASE;200MG | CONSENSI | PURPLE BIOTECH | N210045 | May 31, 2018 | DISCN | TABLET | ORAL | 10925835 | June 14, 2038 | TREATMENT OF ADULT PATIENTS FOR WHOM TREATMENT WITH BOTH AMLODIPINE FOR HYPERTENSION AND CELECOXIB FOR OSTEOARTHRITIS ARE APPROPRIATE |
EQ 2.5MG BASE;200MG | CONSENSI | PURPLE BIOTECH | N210045 | May 31, 2018 | DISCN | TABLET | ORAL | 10925835 | June 14, 2038 | TREATMENT OF ADULT PATIENTS FOR WHOM TREATMENT WITH BOTH AMLODIPINE FOR HYPERTENSION AND CELECOXIB FOR OSTEOARTHRITIS ARE APPROPRIATE |
EQ 5MG BASE;200MG | CONSENSI | PURPLE BIOTECH | N210045 | May 31, 2018 | DISCN | TABLET | ORAL | 10925835 | June 14, 2038 | TREATMENT OF ADULT PATIENTS FOR WHOM TREATMENT WITH BOTH AMLODIPINE FOR HYPERTENSION AND CELECOXIB FOR OSTEOARTHRITIS ARE APPROPRIATE |
EQ 1MG BASE/ML | NORLIQVA | CMP DEV LLC | N214439 | Feb. 24, 2022 | RX | SOLUTION | ORAL | 11253474 | Feb. 24, 2041 | NORLIQVA IS INDICATED FOR THE SYMPTOMATIC TREATMENT OF CHRONIC STABLE ANGINA |
EQ 1MG BASE/ML | NORLIQVA | CMP DEV LLC | N214439 | Feb. 24, 2022 | RX | SOLUTION | ORAL | 11253474 | Feb. 24, 2041 | NORLIQVA IS INDICATED FOR THE TREATMENT OF CONFIRMED OR SUSPECTED VASOSPASTIC ANGINA |
EQ 1MG BASE/ML | NORLIQVA | CMP DEV LLC | N214439 | Feb. 24, 2022 | RX | SOLUTION | ORAL | 11253474 | Feb. 24, 2041 | NORLIQVA IS INDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER |
EQ 1MG BASE/ML | NORLIQVA | CMP DEV LLC | N214439 | Feb. 24, 2022 | RX | SOLUTION | ORAL | 11458095 | Feb. 24, 2041 | NORLIQVA IS INDICATED FOR THE SYMPTOMATIC TREATMENT OF CHRONIC STABLE ANGINA |
EQ 1MG BASE/ML | NORLIQVA | CMP DEV LLC | N214439 | Feb. 24, 2022 | RX | SOLUTION | ORAL | 11458095 | Feb. 24, 2041 | NORLIQVA IS INDICATED FOR THE TREATMENT OF CONFIRMED OR SUSPECTED VASOSPASTIC ANGINA |
EQ 1MG BASE/ML | NORLIQVA | CMP DEV LLC | N214439 | Feb. 24, 2022 | RX | SOLUTION | ORAL | 11458095 | Feb. 24, 2041 | NORLIQVA IS INDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER |
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Voltage-dependent L-type calcium channel subunit alpha-1C | Ion channel | BLOCKER | WOMBAT-PK | CHEMBL | |||||
Voltage-dependent L-type calcium channel subunit alpha-1D | Ion channel | BLOCKER | Ki | 7 | WOMBAT-PK | CHEMBL | |||
Alpha-1A adrenergic receptor | GPCR | Ki | 5.63 | CHEMBL | |||||
Aldehyde oxidase | Enzyme | IC50 | 5.26 | WOMBAT-PK | |||||
Alpha-2C adrenergic receptor | GPCR | Ki | 6.58 | DRUG MATRIX | |||||
Sodium-dependent dopamine transporter | Transporter | Ki | 5.36 | DRUG MATRIX | |||||
Alpha-1D adrenergic receptor | GPCR | Ki | 5.27 | CHEMBL | |||||
Alpha-1B adrenergic receptor | GPCR | Ki | 5.10 | CHEMBL | |||||
Voltage-dependent calcium channel gamma-1 subunit | Ion channel | Ki | 7.20 | WOMBAT-PK | |||||
Carbonic anhydrase 1 | Enzyme | WOMBAT-PK | |||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 | Ion channel | Ki | 7.20 | WOMBAT-PK | |||||
Voltage-dependent T-type calcium channel subunit alpha-1H | Ion channel | Ki | 4.51 | WOMBAT-PK | |||||
Potassium channel subfamily K member 2 | Ion channel | IC50 | 6.40 | CHEMBL | |||||
Alpha-2A adrenergic receptor | GPCR | Ki | 6.65 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 6 | GPCR | Ki | 5.87 | DRUG MATRIX | |||||
Voltage-dependent L-type calcium channel subunit alpha-1C | Ion channel | Ki | 8.70 | CHEMBL | |||||
Potassium channel subfamily K member 2 | Ion channel | IC50 | 6.37 | CHEMBL |
ID | Source |
---|---|
4020813 | VUID |
N0000148333 | NUI |
D00615 | KEGG_DRUG |
111470-99-6 | SECONDARY_CAS_RN |
104416 | RXNORM |
C0051696 | UMLSCUI |
CHEBI:2669 | CHEBI |
06X | PDB_CHEM_ID |
CHEMBL1491 | ChEMBL_ID |
CHEMBL1200402 | ChEMBL_ID |
D017311 | MESH_DESCRIPTOR_UI |
DB00381 | DRUGBANK_ID |
2162 | PUBCHEM_CID |
6981 | IUPHAR_LIGAND_ID |
5729 | INN_ID |
88150-47-4 | SECONDARY_CAS_RN |
246852-12-0 | SECONDARY_CAS_RN |
1J444QC288 | UNII |
108736 | MMSL |
173594 | MMSL |
23944 | MMSL |
27341 | MMSL |
4180 | MMSL |
d00689 | MMSL |
108537001 | SNOMEDCT_US |
1193663008 | SNOMEDCT_US |
384976003 | SNOMEDCT_US |
386864001 | SNOMEDCT_US |
421048000 | SNOMEDCT_US |
CHEMBL1200984 | ChEMBL_ID |
4020586 | VANDF |
4020813 | VANDF |
003672 | NDDF |
003673 | NDDF |
008599 | NDDF |
015579 | NDDF |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Norvasc | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0069-1520 | TABLET | 2.50 mg | ORAL | NDA | 26 sections |
Norvasc | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0069-1520 | TABLET | 2.50 mg | ORAL | NDA | 26 sections |
Norvasc | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0069-1520 | TABLET | 2.50 mg | ORAL | NDA | 26 sections |
Norvasc | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0069-1530 | TABLET | 5 mg | ORAL | NDA | 26 sections |
Norvasc | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0069-1530 | TABLET | 5 mg | ORAL | NDA | 26 sections |
Norvasc | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0069-1530 | TABLET | 5 mg | ORAL | NDA | 26 sections |
Norvasc | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0069-1540 | TABLET | 10 mg | ORAL | NDA | 26 sections |
Norvasc | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0069-1540 | TABLET | 10 mg | ORAL | NDA | 26 sections |
Norvasc | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0069-1540 | TABLET | 10 mg | ORAL | NDA | 26 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2150 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2150 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2150 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2150 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2160 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2160 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2160 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2160 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2170 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2170 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2170 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2170 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2180 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2180 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2180 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2180 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2190 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2190 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2190 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2190 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Caduet | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0069-2250 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |